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Stress is commonly defined as the response to a non-specific situation presenting 
a psychological and/or physical challenge. In order to react in an appropriate 
manner to environmental threats the body will trigger a wide range of defence 
mechanisms. However cases where challenges are sustained and the individual 
does not have the ability to cope with the stress are nowadays believed to be a 
main factor for the onset and exacerbation of a broad range of disorders. Among 
these are psychiatric disorders such as depression but also pain affections. Pain 
is described by the International Association for the study of Pain (IASP) as an 
unpleasant sensory and emotional experience associated with actual or potential 
tissue damage. As for stress, this system aiming at preserving the body integrity 
can become defective and enhance pain sensitivity or foster the development of 
chronic pain. These two health problems categories each represent a 
considerable issue of public health. Indeed the World Health Organization 
(WHO) estimates that 27% of the European adult population had experienced at 
least one episode of mental disorder and the IASP reported that 19% of the pan-
European population experienced chronic pain (Macfarlane, Pain 2016). 
Furthermore, chronic pain and stress-related disorders are greatly comorbid, 
having deleterious effects on the efficacy of treatments. Despite the raising 
awareness of clinical and pre-clinical research on their overlapping pathways, 
common mediators and interactions, the nature of the relationship between 
chronic pain conditions and stress-related disorders is not yet elucidated.  
The studies I undertook during my Ph.D. aimed to understand how chronic 
stress, with an emphasis on early-life stress, is linked to altered nociceptive 
transmission and to modified chronic pain vulnerability. Early life stress (ELS) 
was of particular interest as this period of life is subjected to an intense neuronal 
plasticity of notably stress and pain systems. Furthermore it is increasingly 
accepted that early life factors are linked to the susceptibility to develop chronic 
pain conditions in adulthood. As pain is a multidimensional system, I had to 
restrict my studies to one of the relay stations for the transmission of pain. In the 
Chapter I: Preface
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context of chronic stress, most of the work was done on the brain circuits 
underlying the affective part of pain but little is known about the effect of 
chronic pain on spinal nociceptive processes. Since chronic stress is a broad 
phenomenon altering not only processing at the brain level, I focused my studies 
on spinal dorsal horn noxious transmission.  
The first stage of my work was to assess the impact of ELS on neuropathic pain, 
a type of chronic pain arising from nerve lesions. In a second step, I sought to 
determine if the results obtained in this first study were specific to the type of 
pain (neuropathic) or also were valid for another type of chronic pain, e.g. 
chronic inflammatory pain. The third study aimed to determine if ELS would 
predispose to enhanced vulnerability to stress exposure later in life and to 
concomitant alterations of chronic pain. To finish, during the last year of my 
Ph.D. I investigated the possible mechanisms underlying the behavioural results 
using pharmacological manipulations and initiated a separate project devoted to 
in vivo electrophysiological characterization of the response behaviour of 
nociceptive spinal dorsal horn neurons.  
In the following introduction, I will give an overview of the stress systems, 
focusing on the hypothalamo-pituitary adrenal (HPA) axis and early life stress. 
Then I will outline the different part of the pain system and concepts of central 
sensitization involved in chronic pain.  
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2.1. Introduction 
Stress is a term used in order to define an emotionally and/or physically 
challenging situation. This possible challenge will be interpreted by the 
amygdala that will in turn signal the hypothalamus for a coordinated response. 
The perceived threat will hence induce a so-called “fight or flight” response of 
the organism by promoting a hallmark of physiological and behavioral 
adaptations primarily due to an activation of the sympathetic nervous system 
(SNS). In case where the stress is prolonged, an adaptation syndrome will be 
triggered involving in this case the endocrine system and the hypothalamo-
pituitary adrenal axis.  
In chapter II, I will briefly describe the role of sympathetic nervous system 
during stressful events and I will then focus on the HPA axis and its implication 
in chronic stress. 
2.2. Sympathetic nervous system: 
The sympathetic and the parasympathetic nervous systems are the two main 
functional subdivisions of the autonomous nervous system (ANS). They both 
regulate the function of a multitude of tissues. As they often have opposite 
effects, the activation of one will decrease the activity of the other on a given 
tissue. During stressful events, the sympathetic nervous system is predominantly 
activated resulting in the stimulation the adrenal medulla hence releasing 
adrenaline and noradrenaline into the blood stream. This leads to a whole body 
response comprising, among others, bronchial dilatation or increase of heart rate 
and contraction strength (for review McCorry 2007).  
The ANS and its two subdivisions have often been regarded as structures 
functioning independently from central nervous, endocrine or immune system. 
It is however now clear that the ANS interacts and regulates various 
physiological systems (Kenney and Ganta 2014). Many studies revealed a 
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crucial role of the ANS in mediating nervous and immune systems’ interactions 
(Elenkov et al., 2000; Helwig et al., 2007; Kang et al., 2008; 2009). The relay 
of information from the immune system to the CNS has be shown to be 
performed via two main pathways. The neural communication pathway involves 
mainly the vagal nerve that transmits peripheral immune signals to the brain 
(Maier et al., 1998). Non-neural mechanisms providing transmission of immune 
signals to the CNS are mainly related to the blood brain barrier (Banks and 
Erickson, 2010). Despite the different nature of the communication, both 
pathways largely depend on the actions of cytokines. These molecules are 
signaling proteins synthesized and release throughout the body by a wide variety 
of cells such as neurons, microglia, astrocytes and other immune cells (Galic et 
al., 2010). The sympathetic nervous system is of high biologic relevance during 
acute challenge. In physiological conditions, HPA and SNS work in concert to 
modulate the immune response (Niijma et al 1991; Borovikova et al., 2000). 
However an “uncoupling of SNS and HPA-axis” has been observed that during 
chronic pathological conditions and is thought to play an important role in the 
etiology of diseases (Straub et al., 2006). 
The first autonomic response generally subsides within several minutes, the 
hypothalamus triggers a second and more sustained bodily response: the HPA 
axis activation. Despite the importance of the ANS, the HPA axis is known to 
be largely responsible for long term adaptations, psychiatric disorders and 
vulnerability/resilience phenomenon (for reviews McEwen 2007; Krishnan et 
Nestler, 2007; Lupien et al, 2009; Daskalakis et al, 2013; McEwen 2017).   
2.3. Hypothalamo-pituitary adrenal axis 
The HPA axis is a central neuro-endocrine system mediating not only the stress 
response but also involved in the regulation of the immune system’s function, 
energy expenditure and storage rendering this structure an essential component 
for organisms’ homeostasis (Ulrich-Lai and Herman, 2009). As its name 
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indicates, this system is composed by three major structures: the hypothalamus 
that integrates information and orchestrates the response, the pituitary gland, 
capable to secrete and/or release hormones in the blood stream controlling many 
endocrine functions and finally the cortical part of the adrenal glands, the final 
effector capable of synthetizing steroid hormones.  
2.3.1. Description of the axis 
2.3.1.1. Hypothalamus 
The hypothalamus is a complex structure located in the anterior part of the 
diencephalon regrouping eleven major nuclei that can be regrouped based on 
their location in the hypothalamus regions and zones. The nucleus composing 
the hypothalamus can be regrouped in three sub-regions. The anterior region 
includes the supra-optic and paraventricular nucleus. The median region 
encompassing the mediodorsal, medioventral and the arcuate nucleus. The 
posterior region is composed by the dorsal hypothalamic area and the pre- and 
supra-mammilar nuclei.  
The periventricular zone is bordering the third ventricle. In this zone are located 
two important nuclei involved in neuroendocrine regulation: the arcuate and the 
paraventricular nucleus (PVN). The medial zone is adjoining to the 
periventricular zone and regroup several nuclei specialized in the autonomic and 
neuroendocrine systems. Finally, the lateral hypothalamus contains a large 
fibers pathway connecting the cerebral cortex and the spinal cord.  
Table 1 summarizes the different nucleus, zones, regions of the hypothamlmaus 
and their functions.  
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Table 1: Summary table of the repartition of the hypothalamic nuclei according to the zone and regions 
The regulation of the hypothalamic nuclei function is complex due to a multitude 
of neural and non-neural interconnections between the brain and the periphery. 
Indeed the hypothalamus regulates emotions and learning through its 
connections to limbic circuit structures such as amygdala and hippocampus. It 
also regulates feeding and insulin release via visceral and somatosensory input 
and output. Most importantly for my Ph.D. thesis framework, periventricular 
neurons connect to the median eminence where it can release corticotropin-
releasing hormone (CRH) and vasopressin (AVP) hormones into the 
hypothalamic-neurohypophyseal portal system (specialized region of the 
circulation consisting of two capillary beds directly connected by a set of blood 
vessels and linking these two structures) in order to control the hormone 
secretion of the anterior pituitary gland (Amett et al., 2016).   
2.3.1.2. Pituitary gland 
The pituitary gland is a neuroendocrine structure located in the sphenoid bone, 
at the skull basis and consisting in one anterior and one posterior lobe. The 
pituitary gland is linked to the brain by the infundibulum (or pituitary) stalk. The 
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posterior part of the pituitary gland is a site of storage and release of two 
neurohormones synthesized in hypothalamic nuclei, the vasopressin and 
oxytocin respectively controlling body water balance and parturition. 
Interestingly it was shown recently that oxytocin is also involved in social 
bonding, stress (Olff et al., 2013) and analgesia (Eliava et al., 2016) 
Contrary to the posterior pituitary gland, its anterior counterpart is a pure 
endocrine gland. However, the release of posterior pituitary hormones is still 
under control of the hypothalamic parvocellular neurons secreting releasing or 
release-inhibiting hormones from the arcuate, periventricular and supraoptic 
nuclei. Each releasing hormone will then target a specific cell group specialized 
in synthetizing one of the six anterior pituitary hormone (fig.1): 
- Lactotroph cells under the influence of prolactin releasing factors
(activators) and dopamine (inhibitor) will control the liberation of
prolactin (PRL)
- Growth hormone secretion is under the influence of somatostatin
(inhibitor) and the growth hormone-releasing hormone.
- Gonatrophins secretion, regrouping the luteinizing hormone (LH)
and the follicle-stimulating hormone (FSH), is controlled by the
gonadotropin releasing hormone (GnRH)
- The tyrotropin-releasing hormone (TRH) controls the secretion of the
thyroid stimulating hormone (TSH)
- Finally, CRH governs the release of adrenocorticotropic hormone
(corticotropin) (ACTH) in the blood stream in order to stimulate
glucocorticoid (GC) secretion.
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Figure 1: Schematic representation of the Hypothalamo-pituitary system. From Boron and Boulpaep, Medical 
physiology, second edition. 
Upon release in the median eminence CRH enter the hypophyseal blood portal 
to reach the anterior pituitary. The corticotroph cells capable of synthetizing 
ACTH express the CRH receptor at their membrane surface. The latter is a G-
coupled protein receptor (GPCR) that triggers the cAMP pathway. Upon binding 
of CRH on its receptors, intracellular concentration of cAMP is rising which in 
turn activates the protein kinase A (PKA). Hence, PKA stimulates L-type 
calcium channels leading to a general increase of intracellular concentration. 
This intracellular rise of calcium will lead to the exocytosis of ACTH in the 
blood stream. Interestingly, this also leads to the enhancement of 
proopiomelanocortin (POMC) gene expression. POMC is a large gene translated 
to several proteins such as ACTH and β-endorphin. β-endorphin is a 
neurotransmitter mainly found in the hypothalamus, pituitary gland and nucleus 
tractus solitaris (NTS), structures involved in stress and/or pain processing 
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(Mercer et al., 2013). β-endorphin has been proposed to have important 
ramifications for pain, stress and immune functions (Merenlender et al., 2009; 
Jessop, 1995). Indeed, the analgesic effect of CRH during acute stress (Lariviere 
and Melzack, 2000) is thought to be mediated by β-endorphin. Furthermore, 
peripheral inflammation and/or sustained stress have been shown to upregulate 
both CRH and β-endorphin in lymphocytes, thereby acting as anti-inflammatory 
and analgesic agent on the site of inflammation (Jessop et al., 1995). 
2.3.1.3. Adrenal glands 
The adrenal glands are located above the upper limit of each kidney in the 
retroperitoneal space. Each adrenal is composed of an inner medulla and an 
outer cortex (fig. 2).  
The adrenal medulla is composed by neuroendocrine cells, the chromaffin that 
derive from the neural crest and migrate into the center of the adrenal gland. 
Chromaffins synthetize and secrete catecholamines, especially adrenaline and 
to a lesser extent noradrenaline. The secretion of these catecholamines is 
principally regulated by acetylcholine released by preganglionic sympathetic 
fibers of the splanchnic nerve. Once in the general circulation, adrenaline and 
noradrenaline will have global impact on the organism regulating systemic 
arterial blood pressure, bronchial and pupil dilatation, the blood flow of active 
muscles etc.   
The outer part of the adrenal axis (adrenal cortex) is subdivided in three cellular 
layers. The external one, the glomerulosa layer is responsible for the synthesis 
of aldosterone, the main human mineralocorticoid. Its secretion is principally 
controlled by the angiotensin hormone in order to promote water retention by 
the kidneys. The two other layers, fasciculata (in the middle) and reticularis 
(near the medulla/cortex junction) contain specialized cells synthetizing the 
main glucocorticoid of the organism, cortisol, under the control of ACTH. 
Chapter II: Stress mechanisms
26 
Androgenic steroids are also secreted by adrenal cortex but they are to a large 
extent a byproduct of the production of cortisol.  
Figure 2: Location and structure of the Adrenal glands (https://www.yourhormones.com/adrenal-glands/)
At the cellular level, ACTH binds to the melanocrotin 2 receptor (MC2R) on 
every layer of the adrenal cortex. However, only the cells located in the 
fasciculata and reticularis layers contain the 17α-hydroxylase enzyme necessary 
in order to synthetize cortisol. MC2R is GPCR stimulating adenylate cyclase 
and hence triggers the cAMP pathway. The rapidly rising intracellular calcium 
stimulates the side chain cleavage (SCC) enzyme and enhances the conversion 
of cholesterol into pregnenolone, the rate-limiting step of cortisol synthesis. In 
the longer term, ACTH also increases the synthesis of several other proteins 
needed for cortisol synthesis.  
2.3.2. Glucocorticoids & glucocorticoid receptors: final effector  
The name GC was originally given because this steroid was recognized to 
elevate glucose plasma concentration. In Humans the main GC is cortisol but 
corticosterone (CORT) is its equivalent in rats. As for every steroid the two 
analogues derive from cholesterol and are therefore very similar, the only 
difference emerging from the lack of OH group in position 16. Cortisol is a 
hydrophilic compound and is therefore soluble in the plasma. However once it 
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reaches its target tissue, the steroid is still capable to cross the plasma membrane 
without requiring transporters. Cortisol can bind to the mineralocorticoid 
receptor (MR) and the glucocorticoid receptor (GR).  
MR has a higher affinity for GCs and is nearly saturated during the diurnal 
through of GC and in physiological conditions. As GR has a lower affinity for 
GCs, it is mainly bound during diurnal peaks and following an exposure to 
stress. GR belong to the superfamily of nuclear receptors and can exist as homo- 
or heterodimers. They contains six domains, from A to F (Turner and Muller, 
2005) (fig.3).  
- The A/B domain, located at the N-terminal extremity, represents the
transactivation domain 1 which is involved in the regulation of target
gene transcription
- The C domain or DBD (for DNA binding domain) allows the receptor
to bind to the DNA “zinc fingers” structures and also to form dimers.
- The D region, also called hinge, contains the nuclear localization
signal
- The domain E is responsible for hormone binding and, as the C
region, is involved in dimerization through a basic zipper region.
Similarly to the A/B region, it also bears the transactivation domain
2.
- The F domain of the GR, localized at the C-terminus end seems to
not have a known function yet.
Figure 3: Simplified representation of the GR domains. From Boron and Boulpaep, Medical physiology, second 
edition. 
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GRs are mainly located in the cytoplasm bound to a heat shock protein HSP90. 
Upon binding with GCs, HSP90 and GR segregate and the new GC/GR complex 
translocate in the nucleus. A dimerization is however necessary in order for GR 
to be functional. Once in the nucleus the GR/GC complex will bind to a target 
gene’s GRE (glucocorticoid response element) site where it can enhance or 
repress their expression. The majority of GC actions are through genomic 
regulation. This process is well-known in many somatic tissues such as:   
- The liver where GC upregulates the expression of enzymes involved in
the metabolism of amino acids
- In muscles, GCs promote the breakdown of protein hence supplying the
liver with amino acids
- In fat tissue, a similar process as in the muscles happen and favor the
degradation of fatty acids leading to higher plasmatic glucose
concentration.
More interesting in the framework of my Ph.D., GCs are increasingly considered 
due to their action on the immune system and the regulation of behaviors 
(Tronche et al., 1999; Silverman and Sternberg, 2012).  
Briefly, chronic inflammatory conditions such as asthma or rheumatoid arthritis 
involve the activation of many inflammatory and immune cells releasing 
multiple inflammatory proteins. The genomic upregulation of most of these 
inflammatory mediators requires the activation of the nuclear factor-кB (NF- 
кB) and the activator protein-1 (AP-1). The predominant effect of GCs is to 
interfere with this upregulation by reversing histone acetylation or bind to NF- 
кB (through non genomic effect) and to upregulate anti-inflammatory gene 
expression (Barnes, 2006).  
GCs also act on the CNS through genomic and non-genomic mechanisms. The 
role GCs play in the regulation of mood and behavior seems to be biphasic. For 
example, adequate levels of GCs protect against traumatic stress-induced 
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synapse remodeling in the basolateral amygdala (BlA) (Rao et al., 2012) while 
chronically elevated levels induce dendrite elongation (Mitra and Sapolsky, 
2008). Importantly, in the framework of the present work, it was demonstrated 
that spinal GRs contribute to the establishment of neuropathic hyperalgesia 
through genomic and non-genomic modulation of glutamatergic receptors and 
transporters (Wang et al., 2004, 2005, 2006). 
2.3.3. Regulation of the HPA axis: 
We saw above that cortisol is an essential hormone for the maintenance of 
homeostasis. As for most hormones, daily rhythm and environmental factors 
have the capacity to induce a surge. Therefore, it is essential that, after the loss 
of homeostasis, the organism brings back cortisol levels to its physiological 
range (allostasis). For this purpose, the HPA axis secretion is regulated by 
endocrine and neuronal higher CNS influences.  
Endocrine regulation includes: 
- In the corticotrophs of the anterior pituitary: cortisol binds to the
cytoplasmic GR and inhibits the synthesis of both CRH receptor and
ACTH via negative GRE sites (nGRE). Elevated plasmatic cortisol
levels also reduces ACTH release.
- In the paraventricular cells of the hypothalamus: Through similar
mechanisms as in the pituitary gland, cortisol inhibits the synthesis and
the release of CRH.
Neuronal regulation includes: 
- Catecholaminergic neurons of the nucleus of the solitary tract (NTS)
receiving inputs from cranial nerve from thoracic and abdominal viscera
and hence relaying sensory information to the PVN cells. NTS cells also
receive projections form limbic structures regulating behavioral
adaptations to stress such as prefrontal cortex (PFC) and amygdala.
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- Hypothalamic GABAergic neurons of the dorsomedial nucleus and
preoptic area are able to inhibit glucocorticoid surge after environmental
stress (Roland and Sawchenko, 1993; Cullinan, 2000). Also
hypothalamic neurons of the arcuate nucleus involved in allostasis have
been shown to possess the capacity to increase CRF, ACTH and
corticosterone levels (Smith and Vale, 2006).
- Limbic neurons also regulate the HPA axis activity and are thought to
have a role in the etiology of psychiatric disorders. Indeed, structures
such as the hippocampus and the prefrontal cortex have the capacity to
inhibit hypothalamic PVN cells (Jacobson and Sapolsky, 1991; Herman
et al., 2005). On the contrary amygdala projections have been shown to
activate the HPA axis. However, similarly to the hippocampus and the
PFC, the amygdala influence on the HPA axis seems to depend on
several factors such as the duration and the nature of the stressor.
Chapter II: Stress mechanisms
31 
Figure 4: Summary of the HPA axis functioning  
From Boron and Boulpaep, Medical physiology, second edition.  
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2.4. Chronic Stress 
Stress response is essential for an organism in order to adapt to changes of 
environment and to maintain homeostasis. However, environmental challenge 
can be sustained and lead to a failure to the organism to further cope. Hence, 
this system originally optimized to promote survival is dysregulated. This failure 
of allostasis also called “allostatic load” (McEwen and Stellar, 1993) is thought 
to be at the root of many pathologies due to the general repercussions on 
neuroendocrine, autonomic, metabolic and immune systems. Despite significant 
advances these last decades, the mechanisms by which environmental factors 
can trigger maladaptive responses remain poorly understood. Indeed, the 
elucidation of these mechanisms is of utmost complexity since many factors are 
interacting such as the nature (psychological or physical, sustained or transient, 
mild or intense etc…) and the temporal aspects (prenatal, postnatal, adolescence, 
adulthood) of the stressor will determine how an organism responds depending 
on past experience, sex, genetics background etc...  
The immune system is very sensitive to stress modulation. Indeed, although an 
acute stressor can trigger an immune response via catecholamines and 
glucocorticoids in order to fight infection (Dhabhar, 2009; Dhabhar et al., 2012), 
the sustained exposition to a stressor may result in immune suppression 
(McEwen, 2017). Nevertheless, it should be noted that immune suppression may 
not only be deleterious. Thus, it can be beneficial in cases of auto-immune 
disorders while deleterious during infection. Also, robust evidences show that 
activation of the immune system in circumstances such as peripheral 
inflammation can activate neuro-endocrine stress-related structures (Butts and 
Sternberg. 2008). Hence, neuroendocrine maladaptation such as dysfunction of 
the HPA axis observed during chronic stress-related pathological states have 
been shown to play a critical role in the physiopathology of diseases.  
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2.4.1. Early life stress 
2.4.1.1. Introduction 
The maladaptation that living organisms undergo during chronic stress periods 
largely depends on neuroplastic changes. The HPA axis is a structure highly 
sensitive to reprogramming during the neonatal period. Therefore, given the 
importance of the HPA axis for the integration of the stress and the stress 
response, it seems logical that early adverse experiences alters behaviors and 
brain structures as seen in depression or stress related disorders. It was proposed 
recently by Heim and colleagues (2008), that maltreatments during childhood 
sensitize neurobiological systems involved in the stress response and enhance 
the risk to develop depression. For example, it was later shown that physical 
stressors such as harsh corporal punishment (Tomoda et al, 2009) or emotional 
(Van Harmelen et al, 2010) stressors occurring during childhood are linked with 
reduced frontal cortex volume in adults as well as with suffering from depression 
and/or anxiety disorders. Other structures important for stress response and 
adaptations have been implicated in early life stress and later depression such as 
the hippocampus, the amygdala and the HPA axis (for review McCrory et al, 
2011). Human data on the HPA axis alterations are mixed. Indeed, increased 
cortisol, ACTH and CRH have been reported in maltreated children but mostly 
when associated with depression (Kaufman et al, 1991; 1997). However this was 
also seen in non-maltreated children displaying affective disorders (Tarullo and 
Gunnar 2006). In adults, a loss of adequate HPA axis regulatory negative 
feedback loop was reported in depressed men that underwent maltreatment 
during infancy (Heim et al., 2008). On the other hand, post-traumatic stress 
disorder (PTSD) in the context of childhood abuse has been associated with low 
cortisol levels (Meewisse et al. 2007). Therefore, despite the clear link between 
a dysregulation of the HPA axis and consequences of early life stress, it seems 
yet not clear what distinct pattern of adaptations there is. Despite much work 
ahead to do, fundamental research has already determined several mechanisms 
Chapter II: Stress mechanisms
34 
by which early life stress affects emotional regulation and neuroendocrine 
functions. Indeed, excitotoxicity (Pickering et al., 2006), oxidative stress (Diehl 
et al., 2012) and inflammation (O’Mahony et al., 2009; Roque et al., 2015; 
Green et al., 2011) were implicated.  
2.4.1.2. Interaction with the immune system 
The first studies linking early life adversity to altered immune system were 
conducted in the 1980s (Coe et al., 1988; Coe and Laudenslager, 2007). It is 
now established that one of the major effect of early life stress is to cause an 
immediate as well as delayed and prolonged alterations of the immune response 
as seen in Human and rodents (Carpenter et al., 2010; Roque et al., 2015).  
Apart from its well-known involvement in host defense against infections, the 
immune system also has a capital role for maintaining homeostasis and 
behaviors notably through its interaction with the CNS. For instance, sickness 
behavior is characterized by reduced food and water intake, exploration, social 
and sexual interaction. This state is coordinated by the immune and nervous 
system in order to promote host survival and arises from the activity of 
immunocompetent cells such as microglia or astrocytes and their interaction 
with the brain via cytokines (Bilbo and Schwarz, 2009). Furthermore, recent 
advances have established that on top of their capacity to modulate behavior 
during acute illness, cytokines and glial cells also have a role in the 
establishment and perpetuation of CNS alterations (Dantzer 2010)    
Due to ethical considerations, few human studies have investigated the impact 
of early life adversity on immunological markers in infants. However, the short 
delay consequence of adverse life conditions during childhood seems to be a 
heightened immune system responsivity as shown by increased C reactive 
protein and interleukin-6 levels (Slopen et al., 2013; Miller et al., 2011). In 
humans, this enhanced immune system responsivity seems to be maintained in 
adults (Carpenter et al., 2010; Lacey et al., 2013; 2014; Tiejen et al., 2012). Even 
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though sensitized immune responses could represent an adaptive advantage (e.g. 
better response to infection or injury), many clinical studies provided evidence 
of the association with an amplified immune response in early life and later 
alteration of the CNS in relation with pathologies such as schizophrenia and 
Parkinson’s disease (for reviews Ganguly and Brenhouse 2015).  
2.4.1.3. Animal models and studies 
The first reports suggesting that early life experiences are shaping individuals’ 
future life can be traced back to the beginning of the 20th century as Freud 
describes the formation of behavioral or psychological symptoms (what he 
called neurosis) as a result of repressed impulses often built during infancy. It is 
only later in the 1950s that first experimental evidence started supporting the 
hypothesis that childhood experiences, and especially aversive ones, could have 
long lasting psychological and neuro-endocrine consequences (Weininger, 
1954). Early experiments determined then that the HPA axis plays a major role 
in the potential repercussions of early life adversity. The development of 
primates and rodents’ HPA axis present extensive similarities, hence rodents 
have been used as a model to understand how an alteration of the HPA axis can 
modulate brain functions and behaviors for life. Even though experimental 
models using rodents are very useful, the respective paradigms may not 
completely correspond to human conditions and results must interpreted with 
caution. Indeed, while humans are born with a functional HPA axis, its 
development is still going on in newborn rats. As a consequence, a stress during 
the first week of rodent’s life does not mimic a stress during the same period in 
humans but rather match a stress during the third trimester of gestation (Lupien 
et al., 2009).  In these animals, the HPA axis is not activated following mild 
stress during the first 2 weeks of life. First termed stress non-responsive period 
(SNRP) (Schapiro, 1962), this sensitive interval of time was later better defined 
by the pioneers Seymour Levine (Levine, 1967) and later by Robert M. Sapolsky 
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and Micheal J. Meaney (1986) as a stress hypo-responsiveness (SHRP) rather 
than a non-responsive period. SHRP ranges from postnatal days (PND) 1 to 10 
in mice and 3 to 14 in rats and is characterized by lower baseline glucocorticoid 
plasma levels than normal and by attenuated corticosterone secretion following 
the exposition to a stressor (De Kloet et Daskalakis, 2012; Schmidt, 2010).  
Several hypotheses have been advanced to explain why the HPA axis is hypo 
responsive at birth such as immature hypothalamic neuronal connections (De 
Kloet et al., 1988), an impairment of the CRF cascade (synthesis, release, 
transport) (Grino et al., 1989), or enhanced negative feedback (Walker et al., 
1986). However it seems that the strongest inhibitory factor comes from the 
reduced response of the adrenals to ACTH (Rosenfeld, 1991). Despite 
remaining uncertainties, researcher have now established that maternal presence 
and care is a key regulator of HPA axis hypo-responsiveness during the first 2 
weeks of rodent’s life. Hence, the main models of early life stress in rodents are 
capitalizing on these conclusions and removing the pups from their dam has 
become a standard method. Several variations of maternal separation (MS) exist, 
mostly relying on the period at which the separation is done (number of days 
and PND), the length of these separations (from 2~3 hours to 24 hours) and 
whether the pups are separated all together or separately from the dam 
(deprivation). Furthermore, accumulating data show that small variations of 
protocols can greatly impact the outcome (good example of MS variations on 
BDNF levels see Daskalakis et al., 2015). Nevertheless, two maternal separation 
paradigms may be differentiated, a model using prolonged maternal separation, 
often at one specific day during the SHRP and a model using repeated shorter 
maternal separations done on several consecutive days during the SHRP.  
Evidence shows that one long MS (also called maternal deprivation) during the 
SHRP is sufficient to activate the HPA axis. Consequently neonates display 
elevated basal and stress-induced CORT levels (Stanton et al., 1988) and reduce 
the amount of CRH binding site in the pituitary gland (Anisman et al., 1998). 
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Also the consequences of prolonged MS are not limited to the HPA axis since it 
increases the density of CRH receptors in many other brain areas such as the 
PFC, the amygdala, and the hippocampus. These effects will then lead to 
enhanced anxiety mostly through an enhancement of HPA axis activity (Roceri 
et al., 2002; Fenoglio et al., 2006; Schulkin et al., 1998, Daskalakis et al., 2015). 
On the contrary, a single episode of short MS (up to 3 hours) does not lead to a 
direct HPA axis activation. Only a daily MS is capable to induce a sensitization 
of the HPA axis response and the resulting plasma CORT and ACTH elevation 
following exposition to the stressor (Lippman et al., 2007; Huot et al., 2002; 
Francis et al., 2002). Similarly to the protracted maternal separation paradigm, 
the short repeated MS-induced alterations extend beyond the HPA axis. Indeed, 
altered BDNF protein expression was noted in the cortex, amygdala, ventral 
tegmental area (VTA), hippocampus, nucleus accumbens (Nac) and striatum 
(Lippman et al., 2007). It has also been demonstrated that, following short MS, 
hippocampal astrocytic but not microglial density was decreased coupled with 
an enhanced microglial activity and increased IL-1β. In the hypothalamus, other 
pro-inflammatory cytokines, TN-α and IL-6, saw their levels increase (Roque et 
al., 2015).  
Overall, despite common alterations in different brain areas, it is very difficult 
to draw a uniform consequence of early life stress. Indeed, the multiplicity of 
studies and different paradigms used in fundamental research indicates that 
every protocol should be very carefully compared with existing literature. 
Nevertheless, research indicates that MS-induced perinatal programming 
modulates immune and central nervous systems which can have life-long 
repercussions on anxious and noxious behaviors (Kalinichev et al., 2001; 
Weaver et al., 2007; Hennessy et al., 2011; Chocyk et al., 2011; Diehl et al., 
2012; Rana et al., 2015). Therefore, in order to understand how early life stress 
experiences can predispose individuals to develop chronic pain disorders, 
further studies remain essential.  
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2.4.2. Adult social stress 
2.4.2.1. Introduction 
In addition to the stressful events occurring during perinatal and peri-
adolescence periods, those taking place at adulthood can also lead to enhanced 
probability to develop diseases. From an evolutionary perspective, civilizations 
have at least partly developed in order to provide social structures ensuring 
survival of the individual and hence also of the society. Hence, stable societies 
aim to reduce threats that could lead to potential harm or stress. In this context, 
set of rules maintaining social cohesion are established. They are often dynamic 
and require individuals to adapt to them. Consequently, some circumstances 
such as isolation, social inequalities (poverty), loss of a loved one, bullying or 
other forms of psychological or physical abuse but also environmental factors 
can be important sources of stress and have been associated with high levels of 
violence in human society (Gilbert, 2000; Bushman et al., 2005; Kennedy et 
Adolphs, 2012). On the other hand, stress-related illnesses (from social origins 
or not) are often associated with dysfunctional social behaviors (Rygula et al., 
2005). Indeed, clinical studies have reported that PTSD or depression is often 
associated with reduced social motivation due to enhanced anxiety and group 
avoidance but also anger and violence when facing stressful situations (Nitesh 
et al., 2007; Baddeley et al., 2012).  
2.4.2.2. Animal models 
Similarly to human beings that generally live in close proximity to conspecifics, 
rodents are living in groups and hence are subjected to stress from social nature 
(e.g. during the establishment of hierarchy). Early studies established that one 
of the greatest stress sources of social origin comes from either fighting for 
control and/or losing control (Barnett, 1958; 1964). The analogy to human social 
stressors led scientists to develop several experimental procedures aiming to 
mimic behavioral and biological alterations leading to enhanced vulnerability. 
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Hence, scientists have used two main experimental paradigms in order to evoke 
pronounced psycho-social stress: the chronic social defeat and the resident-
intruder paradigm (Berton et al., 2006; Barik et al., 2013; for review Salttery 
and Cryan, 2014; Koolhaas et al., 2017). In order to create emotional stress the 
models use violent social interactions that are often due to the establishment of 
dominance hierarchy (Pryce and Fuchs, 2016). Classically these paradigms are 
based on the encounter of two foreign individuals (rats, mice or tree shrews) in 
the home cage of one of the two. The resulting fight will give rise to a winner 
and a looser (often the intruder). Biologically, both rodents are undergoing a 
strong stressful situation associated with HPA axis activation and the resulting 
plasma corticosterone elevation (Koolhaas et al., 2017). However, the outcome 
of the conflict is going to determine the subsequent impact. Indeed, the HPA 
axis recovery of a submissive individual will be much slower (Koolhaas et al., 
2011). The weaker negative feedback originates from the uncontrollability of 
the situation (Swenson et Vogel, 1983) and is mediated in part by non-genomic 
actions of GC through MR and GR (De Kloet et al., 2008). The lack of control 
experienced by a submissive individual is often considered as aversive. 
Interestingly however, the control of a group can also be a stressor. Indeed, as 
social groups are a dynamic structure, the dominance can be challenged. Hence, 
a dominant male can experience difficulties to maintain its position and be 
challenged and these difficulties to maintain social hierarchy have been 
associated with stress pathologies (Fokkema et al., 1995; Sapolsky, 1995). 
Another determining factor for the severity of the stress response comes from 
the predictability of the stressor. This parameter was defined as “the rates at 
which environmental harshness varies over time and space” (Brumbach et al., 
2009). It was shown experimentally that this parameter is a capital trait for 
modeling environmental conditions leading to psychiatric disorders (Nederhof 
and Schmidt, 2012).  
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As mentioned above, social groups are a dynamic structure but they are also 
persistent. However many models are relaying on episodic aggression, defeat, 
or intrusion. Even, when the exposure is repeated and hence chronic (chronic 
intermittent stress), it does not perfectly represent the conditions in human 
society.  
In the framework of the present studies, we used a paradigm combining aspects 
of different chronic social stress models. The experimental design was 
introduced in Mormède’s study (1990) and readapted by Schmidt and colleagues 
(2007). This paradigm is based on creating a continuous social instability for 6 
weeks during which animals have to readapt to new congeners and establish 
social hierarchy twice per week. Therefore, rats are facing an unpredictable 
environment maintained over several days from which they cannot escape. This 
model has been shown to induce anxio-depressive state characterized by 
symptoms such as reduced sucrose preference and food intake (Herzog et al., 
2009), reduced time and entries in plus-maze open arm (Schmidt et al., 2007) 
but also noxious sensitivity (Le Coz et al., 2017) and social deficits (Saavedra-
Rodriguez and Feig., 2013). It was established that the consequences of such a 
stress may be very long lasting as they could be seen three generations after the 
stress exposure through epigenetic changes but also presumably through 
constitutive alterations of gene regulated by stress hormones (Saavedra-
Rodriguez and Feig, 2013). Biological alterations of the HPA axis and limbic 
structures were also observed such as increased adrenal weight and sensitivity 
to ACTH, enhanced plasma corticosterone levels, decreased hippocampal GR 
expression and alter neuro-immune responses in amygdala and hippocampus 
(Schmidt et al., 2007; Nowacka et al., 2014). 
Altogether these findings suggest that this model is adequate to study 
psychosocial stress while mimicking conditions observed in human (e.g. 
mobbing). 
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2.4.3. Concepts of vulnerability and resilience 
Initially it has been hypothesized that adverse life conditions occurring during 
critical periods of development (perinatal period or adolescence) or at adulthood 
automatically lead to the development of enhanced vulnerability to diseases. A 
couple of assumptions were discussed in this context. The neurotoxicity 
hypothesis suggests that chronic stress and hence sustained exposure to GC 
weakens the ability of neurons to resist to new insults and enhances their 
vulnerability to toxic challenges (Sapolsky et al., 1986). Although not 
incompatible with neurotoxicity, the vulnerability hypothesis considers that 
neurobiological alterations seen in some diseases are not a consequence but 
rather a pre-existing risk factor originating from adverse early-life experiences 
(Gilbertson et al., 2002).  
Even though these two hypotheses may not be completely dismissed, harsh 
environmental conditions especially when occurring in early life will not 
uniformly lead to a disadvantage (enhanced vulnerability) later on and the 
consequences of early life stress should be considered as a “double-edged 
sword” (Brunson et al., 2003). Indeed, experimental and clinical studies have 
shown that resilience to stress can be an outcome of early life stress (Macri et 
al., 2011). Resilience can be defined as the capacity to cope with challenges 
through neurobiological adaptations maintaining an efficient allostasis (Mitra 
and al., 2009; Karatoreos and McEwen, 2013). Experimental models have 
shown that the severity of stressors applied during early life is one of the 
determining factors for the appearance of resilience as opposed to vulnerability. 
Hence, the relationship between early life adverse conditions and the resilience 
in later life follow a U-shaped curve (Pfau and Russo, 2015). Therefore 
individuals exposed to a mild stress during infancy generally show a better 
outcome when facing stressful situations during adulthood whereas little or 
severe stresses may lead to enhanced vulnerability (Macri et al., 2011).  
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Others have also described resilience or vulnerability taking into consideration 
the accumulation of stress experiences. The two-hit (also sometimes called 
three-hit or multiple hit) or cumulative stress hypothesis is the classical view 
stating that early life adversity would predispose individuals to later pathologies 
due to a buildup of stress progressively increasing risks until individuals reach 
allostatic load (McEwen and Stellar, 1993; McEwen, 1998). However, a more 
evolutionary perspective assumes that adverse early experience may induce 
programming aimed at a better preparation for later and hence better coping with 
subsequent stressful challenges (fig. 5) (Nederhof and Schmidt, 2012; 
Daskalakis et al., 2013). However the match/mismatch notion is considered to 
be a context specific hypothesis which conjectures that adaptive attributes in a 
certain context can be detrimental in another one.  In a similar manner genetic 
predispositions can also modulate vulnerability/resilience and should be taken 
into account and individual vulnerability/resilience should consider the 
interaction of genetic and environmental factors.   
Figure 5: Multiple hit concept of vulnerability and resilience. In this model the first hit is considered to be the 
genetic predispositions determining the biological stress substrate of individuals. The genetic heritage will then 
interacts with early environmental stimuli (hit-2) leading to a predetermined phenotype. This phenotype, when 
interacting with environmental challenges later in life will determine the vulnerability or the resilience of 
individuals to these challenges (Daskalakis et al., 2013). 
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Vulnerability and resilience have been almost exclusively studied in the context 
of psychopathologies. However, many studies are showing that early life stress 
can predispose (or not) to a wide variety of other disorders such as cancer, 
neurological and immune disorders or chronic pain (Schuler and Auger, 2010; 
Hoeijmakers et al., 2017). Interestingly, central structures implicated in stress 
processing are often involved by the pain response and modifications within 
these structures were shown to impact the other systems’ functioning (Felice et 
al., 2014) such that depression is often associated with chronic pain syndromes. 
Nevertheless, not many studies have investigated a possible enhanced resilience 
or vulnerability to such pathologies after stress experiences. Furthermore, stress 
is known to have a broader impact than solely on the brain and stress-related 
disorders, yet there is a paucity of studies investigating the transmission of 
noxious information from nociceptors to second order neurons at the spinal cord 
level (which carry the information to higher brain centers). Hence, in the present 
work, I sought to determine if and how early life and later stressful experiences 
could change pain sensitivity during chronic pain conditions and to gain insight 
about potentially involved alterations in spinal processing.  
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3.1. Introduction 
Pain exerts a capital function of the central nervous systems as it gives essential 
information about potential or existing harmful stimulus, the ultimate goal being 
to avoid potential or further injury. Since these noxious stimuli (from noxia in 
Latin meaning damage) can be very diverse the body has developed a broad 
range of receptors, types of neurons and levels of integrations. Therefore, the 
sensation of pain involves a complex neuronal network. It is mediated in the 
periphery by primary afferent neurons named nociceptors, conducted through 
the spinal cord and processed within the brain. (Milan, 1999). This will be 
further detailed in chapter 3.2. An injury can lead to an enhancement of 
sensitivity to painful stimuli (Sandkühler, 2009). Hyperalgesia (exaggerated 
pain response to a noxious stimuli) and allodynia (the experience of a painful 
sensation with a normally innocuous stimuli) are common symptoms that can 
even be seen in response to small injuries such as a small cut. However, in some 
cases such as the phantom limb pain condition, these symptoms can persist long 
after the initial cause of pain has vanished. In this case, patients that underwent 
an amputation still have the feeling that the missing limb is attached and can 
experience itching, burning or aching in this area. This kind of spontaneous and 
or exaggerated pain can be seen in other conditions like neuropathy or chronic 
inflammation where pain has lost its alarm and protective aim and has become 
persistent and debilitating, constituting a disease of its own. Research has shown 
during the past decades that such pathologies are underlined by long lasting 
modifications of the different components of the pain network (Blackburn-
Munro and Blackburn-Munro, 2001; 2003). However, due to the 
multidimensional organization of the pain system and the great comorbidity 
between painful and stress-related conditions, much work remains in order to 
understand and treat the different pain states.   
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3.2. Anatomy of the pain system 
3.2.1. Nociceptors / primary afferent neurons 
Classically, nociceptor is the name given to the sensory endings of high 
threshold primary somatosensory neurons which are specialized in the detection 
of noxious stimuli. Even though they are capable to encode noxious stimulus, 
some can also detect stimuli in the innocuous range. Alike other primary afferent 
sensory neurons, they are pseudo-unipolar. Their cell body is located in the 
dorsal root ganglia (DRG) or the trigeminal ganglion (TG) and projects one 
axonal branch to the periphery and the other one to the CNS where it makes a 
synapse with a second order neuron. In the periphery they are almost ubiquitous 
as they are found in the skin, ligaments, muscles, deep fascias and membranes, 
arterials and visceral tissues. The synapse connecting primary afferent and 
second order neurons will be detailed further. However, pseudo-unipolar 
neurons are of peculiar nature. Contrary to other neurons composed of dendritic 
receiving and axonal transmitting regions, the nociceptor can send and receive 
messages in both directions (Dubin and Patapoutian, 2010).  
Nociceptors are classified according to their conduction velocity (which 
depends on the type of fibers they are associated with), sensitivity to noxious 
heat, cold or mechanical stimuli, their sensitivity and the repertoire of chemical 
transduction molecules they use. Nevertheless, it is important to bear in mind 
that most nociceptors are polymodal, they express different combinations of 
sensory sensors that allow them to detect different stimuli. Therefore their 
classification is rather complex and will be not detailed fully in this manuscript. 
As already mentioned the first classification differentiates nociceptors according 
to their conduction velocity. The acute and well localized “fast pain” is mediated 
primarily by medium-sized myelinated Aδ afferents while small diameter non-
myelinated C fibers conduct a diffuse and slow “second pain”. In addition to the 
environmental modality it answers to, a nociceptor’s depolarization is also 
determined by the amplitude and duration of the stimulus. Hence, 
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electrophysiological studies have identified subclasses of Aδ and C-fibers 
(Basbaum et al., 2009; Julius and Basbaum, 2001). Briefly, the type I Aδ fibers 
respond to mechanical and chemical stimuli but not well to heat (only to very 
intense heat levels). On the contrary the type II Aδ nociceptors have higher 
mechanical but lower heat thresholds. The slowly conducting nociceptors are 
also subdivided between the C-fibers mechano-heat (C-MHs) (Perl, 2007), 
mechano-chemical (C-MCs), mechano-heat-chemicals (C-MHCs) sensitive 
(Dubin and Patapoutian, 2014). Another type of C-fibers exists, it is insensitive 
to heat and mechanical stimuli during physiological states but not after 
inflammation (Schmidt et al., 1995; Meyer et al., 1991). 
Figure 6: Summary of primary afferent fibers properties. Nociceptors classified upon their diameter. Large 
diameter myelinated A-α and A-β fibers are conducting innocuous stimuli. On the contrary myelinated A-δ and 
unmyelinated C-fibers are responsive to noxious stimulations. (Julius and Basbaum, 2001)
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Figure 7: Involvement of the different nociceptive fibers in the detection of pain. The fiber diameter directly 
determine the conduction velocity. Hence A-δ fibers will conduct the first pain while C-fibers will transmit the 
second pain (Julius and Basbaum, 2001). 
3.2.1.1. Detection of noxious heat 
Capsaicin and vanilloid have the ability to produce a burning pain if applied on 
the skin. The comprehension of molecular mechanisms underlying innocuous 
and noxious heat detection started with the cloning of the capsaicin receptor and 
definition of the related vanilloid family receptors (Lumpkin and Caterina, 
2007). The burning sensation produced by these compounds is principally due 
to their actions on polymodal C- and Aδ-fibers via the activation of the transient 
receptor potential cation channel subfamily V member 1 (TRPV1). This channel 
is one of the transient receptor potential (TRP) ion channel family comprising 
about 30 members. TRPV1 has been shown to be activated by temperatures 
ranging approximately from 43°C (up to 52 C°) which correlates with the human 
pain threshold. However studies show that TRPV1 is not solely responsible for 
the transduction of noxious heat. Indeed, TRPV2, expressed in Aδ-fibers type I 
has a threshold at around 52 °C and would be responsible for high threshold 
noxious heat (Lumpkin and Caterina, 2007). The most recently discussed 
channel participating in the detection and transduction of noxious heat is the 
Anoctamine 1 channel (ANO1). This non-TRP channel is activated by 
temperatures above 44°C.   
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3.2.1.2. Detection of noxious cold 
The understanding of innocuous or noxious thermal discrimination is 
incomplete, especially concerning cold sensitivity. Pharmacological (using 
menthol or eucalyptol) and genetic studies have proposed several candidates 
from the TRP cation channel family to be involved in the transduction of cold 
stimuli. The TRP subfamily member 8 (TRPM8) was the first cold transducer 
identified (McKemy et al., 2002; Peier et al., 2002). Although the TPM8 channel 
is known for innocuous cold transduction (discriminate temperatures under 
28°C) its implication in noxious cold sensitivity is still debated (Knowlton et al., 
2011; Pogoezala et al., 2013). Recently, two other TRP channels were shown to 
be implicated in noxious cold transduction. TRP cation channel subfamily C 
member 5 (TRPC5) is expressed in DRG neurons (Zimmerman et al., 2011) but 
its role in noxious cold transduction still needs further enquiry.  Nevertheless, 
TRP5C-/- mice did not present alteration of noxious cold sensation. TRP cation 
channel subfamily A member 1 (TRPA1) is also expressed in DRG and TG 
neurons and is thought to control the responsiveness to noxious cold (<5°C) 
(Gentry et al., 2010; Knolton et al., 2011). Primary sensory neurons contain a 
multitude of cation channels which are thought to play a capital role in 
innocuous and noxious cold transduction. Indeed, K+ channels (mainly TREK, 
TRAAK) and voltage gated Na+ channels (mostly Nav 1.7, Nav 1.8 and Nav 
1.9) are thought to modulate the transducing properties of nociceptors (Lolignier 
et al., 2016).  
3.2.1.3. Detection of noxious mechanical stimuli 
Similarly to noxious temperatures, nociceptors have the capacity to detect 
noxious mechanical stimuli such as pressure or tissue deformation. However, 
contrary to heat, cold or chemical stimuli the identification of proteins involved 
in noxious and innocuous touch is challenging due to the difficulty to establish 
appropriate stimulation protocols that are valid in and especially ex vivo (Dubin 
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and Patapoutian, 2010). Nevertheless, few candidates are believed to transduce 
mechanical noxious stimulus. Members of the degenerin/epithelial Na+ channel 
(DEG/ENaC) family, the acid-sensitive ion channels (ASICs) 1 to 3 have been 
proposed to play a role in musculoskeletal and ischemic pain (Price et al., 2000; 
Basbaum et al., 2009). TRP channels are also candidates but their contribution 
remains unclear. Indeed, TRPV4 and TRPA1 channels have been proposed as 
modulators of mechanical transduction but results from genetically modified 
mice models are not always consistent (Petrus et al., 2007; Kwan et al., 2006). 
More recently, researchers have identified rapidly-adapting mechanically 
activated cation channels, Piezzo 1 and 2, expressed in DRG neurons and 
involved in nociceptive processes, however further research is needed (Coste et 
al., 2010; Kim et al., 2012).  
3.2.2. Spinal synaptic transmission 
3.2.2.1. Introduction 
Nociceptors will convert the noxious environmental stimuli into a train of action 
potentials. This signal will then be conducted and transmitted to a second order 
neuron at the spinal cord (SC) level. The dorsal horn (DH) of the SC is divided 
into 6 laminae based on neuron size and density (Rexed, 1952). Depending on 
the type of nociceptive fibers that conduct the information, the synapse between 
first and second order neuron will be located in a different layer of the DH. 
Indeed, Aδ fibers generally end up in the laminae I and V while the C-fibers 
finish in the superficial DH in the laminae I and II (Basbaum et al., 2009).  
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Figure 8: Anatomical projections of nociceptive afferent fibers in the dorsal horn of the spinal cord (Kandel et 
al., 5th edition)
Once C and Aδ fibers reach the DH, they will signal to a second order neuron 
via a glutamatergic synapse along with the co-release of peptides such as 
substance P and CGRP (Basbaum et al., 2009). Different types of second order 
neurons can be differentiated by their connections to primary afferents. The 
nociceptive-specific neuronal cells are primarily located in the superficial DH 
and therefore are connected to Aδ and C-fibers and transmit only painful stimuli. 
Neurons receiving inputs from Aβ-fibers are involved in proprioception. 
Finally, wide dynamic range (WDR) neurons are located in deeper laminae of 
the DH and receive inputs from Aβ, Aδ and C-fibers, hence these neurons can 
respond to a range of stimulations from innocuous to noxious stimuli (Collins 
and Ren, 1987). Additionally to these projection neurons, the DH contains 
glutamatergic and GABAergic interneurons that will either facilitate or inhibit 
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the transmission of nociceptive signals. Additionally, the non-neuronal 
microglial and astrocytic cells have raised increasing interest in the past 15 
years. Indeed astroglial cells, are now known to be an important regulator of 
glutamatergic transmission (Ziak et al., 1998; Nie and Weng, 2009) and 
dysfunctional glial cell functions are associated with chronic pain (Romero-
Sadoval et al., 2008; Nie and Weng, 2010; Beggs and Salter, 2010; Mika et al., 
2013). Neurons in the spinal cord DH are also submitted to descending 
modulation from higher brain centers but this will be addressed later.  
3.2.2.2. Glutamatergic system: ionotropic receptors 
Glutamate is the main excitatory neurotransmitter of the CNS and is found in a 
very large majority of primary afferents regardless of their diameter and 
conduction speed. ATP had been proposed as a co-transmitter of noxious stimuli 
transmission however pharmacological studies failed to prove its role. Indeed, 
complete blockade of glutamatergic receptors extinguishes all excitatory 
postsynaptic currents in DH of lumbar SC (Li and Zhuo, 1998). Nevertheless, it 
was shown recently that ATP can act on non-neuronal cells of the DH (Beggs 
and Salter, 2010). Hence, glutamate remains the main excitatory amino acid in 
the SC and upon fixation to its post synaptic receptors it depolarizes second 
order neurons. Therefore glutamate is essential for nociceptive 
neurotransmission but also for synaptic plasticity and is involved in the 
establishment of chronic pain. Glutamate has four different subtypes of 
receptors located at pre, post and peri-synaptic sites: three are ionotropic 
receptors the α-amino-3-hydroxy 5 methyl-4-isoxazeloproprionic acid (AMPA) 
receptor, the N-methyl-d-aspartate (NMDA) receptor and the kainite receptor 
and one G-protein coupled receptor (GPCR) metabotropic receptor (mGluR). 
Most glutamatergic excitatory post-synaptic currents (EPSCs) are composed of 
a rapid AMPA/kainate current depolarizing the cell followed by an NMDA 
current component.  
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AMPA receptor 
The AMPA receptor is a tetrameric structure composed of the assembly of one 
or more of the GLUA1-4 proteins. These subunits are derived from four distinct 
genes GluR1 to GluR4 coding for four different proteins composed of three 
transmembrane domains (Armstrong and Gouaux, 2000). The different 
combinations of GLUA proteins and post-transcriptional mechanisms of the 
four subunits results in a very large diversity of the AMPA receptors. 
Nevertheless, AMPA receptors exhibit a relatively fast opening and deactivation 
when compared to other glutamate receptors. Importantly, calcium permeable 
AMPA receptors have been shown to be of importance regarding synaptic 
strength in the DH (Bleakman et al., 2006). The permeability of AMPA 
receptors for calcium depends on their subunit composition. Most AMPA 
receptors are composed of at least one GLUA2 subunit, however some do not 
and are permeable to calcium. Therefore, the GLUA2-lacking AMPA receptors 
are believed to play an important role in long-term plasticity in the DH (Cull-
Candy et al., 2004).  
Figure 9 : AMPA and NMDA receptors structure. The 
receptor is characterized by two regions S1 
(extracellular region adjacent to TM1) and S2 
(extracellular region between TM3 and TM4) 
corresponding to the ligand binding core (LBC). The 
intracellular domain plays an important role in the 
receptor’s function as it is subjected to phosphorylation 
by various protein kinase such as CamKII, PKC or PKA.
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AMPA receptors have been found in the brain, spinal cord and in the periphery 
however I will focus on the spinal cord. AMPA receptors are present on pre- 
and postsynaptic sites.  
Presynaptic AMPA sub-units are translated in the DRGs and transported to the 
synapse. There, they mediate nociceptor depolarization and glutamate release in 
the synaptic cleft (Bardoni, 2013). Interestingly immunolabelling studies 
showed that GluA2/3 subunits are mainly expressed in myelinated primary 
afferents (Lu et al., 2003) suggesting that most of presynaptic AMPA receptors 
are permeable to calcium and hence involved in synaptic plasticity. 
Nevertheless, about one fourth of GABAergic interneuron terminals are 
immune-reactive to GLUA2/4 antibody and two third of GLUA2/4 terminals are 
GABaergic and/or glycinergic (Lu et al., 2005; Engelman et al., 2006).  
Postsynaptic AMPA receptors are responsible for physiological pain 
transmission and plasticity as most contain the GLUA2 subunits and are 
permeable to calcium. Recently accumulating evidence seems to support that 
AMPA receptor may have a role in chronic painful sensations (Wang et al., 
2010) 
Kainate receptor 
Similarly to AMPA receptors, Kainate receptors are homo-or heterotrimeric. 
The kainate family comprises 5 genes coding for five proteins split into two 
subfamilies: the first one, composed of GluK1 to 3 subunits, presents a quite low 
affinity to glutamate and is capable to form a channel with members of this 
subfamily only. The second, formed by Gluk4-5, has a high affinity for 
glutamate but cannot form a channel solely with members of its own subfamily. 
Indeed, in order to form a functional channel, the kainate receptors necessitate 
at least one of the members of the low-glutamate affinity subfamily (Larsson, 
2009). Kainate receptors have similar kinetics as the AMPA receptors except 
for a slower deactivation. These receptors are primarily present on the 
presynaptic terminals of C-fibers, but also on postsynaptic elements. However, 
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contrary to AMPA receptors they are believed to mediate the transmission of 
higher stimulation intensities due to their slower decay kinetics (Zhuo, 2017). 
NMDA receptor 
NMDA receptors are classically composed of 4 subunits, forming a homo or 
hetero-tetrameric channel. Seven genes are coding for the different channel 
subunits: GLUN1, GLUN2A, GLUN2B, GLUN2C, GLUN2D, GLUN3A, GLUN3B and the 
organization of the channel is similar to AMPA and Kainate receptors. However, 
as the GLUN1 subunit bears the glycine co-agonist binding site and the GLUN2 
the agonist binding site for glutamate, each receptor is formed by 2 GLUN1 in 
combination with two GLUN2 and/or GLUN3. The activation of this receptor 
requires the binding of glycine and glutamate but since glycine is naturally 
present in the extracellular space, most co-agonist sites are constitutively 
occupied. The binding of glutamate to the receptor is however not sufficient to 
open the channel. Indeed, under physiological conditions, at a resting neuronal 
potential (-80mV), the channel pore is blocked by a magnesium plug. It is only 
following a sustained neuronal depolarization that this Mg2+ block is removed 
allowing a calcium influx. Once Ca2+ is inside the cell it will active several 
signaling cascades that can promote plastic changes involved in long term 
potentiation.  
In the spinal cord, the NMDA receptors subunits GLUN1, GLUN2A-D and 
GLUN2B have been detected both pre and post synaptically (Ma and 
Hargreaves, 2000; Boyce et al., 1999). When located on the presynaptic 
elements, NMDA receptors are involved in the modulation of neurotransmitter 
release of glutamatergic but also GABAergic neurons as the structural GLUN1 
subunit has been detected on primary afferent fibers (PAFs) and GABAergic 
interneurons terminals in DH laminae I to IV (Lu and al., 2003; 2005). The 
postsynaptic repartition of the different NMDA receptors subunits is quite 
heterogeneous. While GLUN1 seems to be evenly expressed in the dorsal horn, 
GLUN2A seems to be localized rather superficially whereas GLUN2B is 
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distributed in laminae III-IV (Nagy et al., 2004). Postsynaptic NMDA receptors 
do not seem to be involved in normal physiological nociception. Indeed, it was 
demonstrated that removal of one of the main three NMDA receptor subunits; 
GLUN1, GLUN2A or GLUN2B using genetic models or pharmacological 
intervention does not alter basal nociception. Hence the role of these post-
synaptic receptors would be restricted to long term potentiation seen in the 
framework of chronic pain states (South et al., 2003; Tan et al., 2005).  
3.2.2.3. Glutamatergic system: metabotropic receptors 
Metabotropic glutamate receptors (mGluRs) are a family of GPCR class C. This 
GPCR superfamily is classically composed of an N-terminal extracellular tail, a 
central core constituted of 7 transmembrane α helices linked by intra and 
extracellular loops (3 of each) and terminated by an intracellular C-term tail. 
However, contrary to other GPCR they form a dimer and possess a “two 
extracellular lobes” domain capable of binding natural ligands such as glutamate 
and (Pin et al., 2004). mGluR have another particularity compared to other C 
class GPCR, an extracellular disulfide bridge links the two subunits. This 
influences the functionality of the receptor as two glutamate molecules will be 
necessary to activate fully the receptor (Kniazeff et al., 2004). There are 8 
mGluRs divided in three subfamilies based on their sequence homology, the 
intracellular cascade they trigger and their pharmacological profile.  
Group I mGluRs comprise mGluR 1 and mGluR 5 and are mostly found on post-
synaptic elements. mGluRs 1 and 5 are coupled with the Gq/11 family of G 
proteins. Upon activation of these receptors, the activation of phospholipase C 
(PLC) β1 will lead to the production of inositol-(1, 4, 5)-trisphosphate (InsP3) 
and diacylglycerol (DAG). InsP3 will act to release calcium from intracellular 
stores while DAG actives PKC. The liberation of calcium and the subsequent 
channel phosphorylation due to the activation of group I mGluRs have been 
shown to be a critical component of central sensitization in the context of 
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chronic pain notably by potentiating NMDA and AMPA responses and 
increasing the excitability of second order neurons (Jones and Headley, 1995; 
Walker et al., 2001a, b; Karim et al., 2001; Hu et al., 2006). Importantly, group 
I mGluRs have been detected in glial cells in several CNS regions such as 
hippocampus, the cortex but also the spinal cord (Danbolt, 2001). It has been 
suggested that glial mGluRs participate also in the establishment of chronic pain 
due to their capacity to release glutamate, modulate its transporters’ activity and 
evoke synaptic responses from neighboring neurons but to my knowledge their 
role has not been investigated extensively in the spinal cord (Pocock and 
Kettenmann, 2007).  
Group II (mGlu2 and 3) and group III (mGlu4, 6, 7, 8) sub-families are both 
negatively coupled with adenylate cyclase via a Gi/o-protein (Goudet et al., 
2009). Both subtypes are mostly expressed in the presynaptic elements of 
sensory PAFs (Carlton et al., 2001) and serve as auto-receptors that regulate 
synaptic transmission and presynaptic neuron excitability in a negative way. 
Group II mGluR activation has been demonstrated to have analgesic effect as 
demonstrated by pharmacological activation (Yang and Gereau, 2003; Li and 
Neugebauer, 2006) and their expression is sensitive to painful experiences 
(Dolan et al., 2003). However, activation of the group III mGluRs does not seem 
to affect nociceptive threshold in healthy rats but to inhibit hyperalgesia 
associated with chronic pain (Neugebauer, 2000; Goudet, 2008). Some Group 
II and III mGluRs have been found on glial cells such as mGlu3 and mGlu4 
where they are thought to have a neuroprotective role (D’Antoni et al., 2008). 
3.2.2.4. Glutamatergic system: transporters 
An important factor determining the transmission of the nociceptive signal to 
higher brain center is related to the concentration of glutamate within the 
synaptic cleft. The more glutamate in the cleft, the stronger the signal will be. 
Furthermore, an excessive extracellular glutamate concentration and hence an 
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excessive receptor activation are known to lead to excitotoxicity and neuronal 
death. Therefore, it is important that this amino acid is recaptured. Spinal 
glutamatergic synaptic clearance is predominantly provided by the excitatory 
amino-acid transporters (EAATs). They all derive from the same SLC1 gene-
family of transporters and comprise 5 subtypes, however most of the glutamate 
uptake is secured by the glutamate/aspartate transporter (GLAST or EAAT1), 
the glutamate transporter-1 (GLT-1 or EAAT2) and the excitatory amino acid 
carrier (EAAC 1 or EAAT3). The two other glutamate receptors, EAAT4 and 
EAAT5, are primarily found in cerebellar Purkinje cells and retina respectively 
(Dehnes et al., 1998; Arriza et al., 1997). GLT-1 and GLAST have been shown 
to be expressed almost exclusively in glial cells next to the synapses while 
EAAC1 is found in neurons (Danbolt et al., 2016). Despite their ubiquitous 
distribution, studies suggest that GLT-1 is the major glutamate transporter, 
accounting for at least 80% of glutamate re-uptake (Danbolt, 2001). Glutamate 
transporters, and by extension glial cells, have been shown to greatly influence 
pain transmission, particularly during pathological states (Ni and Weng, 2010; 
Mika and al., 2013). 
3.2.3. Higher brain centers and descending modulation 
3.2.3.1 Ascending pathways and supra-spinal centers 
After the transmission of the noxious signal to the spinal cord, second order 
neurons will form bundles sending their projections to several brain structures. 
The main projections originating from the superficial DH are targeting the 
thalamus as it acts as the principal relay for sensory inputs.   
Traditionally projections have been described to comprise two main pathways, 
medial and lateral. The medial system includes, spino-reticular, spino-
parabrachiohypothalamic, spino-mesencephalic, spino-parabrachio-
amygdaloid, paleospino-thalamic and spino-hypothalamic tracts while the 
lateral system comprises spino-cervical tract and neospino-thalamic tract. These 
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two parallel pathways act in a complementary manner. On one hand, the lateral 
system sends input to the primary and secondary somatosensory cortexes (S1 
and S2) in order to process the sensory quality (stinging, burning, aching), the 
location and the duration of noxious signals. On the other hand, the medial 
pathway extend to the forebrain (anterior cingulate and prefrontal cortexes) in 
combination with limbic structures (amygdala, ventral tegmentum area and 
nucleus accumbens) and is mainly involved in the emotional and motivational 
responses to pain (Almeida et al., 2004). It is only after reaching the higher brain 
centers, allowing perception and emotional evaluation that noxious stimuli lead 
to the subjective experience of pain, until then the processing of noxious 
information is referred to as nociception.  
Despite distinct path and projections the structures involved in the different 
aspects of pain are interconnected with each other and therefore nociceptive 
processing is not limited to the areas receiving direct projections. However, 
some structures are clearly identified and believed to play a role in distinct 
aspect of pain sensation. As the focus of my Ph. D. was the spinal cord, I will 
not provide too many details on the different supra-spinal targets.  
3.2.3.2 Descending modulation 
We mentioned earlier that the transmission of the nociceptive message in the 
DH is modulated by PAFs (through auto-receptors) as well as excitatory and 
inhibitory interneurons. Other regulation mechanisms allowing a very fine 
tuning of the nociceptive information are provided by descending inhibitory or 
facilitatory fibers originating from supraspinal brain centers. The best 
characterized descending modulatory pathway is the periaqueductal gray-rostral 
(PAG) ventral medulla (RVM) pathway. The PAG is a midbrain structure 
interconnected with the RVM and receiving inputs for cortical areas and limbic 
regions. The RVM also receive inputs from other supraspinal structures such as 
the thalamus and the locus coeruleus. These two structures have been shown to 
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influence spinal nociceptive transmission, however it is believe that the RVM is 
the final relay of descending modulatory neurons (Ossipov et al., 2014). The 
RVM is mainly the source of serotoninergic descending projections but 
GABAergic/glycinergic projections have also been described (Kato et al 2006). 
Depending on the receptor subtype activation, serotoninergic projections to the 
dorsal horn can either induce antinociceptive (via activation of 5-HT1A, 5-
HT1B, 5-HT1D or 5-HT7 receptors) or pronociceptive effects (via activation of 
5-HT2A or 5-HT3 receptors) (Suzuki et al., 2004; Dogrul et al., 2009; Bannister
and Dickenson, 2016).  Other monoaminergic projections are known to
modulate spinal transmission. Noradrenergic fibers mainly arising from the
locus coeruleus promote inhibition of the spinal cord activity via an activation
of the α1, α2C and β-adrenoreceptors present on GABAergic interneurons,
hence enhancing inhibition of the noxious signal transmission (BABA et al.,
2000). Lastly, the inhibitory D2-like dopamine receptors are predominantly
expressed in the spinal cord compared to the D1-like ones (Bouthenet et al.,
1987). Through this GPCR, dopamine promotes presynaptic inhibition of
glutamate release and hence has antinociceptive actions (Roca-Lapirot et al.,
2011). Altogether the complex actions of descending modulatory neurons allow
cognitive factors and emotional states to influence the perception of pain
(Bushnell and al., 2013). Indeed, negative expectation can counteract analgesics
effects (Bingel et al., 2011) while distraction or positive anticipation can
produce placebo analgesia (Benedetti et al., 2005; van der Meulen et al., 2017).
3.3. Chronification of pain: peripheral and central sensitization 
3.3.1. Concept of peripheral sensitization 
Peripheral sensitization mostly occurs during inflammation but can also be 
present in the framework of nerve damage. As a result, the threshold of 
activation by noxious stimuli (for heat, cold, pressure and chemicals) can be 
reduced and the general excitability of primary afferents fibers is increased. 
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Inflammatory mediators and growth factors are greatly involved in the induction 
and maintenance of peripheral sensitization. For instance, the nerve growth 
factor (NGF) has been shown to induce a prolonged thermal and mechanical 
hyperalgesia. Both effects components were thought not to be mediated by the 
same mechanisms. Indeed, NGF-thermal hyperalgesia is mediated by mast cell 
degranulation (Lewin et al., 1994). NGF, in combination with other growth 
factors such as GDNF (glial-cell derived neurotrophic factors) and BDNF (brain 
derived neurotrophic factor) can activate intracellular cascades activating 
kinases which can alter the expression and or phosphorylate channels such as 
TRPV1 but also voltage-gated sodium, calcium and potassium channels 
(Mantyh et al., 2011; von Hehn et al., 2012). Altogether, the release of growth 
factors and cytokines can change the electrical properties of injured and 
neighboring non-injured neurons leading to abnormal inputs from PAFs and 
painful sensations (Wu et al., 2002).  
3.3.2. Concept of central sensitization 
As stated above, acute pain has an important physiological role in preserving 
individuals from further damage or injury. However, in some circumstances 
such as neuronal injury and inflammation, pain can turn out to be a disease on 
its own. In this case, patients are not warned any longer from a potential danger 
by noxious stimuli, pain just becomes debilitating. Chronic pain states can arise 
from various causes and are subjected to huge differences in individual 
susceptibility. Chronic neuropathic pain originates from a nerve damage or a 
disease affecting the neurosensory system which can generate pacemakers-like 
potentials from nociceptors and altered processing within pathways involved in 
pain perception (Woolf and Mannion, 1999; Woolf, 2004). Chronic 
inflammatory diseases are mechanistically different since they may be 
accompanied by a sustained peripheral inputs originating from the affected 
tissues in the periphery and leading to central sensitization. Despite the very 
diverse etiologies of chronic pains syndromes several commonalities exist. Of 
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particular interest is the structural and functional remodeling with the DH of the 
spinal cord. For instance, recent studies are suggesting that comparable 
increases of synaptic spine density can be observed in paw inflammation and 
neuropathic pain models (Tan et al., 2012; Lu et al., 2015). These structural 
alterations were linked to a more general phenomenon termed central 
sensitization. The definition of central sensitization has been given by the IASP 
as an “increased responsiveness of nociceptive neurons in the central nervous 
system to their normal or subthreshold afferent input”. This definition is 
however quite vague since the term “nociceptive neurons” a very heterogeneous 
neuronal population comprises. For instance, GABAergic and glycinergic 
neurons of the DH are involved in nociception but an increase of their activity 
leads to a reduced noxious sensitivity. On the other hand, an enhancement of 
PAFs activity generally leads to higher noxious sensitivity. Nevertheless, it is 
generally accepted that the term “central sensitization” implies an enhanced 
responsiveness to noxious stimuli associated with the subjective phenomena of 
hyperalgesia (a state of increased sensitivity to painful stimuli) and/or allodynia 
(a state during which normally non-noxious stimulation are eliciting pain 
sensations) and/or spontaneous pain (Sandkühler, 2009). In the spinal cord, 
central sensitization is characterized by a reduction of the thresholds eliciting a 
response, a widening of the nociceptive neuron’s receptive fields (Cook et al., 
1987), an enhanced synaptic transmission efficacy (Woolf and King, 1990) and 
the acquired capacity of Aβ fibers to transmit noxious stimuli (Woolf and King, 
1990; Simone et al., 1989).  
3.3.2.1. Mechanisms underlying spinal sensitization 
Several distinct but not exclusive causes are believed to underlie the 
establishment of altered noxious transmission seen during chronic pain states.  
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Long term potentiation (LTP): 
Originally discovered in the hippocampus (Bliss and Lomo, 1973) and 
considered to constitute a substrate for mechanisms underlying simple forms of 
learning, LTP was shown later at the level of the spinal cord (Woolf, 1983; Wall 
and Woolf 1984). Although hippocampal and spinal LTP share common 
mediators and mechanisms they are not identical in any case (Ji and al., 2003). 
Spinal LTP results from brief high-frequency (around 100 Hz) repeated trains 
of electrical nociceptor primary afferent stimulation and is claimed to constitute 
a potential mechanism involved in early-onset central sensitization that may 
involve homosynaptic as well as heterosynaptic effects. Briefly, homosynaptic 
plasticity refers to enhanced synaptic transmission between the stimulated 
neurons and their postsynaptic partners whereas heterosynaptic plasticity 
corresponds to the additionally altered processing of neighboring synapses, e.g 
via the co-release of neuropeptides. The reinforcement of synaptic strength 
occurring via repetitive noxious inputs to the spinal cord thus results in 
facilitation of noxious transmission (Woolf and Wall, 1986) characterized by a 
reduction of threshold of the nociceptive second order neurons, increased 
responsiveness and a widening of nociceptive receptive fields (Cook et al., 
1987). A commonly used model selectively studying spinal homosynaptic 
plasticity is the so-called “wind up” paradigm that relies on trains of impulses 
typically applied at a lower frequency (around 1 Hz).  
In the case of heterosynaptic plasticity the repeated stimulation of C-PAFs is 
capable to elicit a response of low threshold Aβ-PAFs (Ji et al., 2003). The 
recruitment of Aβ-PAFs has been proposed to be long lasting and involved in 
the pathogenesis of allodynia during chronic pain as Aβ-fibers have been shown 
to sprout into DH laminae I and II (Woolf and al., 1992). Furthermore, substance 
P, a neuropeptide involved in nociceptive processing, has been detected in Aβ 
primary afferents in models of inflammatory and neuropathic pain (Neumann et 
al., 1996). The long lasting facilitation will lead to activation of ligand gated 
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channels, especially the glutamatergic receptors.  It will lead in turn to the 
activation of multiple kinases (PKA, PKC, and ERK) pathways and the 
phosphorylation of ion channels, subsequently increasing the synaptic efficacy 
and channel opening time. Furthermore, the opening of NMDA receptors will 
allow a massive calcium influx and autophosphorylation of the 
calcium/calmodulin-dependent kinase II (CAM-KII). The classical and more 
comprehensive concept of central sensitization underlying the enhancement and 
long-term maintenance of clinical pain states is however related to the co-release 
of neuropeptides together with glutamate under conditions of pronounced and 
ongoing nociceptive input. Slowly depolarizing neuropeptides like substance P 
may under these conditions act post synaptically via activation of metabotropic 
receptors like the neurokinin-1 (NK-1) receptor. This will lead to the subsequent 
activation of the PLC pathway, in turn releasing calcium from intracellular 
stores and activating PKC (Drdla and Sandkühler, 2008). Altogether, this will 
have several consequences such as maintaining NMDA (Garry and al., 2003) 
receptors in an open state and increasing AMPA receptors single channel 
conductance (Sheng and Kim, 2002). Finally, the described maintenance 
depends on CREB mediated pathways (Nguyen and Kandel, 1996) triggered by 
NMDA and mGluR but also by β-adrenoceptors and dopaminergic receptors 
partly underlying the effects of descending modulation (Sweatt, 2001; for 
review Ossipov and al., 2014).  
Disinhibition of GABAergic/glycinergic interneurons: 
Spinal inhibitory interneurons are an important regulator of DH nociceptive 
transmission, hence death or loss of these cells function can result in enhanced 
pain sensitivity. Most of the studies have investigated GABAergic interneurons, 
however there is a great overlap between GABA and glycine inhibitory 
interneurons (Prescott, 2015). The following studies on the loss of inhibitory 
interneurons as a maladaptive plasticity mechanism have focused on 
GABAergic interneurons which does not necessarily rule out similar effects for 
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glycinergic neurons (Moore et al., 2002; Polgar et al., 2003; 2008). Nevertheless 
other evidence points towards an alteration of these cells during chronic pain 
states. Indeed, other studies have shown diminished GABA and Glutamate 
decarboxylase (GAD) immunoreactivity (Ibuki et al., 1997; Eaton et al., 1998; 
Moore et al., 2002), reduced GABA release and presence at the synapse (Stiller 
et al., 1996; Schoffnegger et al., 2006). Despite those indications of a 
dysfunction of the GABAergic system in the DH, it was discovered later that 
these neurons remain functional (Schoffnegger et al., 2006). It is believed that 
the reason of this disinhibition may be related to the dysregulation of the 
potassium chloride cotransporter 2 (KCC2) (Coull et al., 2005). Indeed, this 
transporter is undergoing a downregulation following nerve injury and this 
seems to be sufficient to alter intracellular chloride levels and cause a disruption 
of anion gradient subsequently leading to a reduced GABAergic inhibitory tone 
(Beggs and Salter, 2010).   
3.3.3. Importance of glial cells 
Originally believed to have a role for the structural support for the CNS, glial 
cells have been largely investigated since and their role proven to be much 
broader. Glial cells represent 70% of the totality brain and spinal cord cells and 
are divided in two major types: astrocytes and microglia.  
Microglia are macrophage-like resident cells of the central nervous system. 
During physiological conditions, microglial cells have a ramified shape but can 
adopt an amoeboid form upon activation. In physiological conditions microglial 
have a capital role since they regulate neuronal environment through their 
interaction with neuronal cells allowing them to provide a structural support, act 
as a nutrient stock and supplier but also to destroy and remove damaged or dead 
neurons. Upon insults these cells undergo rapid morphological and functional 
changes associated with genomic regulation and the release of a multitude of 
factors. These actions have been shown to be a critical factor for the 
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development of neuropathic and inflammatory pain (Lin and al., 2007; 
Raghavendra et al., 2003; 2004; Tanga et al, 2004; Romero-Sandoval et al., 
2008).  
Astrocytes are the most abundant macroglial cells of the CNS such that one 
astrocyte can enwrap tens of thousands of synapses. Originally believed to be 
the “nerve glue” (Virchow 1859), they actually express a multitude of channels 
and transporters at their cell surface allowing them to regulate ionic homeostasis 
of surrounding neurons. Indeed, astrocytes are believed to participate actively in 
synapse regulation. The “tripartite synapse” theory is based on the fact that 
astrocytes can sense neuronal activity, respond by intracellular calcium 
elevation and regulate synaptic strength (Arraque et al., 1999). Comparably to 
microglia, activated astrocytes undergo morphological and functional 
alterations during chronic pain conditions which are believed to underlie 
neuropathy and inflammation (König et al., 2014; Yan and al., 2014; Romero-
Sandoval et al., 2008). 
Microglial and astrocytic activation are believed to have a capital role in the 
establishment of central sensitization of the DH during chronic pain conditions. 
Despite sharing the common ability to release growth factors and pro-
inflammatory cytokines, both glial cells subtypes seem to have complementary 
rather than overlapping roles (for an extensive review Ji and al., 2013). Indeed 
microglia have been claimed to play a greater role in the initiation of chronic 
pain conditions while astrocytes seem to be more involved in the maintenance 
of abnormal pain sensations (Raghavendra and DeLeo, 2003). Nevertheless, 
both cell types have overlapping roles in the establishment of DH sensitization 
and both are involved in the different stages of pain hypersensitivity (Ledeboer 
et al., 2005; McMahon et al., 2005). 
Microglia does e.g. participate in the disinhibition of DH neurons. Indeed, the 
ATP released by primary afferents stimulates the P2X4 receptors expressed at 
the microglial cells’ surface. Activation of P2X4 will in turn trigger the de novo 
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synthesis and release of BDNF. BDNF will subsequently reduce KCC2 
expression of laminae I DH neurons leading to an intracellular chloride ion 
increase and impairing GABAergic inhibition (Coull et al., 2003; Tsuda et al., 
2003; Trang et al., 2009; Tsuda et al., 2013).  
Astrocytes have a tremendous impact on synaptic clearance. Both GLT-1 and 
GLAST are expressed on astrocytes cell membrane and they act as the major 
actor of glutamatergic clearance as they can recapture more than 90% of 
synaptic glutamate (Danbolt, 2001). Hence, the sustained downregulation of 
these transporters is believed to account for a great deal in abnormal pain 
sensations during inflammatory or neuropathic pain (Sung et al., 2003; Maeda 
et al., 2008). 
On top of this, glial cells can both synthetize and release a number of pro-
inflammatory cytokines, growth factors and chemokines. The tumor necrosis 
factor-α (TNF-α), the interleukin-1β and the interleukin-6 (IL-1β and IL-6) are 
the most studied glial mediators.  They have been shown to be upregulated after 
peripheral neuropathy and inflammation (DeLeo and Yezierski, 2001; Watkins 
et al., 2001; McMahon et al., 2005). Furthermore, altogether they participate in 
the development and maintenance of abnormal pain sensation by modulating 
excitatory and inhibitory synaptic transmission. For instance, TNF- α, which is 
primarily produced by microglia, can alter the excitability of the CNS by 
reducing the expression of GLT-1 and GLAST (Sitcheran et al., 2005). 
Additionally, TNF-α possesses the ability to activate p38 MAPK consequently 
modifying AMPA receptor composition via phosphorylation thus increasing 
calcium AMPA permeability (Beattie and al., 2002). IL-1β has been found in 
glia and neurons and have the capacity to increase cell excitability through its 
actions on sodium, calcium and potassium channels (Schäfers and Sorkin, 2008) 
leading to an increase of amplitude and frequency of spontaneous excitatory 
postsynaptic currents (EPSCs). Furthermore, IL-1β and IL-6 were shown to act 
presynaptically leading to a reduction of the frequency of inhibitory 
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postsynaptic currents (Kawasaki et al., 2008). In addition to these actions on 
transporters pro-inflammatory cytokines can also elicit neuronal LTP by 
inducing the phosphorylation of transcription factors such as the CREB and 
promote the expression of pro-nociceptive genes (Ji et al., 2013). 
Figure 10: Involvement of microglial cells in disinhibition. The top half part of the graph represents the 
physiological state, where microglia is resting and GABAergic neurons display normal functioning. Following 
peripheral nerve injury (PNI) microglia takes up its amoeboid form and release BDNF. BDNF will in turn act to 
downregulate neuronal KCC2. The extrusion of chloride will hence be slowed down and chloride intracellular 
concentration will rise leading to the impairment of GABAergic neurons to exert their inhibitory effect (Beggs 
and Salter, 2010).
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3.3.3. Neuropathic pain 
3.3.2.1. Introduction  
The facilitation of pain transmission following injury or inflammation of 
peripheral tissues is a necessary set of adaptive changes evolutionarily set up in 
order to avoid further damage. This leads to the generation of enhanced pain 
sensitivity, as a defense mechanism allowing proper healing. In contrast, 
neuropathic pain occurring following nerve damage that can arise from multiple 
sources (diabetes, nerve injury, cancer, multiple sclerosis etc.), can lead to 
enduring changes in pain sensitivity. In addition to the prolonged and amplified 
pain sensations, concerned patients may have abnormal painful sensations 
triggered by innocuous stimuli (allodynia) and spontaneous pain. As these 
symptoms are underlined by sustained neuronal changes, neuropathic pain is 
nowadays regarded as autonomous nervous disease (von Hehn et al., 2012).  
Neuropathic pain is quite common and can be found in the 7 to 8% of the general 
population (IASP report). Furthermore, this prevalence could be 
underestimating the actual number of patients suffering from neuropathic pain 
since it is often associated with another pathology. For instance, 37% of German 
patients suffering from low back pain have neuropathic pain. This statistical 
value represents 14% of female and 11% males Germans. In UK about 25% of 
patients with diabetes develop neuropathy, this could be a major health issue in 
the future since the prevalence of diabetes has been increasing over the years. 
Lastly, the American Institute of Medicine estimates that approximately 18% of 
people suffer from neuropathic pain (Toth et al., 2009). This debilitating disease 
greatly impairs the quality of life of patients and has a high impact on the 
economy of health systems notably because it is still poorly treated. Several 
genetic polymorphisms have found to confer vulnerability/resilience to 
neuropathic pain (Binder et al., 2011). Furthermore, neuropathic pain presents 
many comorbidities with other syndromes or pathologies such as poor sleep, 
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depression and anxiety. Another difficulty of finding adequate treatment resides 
in the fact that the disease may have peripheral and/or central origins.  
3.3.2.2. Animal models of neuropathic pain 
The first models of neuropathic pain started to emerge in the 1970s responding 
to the need to establish human-like etiologies and symptoms of chronic 
neuropathy. The oldest model is the axotomy model (Wall et al., 1974) 
consisting in a complete transection of the sciatic nerve in the mid-thigh region. 
The surgery leads to the development of a neuroma (regenerative fibers 
sprouting anarchically) at the proximal stump of the nerve (for review Jaggi et 
al., 2011). However this model is not commonly used anymore since complete 
nerve section is rare in the clinical setting and the symptoms observed in rodents 
such as autotomy (self-mutilation of the denervated limb) are ethically hardly 
acceptable. Newer models have hence emerged in the 1980s ~ 1990s. One of the 
most if not the most commonly used is the chronic constriction injury models 
(CCI) established by Bennett and Xie (1988). It consists of inducing a peripheral
mononeuropathy (generally in rats) by placing 3 or 4 loose chromic gut ligatures
(spaced of about 1 mm) around the sciatic nerve. The tightness of the ligature is
a critical factor for the development of CCI-induced neuropathy since the
epineural circulation should not be interrupted. Locally, the constriction induces
an intraneural oedema, ischemia and Wallerian degeneration thereby sensitizing
both A and C-PAFs and in turn initiating central sensitization (Gabay and Tal,
2004). CCI leads to a range of behavioral alteration such as thermal and
mechanical hyperalgesia and spontaneous pain characterized by excessive
licking, limping and avoidance to put weight on the paw ipsilateral to injury
(Wang et al., 2005; 2006; Barrot, 2012; Le coz et al., 2017). These changes have
been shown to develop rapidly (within less than a week) following CCI-surgery
and to be sustained for up to 7 weeks (De vry et al., 2004). Hence, the CCI model
is considered to correspond well to causalgia or complex regional pain syndrome
observed in neuropathic patient (Sandkühler, 2009).
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Figure 11: Schematic representation of neuropathic pain models (Jaggi et al., 2011) 
3.3.4. Inflammatory pain 
3.3.3.1. Introduction 
Inflammation is a reaction of living tissues to an aggression. This reaction 
includes the activation of immune system cells and the release of a multitude of 
mediators such as pro-inflammatory cytokines (TNF-α, IL-1β, IL-6). In the 
same way as peripheral neuropathy, inflammation has the capacity to sensitize 
nociceptors, facilitate pain transmission and if it is sustained lead to chronic 
inflammatory pain. The peripheral sensitization of nociceptors has been for a 
long time attributed solely to the pro-inflammatory mediators found in the 
inflammatory “soup”. However, even though these substances account for a 
great part of the enhanced excitability of nociceptors, other mediators such as 
growth factors have the capacity to sensitize PAFs. Although the chronification 
of inflammatory and neuropathic pain states share a great deal of overlapping 
mechanisms, a few differences have been identified (Latremoliere and Woolf, 
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2009). Indeed, it seems that inflammation-mediated pain hypersensitivity 
involves a Cox-2 (cyclooxygenase)/PGE2 (Prostaglandine E2) pathway which 
in turn potentiates AMPA and NMDA receptors and reduces glycinergic 
inhibition in the DH (Harvey et al., 2004).  
3.3.3.2. Animal models of inflammatory pain 
The great majority of inflammatory pain models rely on the activation of the 
immune system, which leads to a sensitization of the nociceptive system, 
following injection of a substance. The different models vary depending on the 
site of injection (often one of the knee, ankle or paw) and the injected agent such 
as formalin, carrageenan or complete Freund’s adjuvant (CFA). Formalin is 
generally used as a short-term model of inflammation and allows to differentiate 
the direct activation of nociceptors (acute phase) from the inflammatory 
response (late phase) (Hunskaar and Hole, 1987). On the contrary, carrageenan 
and CFA have more antigenic potential and their injection induces thermal and 
mechanical hyperalgesia and swelling for at least several days (Barrot, 2012). 
These models are thought to mimic closely the time course of post-operative and 
long lasting pain (Ke Ren and Dubner, 1999).  In the framework of the present 
work I injected CFA into one of the rat hind footpads. CFA is a heat-killed 
Mycobacterium tuberculosum that is suspended in oil. We preferred this to to 
carrageenan because the hyperalgesia onset time (2-6h) and duration of the 
inflammation (2-3 weeks) was closer to the time scale used during neuropathic 
pain studies. Furthermore, Tanga and colleagues (2004) have shown that CFA-
induced paw inflammation produced a pattern of glial activation and 
proinflammatory cytokine expression that was comparable to the one observed 
under neuropathic conditions. 
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Data have accumulated for several decades about the link between chronic 
stress-related diseases such as major depressive disorders and pain states. 
Indeed, alterations of pain thresholds, pain tolerance and alterations of the 
efficacy of analgesics and inversely, individuals suffering from chronic pain-
related alterations in stress processing have been reported in clinical and 
laboratory settings (Sarlis et al., 1992; Aghajani et al., 2012; Green et al., 2011; 
Nishinaka et al., 2016; Alvarez et al., 2013; Uhelski et al., 2010; Kalinichev et 
al., 2001; Lentjes et al., 1997). As discussed in chapter 2, chronic stress often 
leads to alterations of the HPA axis. Furthermore, clinical and experimental data 
have demonstrated that many major peripheral and central pain mediators (such 
as cytokines, monoamines and hormones) are also implicated in the modulation 
of the HPA axis (Blackburn-Munro and Blackburn-Munro, 2001). Nevertheless, 
the relationship between stress-related disorders and chronic pain is still 
debated. Indeed, several hypotheses have been proposed: 1) both are 
independent diseases despite sharing common substrates and mechanisms, 2) 
stress-related disorders are the main pathology and chronic pain is a resulting 
consequence, 3) conversely some investigators consider that chronic pain 
induces diseases such as depression and 4) prior stress experiences predispose 
patients to develop psychiatric disorders once they are undergoing chronic pain. 
Our laboratory has investigated the impact of HPA axis modulation on painful 
behaviors and on alterations of spinal processing associated with peripheral 
inflammation (Juif et al., 2016; 2014; 2011) and neuropathic pain (Le coz et al., 
2017; 2014a; 2014b). These studies have used various approaches to investigate 
the role of HPA axis activity such as pharmacological manipulation (i.p. 
injection of dexamethasone or RU486), the use of different rat strains known for 
displaying hypo and hypercorticolism (respectively Lewis and Fisher rats) and 
administration of chronic stress (restraint stress or chronic social stress).  
While these publications and others have added to the understanding and 
identification of molecular mediators that are common to stress- and nociception 
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processing such as cytokines, growth factors and monoamines, the respective 
interactions remain unclear. This is especially true regarding possible long term 
alterations at the spinal cord level induced by early life stress.  
Early life stress has been shown to be a factor of vulnerability or resilience 
regarding several psychiatric disorders. Despite the tight association and overlap 
between stress- and pain-related systems very little is known about the potential 
influence of early life stress on pain sensitivity with respect to chronic pain 
conditions in later life. Furthermore, even though early life stress has been 
identified as a factor predisposing to chronic pain conditions, the large majority 
of the studies on potentially underlying mechanisms have been investigating 
supra-spinal but not spinal levels of processing.  
This thesis sought to investigate if and how early life stress affects pain 
sensitivity and the associated spinal processing in Sprague Dawley rats. This 
research was done in several steps:  
- The first study investigated the impact of early life stress (3h MS
protocol) on pain sensitivity at adult age in the framework of
physiological and neuropathic conditions (CCI surgery).
- The second study aimed to determine if early life stress had comparable
consequences for (CFA-induced) inflammatory pain and spinal
biomarkers as for neuropathy-related pain.
- In the third study, a more complex protocol was set up. Based on the
multiple hits hypothesis, I aimed to determine if a second stress insult at
adult age in animals previously exposed to early life stress would lead
to an allostatic load potentially enhancing vulnerability to chronic pain.
The data collected during these experiments allowed me to write the 3 
manuscripts composing this thesis. Furthermore, I participated to a study 
initiated prior my arrival on the effect of chronic social stress on neuropathic 
pain. This article is given in the supplement.  
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Two additional projects were started during the final years of my Ph. D. One 
aimed to determine the role of microglia in the alterations identified in the first 
study. Indeed, some of the data collected could suggest that reduced activity 
and/or number of microglial cells could underlie the reduced pain sensitivity 
during the onset of chronic pain. The hypothesis was that MS could lead to an 
early activation of enduring adaptive modifications of immune system. These 
alterations might thus have positive repercussions during the onset of 
neuropathic pain. Assuming that the respective microglial cells could be hypo-
functional, I intended to pharmacologically enhance their activation. So far 
preliminary results have been obtained and are displayed in chapter 8.   
The final project aimed to characterize the electrophysiological response 
behavior of spinal nociceptive neurons following early life stress. The use of in 
vivo electrophysiology allows the determination of the response behavior of 
nociceptive dorsal horn neurons in naïve and MS rats. Furthermore, this 
approach provides a possibility to investigate early life stress-related differences 
in central sensitization as well as to characterize the influence of potentially 
altered descending pain modulation pathways. A description of this project can 
also be found in chapter 8. 
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5.1. Abstract 
Early life stress (ELS) leads to a permanent reprogramming of biochemical 
stress response cascades that may also be relevant for the processing of chronic 
pain states such as neuropathy. Despite clinical evidence, little is known about 
ELS-related vulnerability for neuropathic pain and the possibly underlying 
etiology. 
In the framework of experimental studies aimed at investigating the respective 
relationships we used the established ELS model of maternal separation (MS). 
Rat dams and neonates were separated for 3 h/day from post-natal day 2 to 12. 
At adulthood, noxious mechanical and thermal thresholds were assessed before 
and during induction of neuropathic pain by chronic constriction injury (CCI). 
The potential involvement of spinal glutamatergic transmission, glial cells, pro-
inflammatory cytokines and growth factors was studied by using qPCR.  
MS per se did not modify pain thresholds. But, when exposed to neuropathic 
pain, MS rats exhibited a marked reduction of thermal sensitivity and a delayed 
development of mechanical allodynia/hyperalgesia when compared to control 
animals. Also, MS did not alter glucocorticoid receptor mRNA levels, but 
prevented the CCI-induced down-regulation of NR1 and NR2 sub-units of the 
NMDA receptor and of the glutamate transporter EAAT3 as observed at 21 days 
post-surgery. Additionally, CCI-provoked up-regulation of glial cell markers 
was either prevented (GFAP for astrocytes) or dampened (Iba1 for microglia) 
by MS. Pro-inflammatory cytokine mRNA expression was either not affected 
(IL-6) or reduced (IL-1β) by MS shortly after CCI. The growth factors GDNF 
and NGF were only slightly downregulated 4 days after CCI in the MS-treated 
animals. The changes in glutamatergic signaling, astroglial and cytokine 
activation as well as neurotrophin expression could, to some extent, explain 
these changes in pain behavior. Taken together, the results obtained in the 
described experimental conditions support the mismatch theory of chronic stress 
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where an early life stress, rather than predisposing individuals to certain 
pathologies, renders them resilient. 
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5.2. Introduction 
The nervous and the immune system are involved in the stress response as well 
as in the processing of pain (Krishnan and Nestler, 2008; Schwaller and 
Fitzgerald, 2014). Stress-related structural or functional modifications within 
these systems are hence likely to impact pain sensitivity (Sandkühler, 2009). 
Early life is a critical period for the normal development of individuals. 
Preclinical (Schmidt, 2010) and clinical (Heim et al., 2010) studies have 
demonstrated that early life stress can have a major impact on neuronal circuits 
and immune system development, possibly leading to enhanced vulnerability to 
physio- and psychopathological states at adulthood. A well-established way of 
modelling early life stress in rodents is to expose new-born pups to maternal 
separation (MS) (Levine, 2001). MS has been shown to induce abnormal 
development of immune and nervous systems (Roque et al., 2015). Among these 
perturbations is a long term modification of the central neuronal circuitry 
involved in relaying noxious stimuli and in controlling pain sensitivity during 
normal and pathological states (Chung et al., 2007; Uhelski and Fuchs, 2010; 
Weaver et al., 2007). Neuropathic pain is a chronic pain state that generally 
occurs following nerve damage. As a consequence, significant peripheral and 
central remodeling leads to enhanced pain sensitivity (hyperalgesia), induction 
of pain by a normally non painful stimulus (allodynia) and to spontaneous pain 
(for review see: von Hehn et al., 2012). Despite significant advances in basic 
and clinical research, this condition remains difficult to treat since our 
understanding of the underlying pathophysiological mechanisms is still 
insufficient (von Hehn et al., 2012).  
Although spinal synaptic transmission of noxious stimuli constitutes the first 
relay of this network, it has scarcely been studied in the context of stress. Among 
the molecular mediators involved in nociceptive transmission and in the 
establishment of neuropathic pain, several key players such as the glucocorticoid 
receptor (GR) (Ladd et al., 2004; Wang et al., 2005), glutamatergic receptors 
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and transporters (Toya et al., 2014), cytokines (Alvarez et al., 2013) and 
neurotrophins (Faure et al., 2007) are modulated by MS. Thus, it seems plausible 
that MS could have an impact on neuropathic pain vulnerability at least in a 
subset of individuals. In addition changes of neuro-immune and/or 
neuroendocrine systems induced by chronic stress could facilitate or hamper the 
development of chronic pain independently of classical stress processing 
pathways. To our knowledge, no study has investigated the effect of MS on pain 
thresholds and potential spinal molecular mediators involved in the change of 
nociceptive transmission under conditions of neuropathy. In the present work 
we used behavioral (mechanical and thermal thresholds) and biochemical 
(mRNA expression of spinal markers) approaches to assess the impact of MS 
on the onset and the maintenance of neuropathic pain. In order to induce this 
pain condition, we decided to use the well-established chronic constriction 
injury (CCI) model initially described by Bennett and Xie (1988).  
5.3. Material and Methods 
5.3.1. Animals 
Female (nulliparous) and male Sprague Dawley rats were purchased from 
Harlan Laboratories (Netherland). They were then reared in our facility to 
provide the offspring used for the experimental studies. All animals were housed 
under standardized conditions: temperature controlled room (21-23°C), relative 
humidity 60 ± 10%, 12 h light/dark cycle, food and water provided ad libitum. 
Rats were only briefly handled twice per week during the cage changes. Except 
for the maternal separation procedure in the respective groups, pups were left 
undisturbed until weaning at post-natal day 21. Experiments started when the 
animals reached the age of 8 weeks.  
Animals were divided in 4 groups (see Fig. 1) depending on the stress and pain 
conditions they were exposed to: controls CON (no MS, no CCI; n=10), 
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CON+CCI (no MS but CCI; n=15), MS (MS but no CCI; n=15), and MS+CCI 
(MS and CCI; n=14). 
All animal experiments were carried out in accordance with the Directive 
2010/63/EU of the European Parliament and of the Council of 22 September 
2010 on the protection of animals used for scientific purposes and met the 
ARRIVE guidelines. The animal procedures were approved by the Animal 
Experimentation Ethics Committee (AEEC) of the University of Luxembourg 
(Project ID 15-SPM-01-UH) and the "Ministère de l'Agriculture, de la 
Viticulture et de la Protection des consommateurs". 
5.3.2. Maternal separation 
Maternal separation was carried out on at least four different litters. The day 
pups were first seen was marked as P0. From P2 to P12 pups were separated 
from the dam, placed on a heated pad at 33 °C (+/- 2°C) and left undisturbed for 
3 hours/day. At the end of each separation period pups were returned to their 
home cage. No other manipulation was done than indicated.  
5.3.3. Chronic constriction injury (CCI) surgery 
At two months of age, after baseline behavioral testing, rats underwent the CCI 
surgery. They were deeply anaesthetized with isoflurane (4.5% for induction, 
2.0-2.2% for maintenance) during the entire procedure using an anesthesia 
apparatus (Univentor 400, Zejtun, Malta). The right sciatic nerve was exposed 
in the mid-thigh and three natural chromic gut 4-0 (Stoelting Europe, Dublin, 
Ireland) loose ligatures were placed around the nerve at a distance of 1 mm. The 
muscle layer was closed with 4-0 silk sutures and the skin layer with surgical 
skin staples. 
In case animals presented signs of autotomy in the course of the experiments, 
they were immediately removed and sacrificed in order to minimize their 
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suffering. For this reason 2 CON+CCI and 3 MS+CCI animals were sacrificed 
before the end of the neuropathy protocol and their results were discarded. 
5.3.4. Behavioral tests 
Noxious mechanical and thermal thresholds were assessed in 54 male rats using 
the von Frey monofilament test and the cold plate test respectively. All 
behavioral tests were done in the morning between 8:00 and 12:00 a.m. During 
each session, animals were moved to the experimentation room at least 1 hour 
before the start of the experiments to allow them to habituate to the environment. 
Rats underwent the von Frey monofilament test, followed by the cold plate test. 
Baseline thresholds were assessed on three consecutive days prior to the CCI 
surgery. To assess the impact of maternal separation on neuropathic pain, the 
pain sensitivity was tested at days 4, 7, 10, 14, and 21 after the CCI surgery. 
5.3.4.1. Von Frey monofilament test 
To evaluate mechanical pain thresholds, animals were placed on a metal wire 
mesh floor, covered by a Plexiglas chamber (19.5x19.5x14 cm) and given at 
least 15 minutes to acclimate, until exploratory activity ceased. Filaments 
(OptiHair, MarstockNervTest, Germany) were applied perpendicularly on the 
mid-plantar region of the hind paw and pressure was gradually increased until 
the deflection point of the filament. Pain thresholds were determined with the 
ascending and descending method of limits with forces ranging from 8 to 256 
mN. The threshold force was defined as the first filament evoking at least a 40% 
response rate (two withdrawals out of five consecutive applications). Both hind 
paws were tested three times in an alternative order and the mean results were 
defined as the respective thresholds. Results were then normalized for each 
animal by computing the ratio of ipsi- to contralateral side expressed in percent. 
Finally, data for each group were averaged. 
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5.3.4.2. Cold plate test 
This test was used to assess stress- and pain-related changes in thermal 
thresholds. To avoid sensitization it was performed at least 30 minutes after the 
von Frey test. In order to establish a baseline, rats were placed on the cold plate 
set at a temperature of 5°C for maximally three minutes (cut-off time). In each 
session, this procedure was repeated three times with a ten minute interval. 
Lifting or licking the paw as well as jumping are commonly considered as 
behavioral indicators of pain. We selected the number of paw lifts as behavioral 
parameter for the assessment of thermal thresholds since CCI-induced 
neuropathy produced pronounced limping and reduced the animal capacity to 
jump. The mean values of the three cold plate tests were defined as the score of 
a session. 
5.3.5. Reverse transcription and Real-Time qPCR 
Rats were rapidly killed by decapitation under deep anesthesia (Isoflurane 
4.5%). Levels L4/L5 of the spinal cord were harvested and divided into 
ipsilateral-contralateral sides. Total RNA was extracted by the acid guanidium–
thiocyanate–phenol–chloroform method using TRIzol® reagent (Life 
Technologies, Halle, Belgium). The aqueous phase containing RNA was 
collected and precipitated with isopropanol. The RNA pellet was washed with 
70% ethanol, air dried, dissolved in Rnase free water (VWR, Leuven, Belgium) 
and stored at -80°C until further analysis. 
RNA quality was assessed with the Experion system or the Experion Automated 
Electrophoresis Station (Bio-Rad Laboratories, Nazareth, Belgium) using 
StdSens chips (Bio-Rad). The RNA quality indicator was between 7 and 9. RNA 
concentration was measured using the Nanodrop 2000 spectrophotometer 
quantification system (Isogen Life Sciences, Netherlands). Reverse 
transcription was performed with the Improm-II reverse transcription kit 
(Promega, Leiden, Netherlands) to convert 500 ng of total RNA into cDNA with 
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0.5 µg/ml of Oligo dT15 primer by using a C1000 Touch thermocycler. qPCR 
experiments were carried out on a CFX 96 real time system (Bio-Rad, Nazareth, 
Belgium) with 12.5 ng of cDNA in a final volume of 20 µl using PerfeCTa® 
SYBR® Green SuperMix (VWR, Leuven, Belgium) containing 2X reaction 
buffer with optimized concentrations of MgCl2, dNTPs, AccuStart Taq 
Polymerase, SYBR Green I dye, stabilizers as well as forward and reverse 
primers at 2 µM. Primers were designed using Beacon Designer™ software, 
tested for sequence specificity using the Basic Local Alignment Search Tool at 
NCBI and validated on spinal cord (for list of primers used in the study, see 
Table 1). The following protocol was used: polymerase activation at 95°C for 3 
min, 40 cycles of denaturation at 95°C for 10 s and annealing at 61°C for 30 s. 
Finally, the melting curves were recorded between 65°C and 95°C in 0.5°C 
intervals. Each qPCR experiment was run in triplicate and no-template controls 
were added as negative controls. Threshold cycle values (Cq) were used to 
compute the amount of target gene mRNA in relation to the reference gene 
mRNA (actin, beta). ∆Cq represents the difference between the number of 
cycles that were necessary to detect the PCR products of the target genes and 
that of the reference gene. ∆∆Cq indicates the difference between the ∆Cq of 
the experimental groups (CON+CCI, MS and MS+CCI) and the ∆Cq of the 
control animals (CON) animals.  
The data were expressed as 2-∆∆Cq and the mean of the right injured side was 
computed for each group.  
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Table 2: Summary of the primers used 
Name 
gene 
Accession Sequence 
Amplicon 
size (bp) 
Actin β 
NM_031144.
3 
F: 5' GCT GAG AGG GAA ATC GTG CGT GAC 3' 
96 
R: 5' GGA GGA AGA GGA TGC GGC AGT GG 3' 
GR 
NR3C1 
NM_012576.
2 
F: 5' TGG AAA CCT GCT CTG CTT TG 3' 
102 
R: 5' GAG GAG ACA AAC AGC ATG TG 3' 
NR1  
GRIN1 
NM_001270
608.1 
F: 5' GGT TGC GTG GGC AAC ACC AA 3' 
80 
R: 5' CCG TCC GCA TAC TTA GAA GA 3' 
NR2a 
GRIN2a 
NM_012573.
3 
F: 5' CAG ATA ACA ATA AGA ACC ACA AG 3' 
83 
R: 5' AAC ATC GCT ACA GTC CTT 3' 
NR2b 
GRIN2b 
NM_012574.
1 
F: 5' AGG AAC CAG GCT ACA TCA AAA A 3' 
197 
R: 5' TAG TGA TCC CAC TGC CAT GTA G 3' 
EAAT2 
Slc1a2 
NM_017215.
2 
F: 5' ATG CTC CTC ATT CTC ACA G 3' 
103 
R: 5' CTA CAT TGA CCG AAG TTC TC 3' 
EAAT3 
Slc1a1 
NM_013032.
3 
F: 5' TCA TAG TCG TGC GGA AGA AC 3' 
111 
R: 5' AGC GGA ATG TAA CTG GAA GG 3' 
GFAP 
NM_017009.
2 
F: 5' TAC AGG AAA TTG CTG GAG GG 3' 
104 
R: 5' GAC ACA GAT TTG GTG TCC AG 3' 
Iba1 
AIF1 
NM_017196.
3 
F: 5' AAT GAT GCT GGG CAA GAG AT 3' 
129 
R: 5' ACC TCC AAT TAG GGC AAC TC 3' 
IL-1β 
NM_031512.
2 
F: 5' AGA GTG TGG ATC CCA AAC AA 3' 
105 
R: 5' GGA ACT GTG CAG ACT CAA AC 3' 
IL-6 
NM_012589.
2 
F: 5' CCA GAG TCA TTC AGA GCA ATA C 3' 
116 
R: 5' CTT CTC CAT TAG GAG AGC AT 3' 
GDNF 
NM_019139.
1 
F: 5' GTG TTG CTC CAC ACC GCG TCT 3' 
73 
R: 5' GGT CTT CGG CGG GCG CTT C 3' 
NGF 
NM_001277
055.1 
F: 5' CAC GGA CAT CAA GGG CAA GGA 3' 
96 
R: 5' GCT CGG CAC TTG GTC TCA AA 3' 
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5.3.6. Statistical analysis 
Data are presented as mean ± SEM. Homogeneity of variance was tested using 
Levene’s test or Shapiro-Wilk test. Statistical analysis for the von Frey and the 
cold plate experiments was carried out using a two-way (time x group) repeated 
measures analysis of variance (ANOVA) followed by a Tukey’s multiple 
comparison post hoc test to check for differences between groups. 
For all gene expression experiments, the ipsilateral spinal cord of CON (no CCI) 
served as control and the relative expression level was set to 1. The expression 
levels of the treatment groups CON+CCI 4d, CON+CCI 21d, MS, MS+CCI 4d 
and MS+CCI 21d were expressed as fold of CON. For statistical analysis, these 
relative expression levels (fold) were compared using a two-way (stress x CCI) 
ANOVA with Tukey’s multiple comparison post hoc test. 
A summary of the statistical analysis is given in Table 2. 
Figure 12: Experimental timeline. After birth (P0), rats were separated into 2 experimental groups. The first 
one was left undisturbed while the second underwent the maternal separation (MS) procedure from postnatal 
day 2 (P2) to P12. At two months of age, the animals in each of the two groups were either assigned to a non-
operated group (CON resp. MS) or to a group that underwent chronic constriction injury (CON+CCI resp. 
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MS+CCI). All four groups were then tested for noxious mechanical and cold sensitivity three days in a row to 
assess baseline values. At day 0, CCI was performed in the respective groups (CON+CCI and MS+CCI) and 
further behavioral tests were performed in all of the animals on days 4, 7, 10, 14 and 21.  After the last testing, 
animals were sacrificed and the L4-L5 segments of the spinal cord were removed for qPCR analysis of 
biochemical markers. Two additional sets of animals in the CON+CCI and MS+CCI groups were included to 
study changes in the expression of biochemical markers early after CCI surgery. They did not undergo 
behavioral tests and were sacrificed 4 days post-CCI. 
5.4. Results 
5.4.1. Effect of MS and CCI surgery on pain-related behavior 
5.4.1.1 Mechanical pain sensitivity 
Baseline mechanical thresholds were assessed in all four groups before 
performing CCI-surgery in the respective groups at d0 (Fig. 13). No significant 
differences could be found between groups (CON: 103.27 ± 5.65; CON+CCI: 
94.68 ± 4.20; MS: 99.29 ± 5.30; MS+CCI: 96.61 ± 4.00), indicating that MS per 
se had no effect on mechanical pain threshold. This was true for the entire period 
of testing in which the MS group did not present any significant differences as 
compared to CON (d4: CON 101.94 ± 5.08, MS 101.18 ± 5.46; d7: CON 104.44 
± 6.34, MS 108.46 ± 4.91; d10: CON 100.15 ± 6.61, MS 96.23 ± 3.83; d14: 
CON 94.48 ± 6.04, MS 99.96 ± 2.66; d21: CON 105.41 ± 5.98, MS 111.22 ± 
8.32).  
As expected, CCI-surgery resulted in a decrease of mechanical thresholds in 
CON+CCI and MS+CCI groups. In CON+CCI the threshold constantly dropped 
until d14 and then started to recover on d21 (d4: 71.12 ± 10.22; d7: 46.94 ± 7.83; 
d10: 41.85 ± 5.82; d14: 24.32 ± 2.05; d21: 42.14 ± 6.47). When compared to 
CON this decrease turned out to be significantly different at d4 (p<0.01) and 
highly significant from d7 on (p<0.001). The reduction of mechanical thresholds 
observed in MS+CCI animals did not display a parallel time course. Pain 
thresholds slowly but constantly decreased until the end of the experiment at 
d21 without showing recovery (d4: 93.98 ± 9.16; d7: 77.18 ± 5.44; d10: 78.21 
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± 7.50; d14: 59.51 ± 9.95; d21: 43.86 ± 7.04). When comparing to the group 
only exposed to MS, significant differences were found for all time points (d4: 
p<0.05, d7: p<0.01, d14: p<0.001, d21: p<0.001). 
Animals with a history of maternal separation (MS+CCI) exhibited a clearly 
higher mechanical threshold after induction of neuropathic pain than rats that 
were not subjected to this early life stress (CON+CCI). Shortly after CCI surgery 
at d4, a significant difference (p<0.05) between the two groups could already be 
seen. From d7 to d14, the difference between groups was pronounced (d7: 
p<0.01; d10 and d14: p<0.001). At d21 the mechanical thresholds of CON+CCI 
and MS+CCI groups became comparable again. 
Taken together, these results indicate that MS protracts the appearance of 
mechanical hyperalgesia associated with neuropathy. 
Figure 13: Maternal separation stress reduces CCI-induced mechanical and cold hypersensitivity. Mechanical 
pain thresholds were measured by the Von Frey test before and during the 21 days of neuropathy and 
expressed as percent ratio of ipsi- to contralateral side. Before induction of CCI, all four groups presented 
similar mechanical thresholds. The control (CON, black circles) and the maternally separated group (MS, black 
triangles) were not subjected to CCI; their mechanical threshold was unchanged in the course of the 
experiment. In the control group that underwent CCI surgery (CON+CCI, white circles) the mechanical pain 
threshold decreased until day 14 and started to recover at day 21. The maternally separated group that was 
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subjected to CCI (MS+CCI, white triangles) reacted with a steady decrease of pain thresholds until the end of 
the experiment. MS+CCI animals were less sensitive than the CON+CCI group for up to 14 days. 
5.4.1.2. Thermal pain sensitivity 
As described for the assessment of baseline mechanical thresholds, the thermal 
sensitivity was measured in the four experimental groups prior to CCI on d0 
(Fig. 14). No significant differences in the number of paw lifts were observed 
between the groups (CON: 0.03 ± 0.02, CON+CCI: 0.00, MS: 0.00, MS+CCI: 
0.00). The thermal sensitivity of CON and MS animals remained constantly low 
throughout the experiment; the two groups did not display any significant 
differences.  
CCI surgery in the CON+CCI and MS+CCI groups resulted in a decrease of 
nociceptive thermal thresholds. The rise in paw lifts was much more pronounced 
in the CON+CCI animals and steadily increased throughout the experiment until 
d21 (d4: 5.82 ± 0.66, d7: 5.21 ± 0.94, d10: 8.68 ± 1.64, d14: 10.77 ± 1.85, d21: 
11.56 ± 1.73). The comparison with its control CON yielded a high statistical 
significance (p<0.001) for all time points. In MS+CCI the number of paw lifts 
slightly increased after induction of neuropathy (d4: 1.71 ± 0.64, d7: 2.14 ± 0.70, 
d10: 2.17 ± 0.92) without gaining statistical significance when comparing to the 
MS group. From d14 on the thermal sensitivity further increased reaching a 
significant level (d14: 2.53 ± 0.73, p<0.05; d21: 4.43 ± 0.74, p<0.001). Rats that 
underwent early life stress (MS+CCI) developed clearly less thermal 
hyperalgesia under conditions of neuropathic pain than animals that grow up 
normally (CON+CCI). This difference could already be seen early after 
induction of CCI and lasted until the end of the experiment. Statistical tests 
revealed significances between the two groups of p<0.01 for d4, p<0.05 for d7 
and p<0.001 for d10, d14 and d21. Altogether these results suggest that animals 
that were subjected to MS present reduced and delayed development of thermal 
hyperalgesia in neuropathic pain states. 
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Figure 14: Maternal separation stress reduces CCI-induced mechanical and cold hypersensitivity. Thermal pain 
thresholds were evaluated by using the cold plate test. The number of lifts of the ipsilateral (right) paw was 
recorded before and up to 21 days after induction of CCI. No paw lifts could be observed in the baseline testing 
of all four groups before CCI surgery. The two groups, CON (black circles) and MS (black triangles), that were 
not exposed to neuropathic pain remained insensitive to cold stimuli throughout the testing period. Control 
animals undergoing CCI surgery (CON+CCI, white circles) rapidly developed a pronounced cold allodynia that 
steadily increased until the end of the experiment at day 21. Rats with a history of early life stress that were 
exposed to neuropathic pain (MS+CCI, white triangles), exhibited a slight but insignificant increase in cold 
sensitivity during the first 10 days of the testing period and exhibited significant cold allodynia only in the late 
phase of CCI at d14 and d21. Data are expressed as mean ± SEM per group per day. * represents a significant 
difference between CON and CON+CCI or MS and MS+CCI for the individual time point (*p < 0.05, **p < 0.01, 
***p < 0.001). # indicates a significant difference between CON+CCI and MS+CCI (#p < 0.05, ##p <0.01, ###p 
< 0.001). 
5.4.2. Impact of early life stress and neuropathic pain on the 
expression of spinal biochemical markers 
5.4.2.1. Glucocorticoid receptor regulation 
CON and MS presented comparable GR mRNA levels (1.03 ± 0.25 and 1.16 ± 
0.16 resp.) (Fig. 15A), suggesting that maternal separation stress per se did not 
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affect the expression of the glucocorticoid receptor. The induction of CCI 
resulted in a significant downregulation of GR mRNA at d4 in CON+CCI (0.72 
± 0.11; p<0.01 compared to CON) as well as in MS+CCI rats (0.72 ± 0.41; 
p<0.001 compared to MS). At a later state of neuropathy, on d21, GR mRNA 
expression returned to normal levels in the CON+CCI group (1.02 ± 0.85; 
p<0.001 to CON+CCI 4d) and in MS+CCI animals (0.99 ± 0.09; p<0.001 to 
MS+CCI 4d). The two-way ANOVA revealed significant main effects only for 
CCI, not for stress or interaction (Table 3). 
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Table 3: Analysis of variance (ANOVA): Summary of F-values of the behavioral (two-way repeated measures) 
and biochemical (two-way) studies
Two-way repeated measures ANOVA 
interaction time group 
Von Frey test F (15,225) = 6. 84 F(5,225) = 13.09 F(3,45) = 41.88 
Cold plate test F(15,225) = 14.38 F(5,225) = 26.09 F(3,45) = 33.25 
p < 0.0001 for all values 
Two-way ANOVA 
interaction CCI stress 
GR F(2,37) = 1.195 
P=0.3141 
F(2,37) = 26.35 
P<0.0001 
F(1,37) = 0.4873 
P=0.4895 
NR1 F(2,36) = 8.798 P=0.0008 
F(2,36) = 0.9035 
P=0.4145 
F (1, 36) = 13. 78 
P=0.0007 
NR2a F(2,36) = 9.486 
P=0.0005 
F(2,36) = 8.985 
P=0.0007 
F(1,36) = 17.45 
P=0.0002 
NR2b F(2,37) = 1.896 
P=0.1645 
F(2,37) = 2.397 
P=0.1050 
F(1,37) = 19.47 
P<0.0001 
EAAT2 F(2,36) = 0.7511 
P=0.4791 
F(2,36) = 20.60 
P<0.0001 
F(1,36) = 5.740 
P=0.0219 
EAAT3 F(2,36) = 11.14 
P=0.0002 
F(2,36) = 8.542 
P=0.0009 
F(1,36) = 44.50 
P<0.0001 
Iba1 F(2,36) = 1.013 
P=0.3734 
F(2,36) = 47.00 
P<0.0001 
F(1,36) = 14.23 
P=0.0006 
GFAP F(2,36) = 2.701 
P=0.0807 
F(2,36) = 6.238 
P=0.0047 
F(1,36) = 6.033 
P=0.0190 
IL-1β F(2,36) = 3.310 P=0.0479 
F(2,36) = 11.87 
P=0.0001 
F(1,36) = 5.701 
P=0.0223 
IL-6 F(2,36) = 3.259 
P=0.0500 
F(2,36) = 24.10 
P<0.0001 
F(1,36) = 0.9615 
P=0.3334 
GDNF F(2,36) = 4.952 
P=0.0126 
F(2,36) = 1.895 
P=0.1651 
F(1,36) = 6.573 
P=0.0147 
NGF F(2,36) = 23.18 
P<0.0001 
F(2,36) = 0.0808 
P=0.9225 
F(1,36) = 0.02879 
P=0.8662 
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5.4.2.2. Regulation of glutamate receptors and transporters 
In comparison to CON, MS per se significantly increased the mRNA expression 
of all three examined subunits of the NMDA receptor, NR1 (CON: 1.01 ± 0.07, 
MS: 1.60 ± 0.06; p<0.05), NR2a (CON: 1.01 ± 0.09, MS: 1.65 ± 0.05; p<0.001) 
and NR2b (CON: 1.07 ± 0.15, MS: 1.54 ± 0.06; p<0.01) (Fig. 15B, 15C, 15D).  
In the initial post-surgical phase, at d4, CCI had no influence on the mRNA 
levels of NR1 (1.12 ± 0.08), NR2a (1.08 ± 0.6) and NR2b (0.99 ± 0.1) in 
CON+CCI rats. In contrast, MS+CCI animals reacted with a significant decrease 
of NR1 (1.07 ± 0.11; p<0.05 to MS) and NR2a (0.94 ± 0.07; p<0.001 to MS) 
mRNA levels and a clear tendency to reduced mRNA expression in NR2b (1.15 
± 0.17) at this time point, now being comparable to CON+CCI.  
At post-CCI day 21, animals from the CON+CCI group presented a trend to 
reduced NR1 (0.78 ± 0.05; n.s. to CON, but p<0.01 to CON+CCI 4d) and 
significantly decreased NR2a levels (0.74 ± 0.06; p<0.05 to CON), but no 
significant change in NR2b (0.86 ± 0.05) mRNA expression.  
In MS+CCI animals a tendency to recover could be observed on d21. The 
mRNA levels of all three subunits increased slightly (NR1: 1.24 ± 0.17, NR2a: 
1.19 ± 0.21, NR2b: 1.43 ± 0.15), returning nearly to basal values, except for 
NR2a which was still significant different from MS (p<0.05). Nevertheless, for 
NR1, NR2a and NR2b a significant difference (p<0.01, p<0.05 and p<0.01 
resp.) to the CON+CCI group could be assessed. Generally, significant main 
effects were revealed for stress (NR1, NR2a, NR2b), CCI (NR2a) and 
interaction (NR1, NR2a) (Table 3). 
EAAT2 mRNA levels did not significantly differ between non-injured CON and 
MS animals (CON: 1.02 ± 0.1; MS: 0.93 ± 0.48) (Fig 15E). Post-CCI, at d4, 
CON+CCI and MS+CCI groups presented a similar and significant reduction of 
EAAT2 mRNA levels when compared to the respective controls (CON+CCI: 
0.67 ± 0.03, p<0.001 to CON; MS+CCI: 0.63 ± 0.04, p<0.01 to MS). In the later 
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phase of the neuropathic state, at d21, EAAT2 mRNA levels of CON+CCI 
returned approximately to basal values (0.89 ± 0.05), thus being no longer 
significantly different from CON, but remaining different from CON+CCI at d4 
(p<0.001). In the same line the EAAT2 mRNA expression in MS+CCI animals 
slightly increased at d21 (0.73 ± 0.05), leading also to a loss of significant 
difference to MS. 
Regarding EAAT3, early life stress had a clear impact on the mRNA expression 
(Fig. 15F). The mRNA level increased to 1.38 ± 0.01 in MS and was hence 
significantly higher than seen in CON (1.00 ± 0.03; p<0.001). Induction of 
neuropathic pain had no effect on the CON+CCI group at d4 (1.13 ± 0.06), but 
led to a significant decrease of EAAT3 mRNA levels in the maternally separated 
animals MS+CCI (1.13 ± 0.06; p<0.01 to MS), that now were similar to 
CON+CCI. At d21 post-surgery the EAAT3 mRNA level dropped in the 
CON+CCI group (0.8 ± 0.05; n.s. to CON but p<0.001 to CON+CCI 4d), 
whereas the level slightly increased in the MS+CCI animals (1.20 ± 0.06), thus 
being no longer significantly different from MS. The small downregulation in 
CON+CCI 21d and the minor upregulation in MS+CCI 21d finally resulted in a 
highly significant difference between these two groups (p<0.001). Significant 
main effects were obtained for stress (EAAT2, EAAT3), CCI (EAAT2, EAAT3) 
and interaction (EAAT3) (Table 3). 
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Figure 15: Regulation of actors of spinal glutamatergic synapse function. Gene expression in the spinal cord 
was examined for the glucocorticoid receptor (GR) (A), the NMDA receptor subunits NR1 (B), NR2a (C), NR2b 
(D) and the glutamate transporters EAAT2 (E) and EAAT3 (F). Mean mRNA levels where assessed in control
(CON, black bars) and maternally separated animals (MS, white bars) under three different conditions: without 
CCI surgery (no CCI), CCI lasting four days (CCI 4d) and CCI lasting 21 days (CCI 21d). (A) GR expression did not
differ between CON and MS animals in the three conditions. GR mRNA was downregulated at 4 days after
induction of CCI and recovered in the late phase at 21 days. (B-D) The three NMDA receptor subunits followed 
a similar regulation scheme: mRNA upregulation in MS animals per se, downregulation in MS 4 days after CCI 
but no change in CON, and downregulation in CON after 21 days of CCI when MS started to recover. (E, F) The 
regulation of mRNA expression was different in the glial EAAT2 and the neuronal EAAT3 transporter. The level 
of EAAT2 mRNA did not differ between CON and MS under the conditions of no CCI and CCI 4d. Only in the CCI
21d a small difference was obtained. CCI surgery downregulated EAAT2 mRNA at 4d followed by a recovery at 
21d at least in CON. The regulation of EAAT3 mRNA resembles the scheme seen for the NMDA subunits:
upregulation in MS per se, downregulation in MS 4 days after CCI but no change in CON, and downregulation
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in CON after 21 days of CCI. Data are expressed as relative expression level (fold) of “CON, no CCI” (=1) and 
are shown as mean ± SEM. # represents a significant difference between “CON, no CCI” and “CON+CCI 4d” or 
“CON+CCI 21d” or between “MS, no CCI” and “MS+CCI 4d” or “MS+CCI 21d” (#p < 0.05, ##p < 0.01, ###p < 
0.001). * indicates a significant difference between groups for other comparisons than the ones covered by # 
(*p < 0.05, **p < 0.01, ***p < 0.001). 
5.4.2.3. Glial cell activation 
The expression of Iba1 (ionized calcium-binding adaptor protein-1) mRNA in 
microglia was affected by early life stress (Fig. 16A). The MS group exhibited 
a significantly reduced mRNA level (0.74 ± 0.01) as compared to CON (1.00 ± 
0.05; p<0.05). Shortly after CCI surgery, the Iba1 mRNA expression 
significantly increased in the CON+CCI (2.69 ± 0.08; p<0.001 to CON) as well 
as in the MS+CCI group (1.84 ± 0.14; p<0.001 to MS). The difference between 
the two groups did stay statistically significant (p<0.05), as seen between CON 
and MS. At the early chronification phase of neuropathic pain (d21), the Iba1 
mRNA level decreased in the CON+CCI group (1.84 ± 0.03; p<0.001 to 
CON+CCI 4d) and was still significantly different from the basal level in CON 
(p<0.01). The expression in the MS+CCI group, did however not change as 
compared to d4 and hence remained significantly different from the non-injured 
MS (p<0.01). At this time point the difference between CON+CCI and MS+CCI 
became smaller and lost significance. In summary, maternal separation stress 
led to a decrease of microglia activation under normal conditions (no 
neuropathy) and to a reduced upregulation of Iba1 mRNA under CCI conditions. 
In contrast to the upregulation of the microglia marker Iba1 observed in animals 
subjected to early life stress, MS per se had no impact on the mRNA expression 
of the astrocytic marker GFAP (glial fibrillary acidic protein) (CON: 1.03 ± 
0.11, MS: 1.07 ± 0.06) (Fig. 16B). CCI led to a statistically significant 
upregulation of GFAP mRNA in CON+CCI at d4 post-surgery (1.43 ± 0.08; 
p<0.05 to CON), but not in the MS+CCI group (1.24 ± 0.9). Nevertheless, the 
difference between the CON-CCI and the MS+CCI groups did not reach 
statistical significance in the early phase of neuropathy. Later on, at d21, the 
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GFAP mRNA stayed upregulated in the CON+CCI animals (1.44 ± 0.07; p<0.05 
to CON) and the MS+CCI group remained unaffected by the surgery (1.09 ± 
0.08). In this state, a significant difference between the two groups could be 
observed (p<0.05). Taken together, MS prevented the upregulation of GFAP 
mRNA triggered by CCI. The two-way ANOVA revealed significant main 
effects for stress and CCI for Iba1 as well as for GFAP (Table 3). 
5.4.2.4. Regulation of pro-inflammatory cytokines 
The IL-1β mRNA expression was slightly, but not significantly reduced in MS 
per se (CON: 1.02 ± 0.12, MS: 0.77 ± 0.04) (Fig. 16C). On post-CCI day 4, IL-
1β mRNA was clearly upregulated in CON+CCI (2.69 ± 0.82; p<0.01 to CON) 
but only a tendency to higher levels was observed in MS+CCI animals (1.15 ± 
0.13), leading to a significant difference between the two groups (p<0.05). The 
IL-1β mRNA level started to decrease in CON+CCI animals at d21 after CCI 
surgery (1.79 ± 0.08; n.s. to CON and n.s. to CON+CCI 4d) but further increased 
in MS+CCI (1.83 ± 0.25; p<0.01 to MS), resulting in the loss of a significant 
difference between the CON+CCI and MS+CCI group. The data do hence 
suggest that the early life stress tended to decrease the expression of IL-1β under 
normal conditions, and particularly delayed the upregulation seen in neuropathic 
states. Statistical significant main effects were obtained for stress, CCI and 
interaction (Table 3). 
Regarding the IL-6 mRNA expression, no difference was found between CON 
(1.01 ± 0.9) and MS (1.17 ± 0.09). Four days after induction of CCI the IL-6 
mRNA level increased considerably in CON+CCI (12.59 ± 1.44; p<0.001 to 
CON) and in MS+CCI (8.28 ± 1.50; p<0.01 to MS). Although the CON+CCI 
and MS+CCI groups respectively presented a 12 fold and an 8 fold increase of 
IL-6 mRNA levels, this difference did not turn out to be statistically significant 
due to high levels of variance in the two groups. In the later phase of the 
experiment, at d21, the IL-6 mRNA levels decreased significantly for 
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CON+CCI (4.08 ± 0.59; p<0.001 to CON+CCI 4d) and also dropped in 
MS+CCI (5.98 ± 0.55) being no longer significantly different from CON resp. 
MS. The statistical analysis revealed that animals with a history of maternal 
separation did not display any differences in IL-6 mRNA levels as compared to 
the respective controls. A significant main effect was only found for CCI Table 
3). 
Figure 16: Regulation of markers of spinal immunocompetent cell activation and of pro-inflammatory 
cytokines. Gene expression in the spinal cord was examined for the microglial marker Iba1 (A), the astroglial 
marker GFAP (B) and the pro-inflammatory cytokines IL-1β (C) and IL-6 (D).  Mean mRNA levels where assessed 
in control (CON, black bars) and maternally separated animals (MS, white bars) under three different 
conditions: without CCI surgery (no CCI), CCI lasting four days (CCI 4d) and CCI lasting 21 days (CCI 21d). (A) 
Iba1 mRNA levels were downregulated in MS as compared to CON. Induction of CCI upregulated the gene 
expression at 4d in both groups, the significant difference between groups remained. A beginning recovery 
could be observed at d21 in CON and a tendency to recover in MS. (B) GFAP mRNA levels did not differ between 
“CON, no CCI” and “MS, no CCI”. Neuropathy surgery upregulated the gene expression only in “CON+CCI 4d 
and 21d” but not in MS. (C) IL-1β mRNA expression tended to be lower in “MS, no CCI” as compared to “CON, 
no CCI”. After induction of CCI at d4, IL-1β was quickly upregulated in CON and started to increase in MS.. 
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Later, at day 21, the IL-1β mRNA level already decreased in CON whereas it further increased in MS. (D) IL-6 
mRNA levels did not significantly differ between CON and MS in all three conditions. The gene expression was 
highly upregulated in CON and MS 4 days after CCI surgery. Under long-term neuropathy conditions, mRNA 
levels decreased coming close to normal expression rates. Data are expressed as relative expression level (fold) 
of “CON, no CCI” (=1) and are shown as mean ± SEM. # represents a significant difference between “CON, no 
CCI” and “CON+CCI 4d” or “CON+CCI 21d” or between “MS, no CCI” and “MS+CCI 4d” or “MS+CCI 21d” (#p < 
0.05, ##p < 0.01, ###p < 0.001). * indicates a significant difference between groups for other comparisons than 
the ones covered by # (*p < 0.05, **p < 0.01, ***p < 0.001). 
5.4.2.5. Expression of neurotrophins 
MS per se did not modify GDNF mRNA levels (CON: 1.01 ± 0.07, MS 1.15 ± 
0.11) (Fig 17A). The induction of neuropathic pain had no significant influence 
on the expression of GDNF mRNA in CON+CCI animals (0.94 ± 0.10) early 
after surgery at d4, however a reduction could be observed in MS+CCI (0.88 ± 
0.04; p<0.05 to MS). After 21 days of injury, a significant decrease of the GDNF 
mRNA level took place in the CON+CCI group (0.79 ± 0.03; p<0.05 to CON), 
whereas animals with a history of early life stress reacted with an increase of 
this neurotrophin mRNA (1.20 ± 0.10; p<0.01 to MS+CCI 4d) at this time point, 
ending up with an mRNA level numerically above but not significantly different 
to MS. However, in this late phase of neuropathy, a significant difference was 
obtained when comparing CON+CCI and MS+CCI (p<0.01). Statistically 
significant main effects were obtained for stress and interaction (Table 3). 
The baseline NGF gene expression was comparable between the CON (1.15 ± 
0.62) and MS (1.01 ± 0.08) group (Fig. 17B). Four days following CCI surgery, 
NGF mRNA levels increased in CON+CCI (1.36 ± 0.06; p<0.05 to CON) and 
decreased in MS+CCI (0.79 ± 0.07, p<0.05 to MS) resulting in a highly 
significant difference between the two groups (p<0.001). After 21 days, both 
groups roughly returned to control levels (CON+CCI: 0.85 ± 0.07; p<0.001 to 
CON+CCI 4d; MS+CCI: 1.26 ± 0.10, p<0.01 to MS+CCI 4d) but remained 
significantly different from each other (p<0.01). A significant main effect was 
obtained for interaction (Table 3). 
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Figure 17: Regulation of spinal neurotrophins. Spinal gene expression was examined for the neurotrophins 
GDNF (A) and NGF (B). Mean mRNA levels where assessed in control (CON, black bars) and maternally 
separated animals (MS, white bars) under three different conditions: without CCI surgery (no CCI), CCI lasting 
four days (CCI 4d) and CCI lasting 21 days (CCI 21d). (A) GDNF mRNA expression did not differ between CON 
and MS under the conditions of no CCI and CCI 4d. In the long-term CCI condition, GDNF mRNA level differed 
between CON and MS, due to an upregulation in MS animals. (B) NGF mRNA levels were not different in “CON, 
no CCI” and “MS, no CCI” animals. The induction of CCI triggered an increase in CON and a decrease in MS 4 
days post-surgery. At d21, a recovery occurred, which partly overshoot and consequently resulted in a 
difference in mRNA expression between CON and MS. Data are expressed as relative expression level (fold) of 
“CON, no CCI” (=1) and are shown as mean ± SEM. # represents a significant difference between “CON, no CCI” 
and “CON+CCI 4d” or “CON+CCI 21d” or between “MS, no CCI” and “MS+CCI 4d” or “MS+CCI 21d” (#p < 0.05, 
##p < 0.01). * indicates a significant difference between groups for other comparisons than the ones covered 
by # (**p < 0.01, ***p < 0.001). 
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5.5. Discussion 
The present study shows that early life stress related to MS in rodents does not 
affect basal thermal and mechanical nociceptive thresholds per se but has a 
protective effect on both modalities under neuropathic conditions. This 
behavioral change was accompanied by molecular alterations in the spinal cord. 
To our knowledge the impact of MS on mediators involved in the spinal 
processing of neuropathic pain has not been studied so far.  
5.5.1. MS reduces CCI-induced hyperalgesia/allodynia 
In humans, adverse early life events are associated with enhanced risks of 
developing mental or physical health problems including chronic pain disorders 
later in life (Heim et al., 2010; Heim and Binder, 2012; Lupien et al., 2009). 
This has been shown to be related to a permanent alteration of the hypothalamo-
pituitary-adrenal (HPA) axis (Sapolsky and Meaney, 1986), as well as of neural 
(Lippmann et al., 2007; Mintz et al., 2005; Rana et al., 2014) and immune 
functioning (Bilbo and Schwarz, 2009; Carpenter et al., 2010; Wieck et al., 
2013). In rodents, normal development during the critically vulnerable stress 
hyporesponsive period (SHRP) in the first two post-natal weeks essentially 
depends on maternal care (Caldji et al., 1998). Disruption by prolonged and or 
repeated sequences of MS leads to alterations comparable to those observed in 
humans (Schmidt, 2010). Furthermore, the first week of the rodent’s life 
corresponds developmentally to the third trimester of human gestation (Lupien 
et al., 2009) making MS an adequate model for the stress premature infants are 
exposed to.  
In rats, early life stress has been associated with an attenuation of drug-induced 
analgesic effects (Dickinson et al., 2009; Kalinichev et al., 2001), increased pain 
sensitivity in normal conditions (Alvarez et al., 2013; Green et al., 2011) but 
also in the framework of several experimental and clinical pain states such as 
chronic bowel syndrome (O’Mahony et al., 2009), visceral hyperalgesia (Chung 
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et al., 2007; Tsang et al., 2012) and neuropathic pain (Zeng et al., 2008). While 
rats undergoing early life stress have mostly been reported to present increased 
nociceptive responses to mechanical and/or thermal nociceptive stimulation 
(Chung et al., 2007; Tsang et al., 2012; Uhelski and Fuchs, 2010), we did not 
observe any change in basal nociceptive thresholds, but a reduced CCI-induced 
hypersensitivity for both modalities. It should be noted here that MS does not in 
every case lead to the development of psychiatric diseases (Rana et al., 2014) or 
enhanced pain sensitivity (Weaver et al., 2007) later in life. Resilience, an 
adaptive process allowing physiological (homeostatic) and behavioral 
adaptation to stress, has also been observed in rodent models of early life stress 
such as MS (Macrì et al., 2011). Pfau et Russo (2015) propose that the resilience 
observed in rodents undergoing early life stress follows a U-shaped curve. 
Exposure to a medium amount of stress could hence lead to resilience while very 
low or very high levels would lead to vulnerability. It should be noted here that 
the term "resilience" is generally considered to represent a positive adaptation 
of stress processing to a context specific stressor while "vulnerability" is 
commonly used to describe stress-related alterations in susceptibility to health 
disorders like chronic pain syndromes later in life (Alvarez et al., 2013). The 
fact that early life stress leads to alterations of brain structures is involved both 
in stress and in pain processing (Prusator & Greenwood-Van Meerveld, 2016) 
may impede a clear differentiation between these two terms. Hence, we suggest 
that MS could lead to a form of resilience to CCI-induced hypersensitivity 
independently to its effects on vulnerability or resilience to further stress 
processing.  
Furthermore, differences in methodology across studies such as rearing of the 
dams could lead to differences in experimental outcomes. Transportation from 
the animal supplier to the client is a routine practice but the stress induced by 
the shipping is rarely considered. Despite the few studies investigating the 
implications of the shipping in stress paradigms, increased blood corticosterone 
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levels, decrease of social behavior and locomotor activity up to 16 days after 
transportation have been observed (Arts et al., 2012). These results suggest that 
shipping can have long lasting physiological and behavioral effects. This would 
especially be true for developmental and high plasticity periods such as gestation 
(Lupien et al., 2009; Weinstock, 2008). Nevertheless, several studies showing 
an increased sensitivity following early life stress were performed in the 
offspring of females that were pregnant at the time point of shipment (Alvarez 
et al., 2013; Chung et al., 2007; Green et al., 2011; Kalinichev et al., 2001; 
Nishinaka et al., 2016; Tsang et al., 2012). The animals to be tested could hence 
have accumulated pre- and post-natal stress. Variations in experimental 
outcomes could thus at least partly be related to our rearing the dams in our 
facility.  
5.5.2. MS alters spinal glutamatergic transmission and 
transport 
The glucocorticoid receptor (GR) is a key regulator of the amplitude of the HPA 
response to stressors (Strüber et al., 2014) and of neuropathy-induced plastic 
changes (Wang et al., 2004, 2005, 2006). In the present study we observed that 
spinal GR expression was not different between CON and MS groups, neither 
under basal conditions, nor shortly (4d) and later (21d) after the CCI surgery. 
There is a paucity of studies investigating the impact of circulating 
corticosterone on spinal GR expression and to our knowledge no study has 
explored the impact of chronic stress on spinal GR expression. However, 
Patacchioli and colleagues (1998) showed no effect of 21 days of corticosterone 
treatment on spinal GR mRNA. Therefore, it is difficult to establish a parallel 
between our spinal GR mRNA results and a hypothetical HPA axis alteration by 
MS. In our hands only CCI had an impact on GR mRNA expression levels. 
Indeed, CON and MS groups presented a decrease of GR expression 4 days after 
CCI and recovered after 21 days. CCI-induced reduction of GR expression was 
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not expected since Wang and collaborators (2004, 2005, 2006) reported that CCI 
induced a time-dependent increase of GR protein and mRNA expression parallel 
to the development of painful behaviors. The pattern of expression found in 
CON and MS animals following CCI could be due to injury-related pain and 
distress, where the resulting hypothetical increase of corticosteroid 
concentration might have been compensated by a decrease of GR expression. 
Subsequently, as the animals recovered from the injury, the GR mRNA 
expression returned to levels comparable to those of non-injured rats. The 
finding that only MS rats displayed a strong increase of neuropathy-related pain 
thresholds while both CON and MS animals presented similar reduction of GR 
expression during the CCI phase may point to an alternative CORT-dependent 
mechanism of pain inhibition potentially emerging in the MS animals. In these 
rats, the production of spinal neurosteroids might have enhanced GABAergic 
and hence inhibitory transmission (Zell et al., 2015). 
Since corticosterone may regulate glutamate receptors (Wang et al., 2005) and 
transporters (Wang et al., 2006) through GR activation under neuropathic pain 
conditions we investigated NMDA receptor and transporter subunit mRNA 
expression levels.  
Experimental neuropathic pain models resulted in enhanced NR1 and NR2 
expression levels ipsilateral to injury (Abe et al., 2005; Wang et al., 2005). We 
report a differential effect of CCI on animals that underwent MS as compared 
to CON. Although these results are not directly indicative of spinal nociceptive 
transmission, the functional properties of the NMDA receptor depend on 
patterns of subunit associations reflecting enduring plastic changes in synaptic 
efficacy. The association of NR1 and NR2a subunits does e.g. provide a higher 
opening probability, a reduced sensitivity to glutamate and a faster decay of 
excitatory postsynaptic current (EPSC) than the NR1/NR2b NMDA subunit 
association (Paoletti et al., 2013). This association has been proposed to be, at 
least to some extent, responsible for the central sensitization involved in the 
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development of neuropathic pain (Wilson et al., 2005; Wu and Zhuo, 2009). In 
adult male Wistar rats, a decay of NR1 protein has previously been reported by 
Wilson and colleagues (2005) 16 days after CCI. In that study, the authors did 
not report a decrease of NR2a but we cannot exclude the possibility that the 
decrease we observed at post-CCI day 21 occurred after the 16th day post-CCI. 
Whereas several studies suggest a primordial role of NR2b in the establishment 
and maintenance of neuropathic pain (Karlsson et al., 2002; Wilson et al., 2005; 
Wu and Zhuo, 2009) we did not observe any drastic change in the NR2a/NR2b 
ratio following CCI. MS animals presented a general augmentation of all three 
NMDA receptor subunit mRNA levels that would suggest an enhanced 
nociceptive transmission and a resulting decrease of pain thresholds. Shortly 
after the CCI surgery, NR1 and NR2a subunit mRNA expression seemed to 
decrease to a larger extent than NR2b mRNA. This would suggest a change of 
NMDA subunit proportions toward more NR1/NR2b association in MS animals. 
Furthermore, 21 days after CCI NR1 and NR2b subunits expression recovered 
to MS basal levels. The observation that MS+CCI rats seemed to display a 
greater NR1/NR2b subunit association than CON+CCI might indicate a 
mechanism underlying delayed development of neuropathic 
allodynia/hyperalgesia in MS animals when compared to CON.  
Neuronal (EAAT3) and glial (EAAT2) glutamate transporters are involved in 
nociceptive processing in healthy individuals since injection of blockers elicits 
a dose-dependent spontaneous nociceptive behavior (Liaw et al., 2005), but also 
in neuropathic animals since their protein and mRNA expression are modified 
following CCI (Sung et al., 2003; Wang et al., 2006). In the present study, MS 
animals presented higher mRNA levels of EAAT3, but not EAAT2, suggesting 
an increased glutamate re-uptake in MS and therefore a reduced spinal 
transmission of noxious information. In association with the increase of NMDA 
receptor subunit expression, this result could explain the lack of difference in 
nociceptive thresholds between MS and CON animals. In CON, CCI tended to 
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decrease the EAAT3 mRNA expression 21 days after surgery. A reduction of 
EAAT3 expression was also reported by Sung and colleagues (2003) who 
proposed that this was due to a loss of primary afferents resulting from the CCI, 
considering that most of glutamate transporters are located at presynaptic sites 
(Danbolt, 2001). 
Concerning EAAT2, we and other investigators observed a decreased 
expression at 4 but not 21 days after CCI in CON animals (Napier et al., 2012; 
Xin et al., 2009). It is probable that this recovery was due to a compensatory 
mechanism aimed at re-establishing a “normal” re-uptake of glutamate by glial 
cells. Furthermore, since glial glutamate transporters are believed to account for 
90 % of glutamate clearance in the CNS (Danbolt, 2001), this result could be in 
line with the initiation of a possible recovery of a normal sensitivity observed at 
post-CCI day 21 in CON animals. In agreement with Gosselin and colleagues 
(2010), MS did not impact the EAAT2 expression in non-injured conditions. 
Likewise EAAT2 mRNA expression followed a comparable pattern in MS and 
CON animals 4 and 21 days after CCI. This lack of group differences suggests 
that the EAAT2 glutamate transporter does not considerably contribute to CCI-
related alterations in mechanical and thermal hypersensitivity as seen between 
CON and MS in our behavioral experiments. 
5.5.3. Glial activation is depressed in animals with early life 
stress history  
Nerve injury is associated with a strong activation of glial cells (Mika et al., 
2013). This activation results in the release of pro-inflammatory cytokines and 
growth factors involved in the establishment of central sensitization and in the 
development of neuropathic pain (Marchand et al., 2005). In this context 
microglia and astrocytes do not seem to be engaged in a similar manner. Iba1 
and GFAP were respectively chosen as markers of microglia and astrocytes 
because they are both constitutively expressed and their expression is increased 
Chapter V: Impact of early life stress on neuropathic pain
109 
upon activation (Ito et al., 1998; McMahon et al., 2005), allowing us to evaluate 
basal and MS- or CCI-related levels. The pronounced and immediate microglia 
activation after injury (Tanga et al., 2004) is believed to play a more prominent 
role in the establishment of mechanical hypersensitivity (Raghavendra et al., 
2004). Our results showing a more pronounced Iba1 mRNA expression 4 days 
after neuropathy followed by a recovery to lower levels at 21 days are in 
agreement with previous studies (Mika et al., 2010). However, since there is a 
delay between the behavioral establishment of a significant mechanical 
hyperalgesia and allodynia and the qPCR-related findings, it seems plausible 
that we could have missed the peak of microglia activation. Furthermore, 
variability can occur due to differences in neuropathy models. Indeed, it has 
been shown that the activation of immunocompetent cells may partly depend on 
the location and type of the nerve lesion (Colburn et al., 1999; Hu et al., 2007). 
MS animals presented lower microglia activation than CON animals during 
normal and neuropathic conditions. Despite an increase of Iba1 mRNA levels 
following CCI, microglial activity seemed dampened in MS animals. This is 
consistent with the higher mechanical threshold observed from day 7 to 14 after 
CCI. The lack of difference in mechanical thresholds between CON+CCI and
MS+CCI animals 21 days after surgery could be another indication that
microglia was predominantly involved in the establishment of mechanical
hypersensitivity but not in its maintenance. Astrocytic activation is weaker but
long lasting (Mika et al., 2013). Maintenance of neuropathic states may depend
on this sustained activation. Our result is consistent with the existing literature
since the CON+CCI group presented an early but mild GFAP mRNA level
increase which was sustained until post-CCI day 21. It is interesting to note that
the astrocytic activation was also dampened in the MS+CCI group during
neuropathic pain.
Glial activation plays a capital role in neuropathic pain through the release of 
pro-inflammatory cytokines (Ledeboer et al., 2005) and neurotrophins (Li et al., 
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2003). We focused on the interleukins 1-beta (IL-1β) and 6 (IL-6) due to their 
well-documented involvement in neuropathic states. Upon nerve injury, IL-1β 
is released concomitantly with the induction of allodynia and hyperalgesia 
through its actions on NMDA and GABA currents (Kawasaki et al., 2008; Wolf 
et al., 2006). IL-1β also induces the secretion of other inflammatory mediators 
such as itself, IL-6, TNF-α or NGF therefore contributing to neuropathic pain 
(Marchand et al., 2005). 
CCI alone induced a clear increase of IL-1β mRNA levels 4 days after the 
surgery and started to recover at 21 days. On the contrary, in MS the onset and 
extent of this upregulation was delayed. IL-6 on the other hand presented a 
similar expression pattern in CON and MS 4 and 21 days after induction of 
neuropathic pain.   
It is interesting to note that, in concordance with the Iba1 and GFAP expression 
results, MS had an overall dampening effect on the regulation of pro-
inflammatory cytokines in the early phase of neuropathy, but not later at the 
beginning state of chronification. This could be of importance because IL-1β 
and IL-6 increase are both associated with the development of abnormal 
sensitivity during neuropathic pain due to their capacity to enhance not only 
NMDA receptor currents but also AMPA receptor-mediated post-synaptic 
potentials (Liu et al., 2013; Schäfers and Sorkin, 2008). The MS-related 
dampened immunocompetent reactivity observed in our hands could explain the 
enhanced thermal and mechanical thresholds of these animals seen during the 
early neuropathic pain states. Although a longer observation period of 
neuropathy may be required, these results seem to indicate that MS delays or 
reduces the appearance of neuropathy-related pain hypersensitivity. 
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5.5.4. MS affects CCI-induced alterations in growth factor 
mRNA expression  
Neurotrophins such as NGF are additional pro-algesic mediators released in the 
spinal cord upon nerve injury (Li et al., 2003). The increase of NGF levels 
shortly after CCI surgery observed in this study could result from glial 
activation-related secretion of IL-1β (Spranger et al., 1990). This would be in 
line with the decreased thermal threshold observed shortly after the CCI surgery 
in CON animals since NGF is known to be retrogradely transported to the 
periphery resulting in a sensitization of nociceptors (Ji et al., 2002). In addition, 
TRPM8 a cation channel able to sense both innocuous and noxious cold, notably 
after nerve injury (Xing et al., 2007), has been shown to be upregulated in a 
NGF-dependent manner (Babes et al., 2004). In the present study, NGF mRNA 
expression was decreased in MS animals shortly after CCI potentially resulting 
in a higher cold threshold as compared to controls. The return to basal mRNA 
levels at day 21 post-CCI may consequently have lowered the threshold to cold 
stimuli. However, the increase of NGF mRNA levels cannot solely explain the 
course of cold hyperalgesia/allodynia since CON+CCI animals presented a 
decrease of NGF mRNA levels at 21 days post CCI while remaining highly 
sensitive. 
The implication of GDNF in neuropathic pain is controversial due to its potent 
analgesic effect following intrathecal administration (Boucher et al., 2000) 
while it can also sensitize nociceptors leading to mechanical hyperalgesia 
(Bogen et al., 2008). The slight decrease in MS animals and the lack of change 
in CON animals 4 days after surgery suggest that GDNF did not participate to a 
great extent to the establishment of neuropathic pain. However, given the 
mechanical threshold of both groups 21 days after surgery, we hypothesize that 
GDNF might have displayed a pro-algesic effect. Indeed, the decrease of GDNF 
mRNA expression in the CON group during neuropathy is concomitant with a 
reduction of mechanical allodynia/hyperalgesia and the increase of GDNF 
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mRNA in MS animals would agree with the ongoing decrease in abnormal 
mechanical thresholds.  
5.6. Conclusion 
Our study surprisingly shows that MS protects from an increase or at least delays 
the occurrence of neuropathy-related pain hypersensitivity. The assessed 
biochemical markers do not fully reveal the biochemical cascades involved in 
the MS-related modification of pain thresholds under neuropathic conditions. 
Considering that most nociceptive primary afferents project to the dorsal horn 
of the spinal cord (Basbaum et al., 2009), it is conceivable that an analysis of 
biochemical markers restricted to the dorsal quadrant would yield stronger 
effects after CCI than one that includes dorsal and ventral quadrants as was done 
here. Further studies are required to confirm these results and to eventually 
elucidate the mechanisms involved in the described stress-related resilience to 
neuropathic pain. In this framework it will be important to extend the 
biochemical investigations to the respective protein levels. Importantly, MS has 
been shown to have differential effects on males and females. Moreover the 
additionally observed sexual dimorphism in the framework of neuropathic pain 
has recently been shown to be mediated by sex-based differences in immune 
responses (Sorge et al., 2015). It thus remains essential to investigate the impact 
of MS on neuropathic pain as potentially underlying sex-dependent 
mechanisms. Electrophysiological and pharmacological studies should further 
add to the elucidation of these relationships. 
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6.1. Abstract 
Early life stress (ELS) is claimed to constitute a major risk factor for developing 
psychopathological disorders in later life neurobiological disorders. Since brain 
structures involved in the processing of stress and of pain are overlapping, 
exposition to stressors could at least under some circumstances, be expected to 
enhance the vulnerability for pain syndromes. It is however recognized that not 
all individuals are impacted in a similar manner and that some could even benefit 
from stress experiences. In this context we have previously observed that ELS 
can reduce mechanical and cold hypersensitivity caused by nerve injury during 
adulthood. The goal of the present study was to test the hypothesis that ELS 
could be a factor of resilience against an enhancement of noxious sensitivity in 
the framework of enduring inflammatory pain.  
Rats were exposed to the maternal separation (MS) paradigm, an established 
model of early life stress. At adulthood, corticosterone levels and anxiety-related 
behaviors were evaluated. Subsequently noxious mechanical and heat sensitivity 
as well as paw edema were measured prior and during an inflammation of the 
hind paw induced by the injection of Complete Freunds Adjuvant (CFA). Four 
groups of animals were thus compared: CON (no manipulations), MS 
(undergoing maternal separation stress), CON+CFA (no stress but CFA 
injection) and MS+CFA (undergoing maternal separation and CFA injection). 
In the open field test no stress related behavior was observed in MS animals. 
Corticosterone levels were also not changed by the early life manipulation. 
Concerning pain sensitivity, results partly confirm our previous neuropathy-
related results. Regardless of the group, animals showed identical mechanical 
thresholds prior to inflammation but after CFA-injection MS tended to display 
reduced mechanical hyperalgesia. Results on noxious heat sensitivity were more 
complex. Indeed, MS animals presented shorter latencies of nocifensive 
behaviors compared to CON. In CON but not in MS animals, the repetitions of 
noxious heat sensory testing led to a decrease of the latencies of pain-related 
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behavior. Finally, when normalized to their non-inflamed conspecifics 
(CON+CFA to CON and MS+CFA to MS), MS+CFA had a tendency to display 
less hyperalgesia than CON+CFA animals.   
Altogether this study tends to confirm that long lasting stress-related alterations 
of neurobiological circuits could have a positive impact on chronic pain-related 
hypersensitivity. 
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HIGHLIGHTS: 
1) Maternal separation (MS) did not lead to a change of anxiety-related
behavior and corticosterone levels.
2) Under baseline conditions MS rats displayed a more pronounced noxious
heat sensitivity
3) While hot plate latencies decreased over time in control animals, they
remained constant in MS
4) MS attenuated the development of inflammatory pain-related
hypersensitivity
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6.2. Introduction 
While chronic stress has been recognized to be one of the major causes for 
developing anxio-depressive and metabolic disorders, not everyone shows 
comparable levels of vulnerability [1–3]. In this context, the hypothalamo-
pituitary-adrenal axis (HPA) and its final effector cortisol in humans or 
corticosterone (CORT) in rats, serve as major actors for the organisms’ 
adaptability to environmental challenges [4]. In this respect the perinatal period, 
particularly the two weeks after birth, has been shown to be very sensitive since 
the HPA axis is still immature. A stress at this moment of life such as abuse or 
neglect can have a tremendous impact for later life, notably through long-term 
programming of the HPA axis [5,6]. Early life stress (ELS) does not only lead 
to alterations of the HPA axis, it does also perturb the maturation of the immune 
system [7] and the expression of the associated hippocampal pro-inflammatory 
cytokines and peripheral CD8+ T cells, two mediators of the immune defense 
[8,9]. A well-established animal model, the maternal separation (MS) paradigm 
has commonly been used to investigate the relationship between early life stress 
and the potential predisposition to psychopathology [10]. The studies have 
partly confirmed a causal relationship of early adverse experiences and the 
development and/or worsening of pathologies such as chronic inflammatory 
diseases in later life [11,12].  
The capacity of stress to modulate pain sensitivity has been established over 30 
years ago, for instance in the framework of stress-induced analgesia (SIA). 
More recent findings suggested that stress may under some conditions also lead 
to enhanced pain sensitivity (stress-induced hyperalgesia, SIH, for review see 
[13]). In this context, brain structures as well as mediators simultaneously 
involved in pain and stress processing have been identified [14,15]. 
Furthermore stress-related psychopathology is commonly accompanied by 
comorbid chronic pain disorders [16,17]. Since CORT has strong anti-
inflammatory effects, differential susceptibility to chronic pain conditions 
involving to a great extent neuro-inflammatory mechanisms, is thought to be 
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largely mediated by differences in HPA axis reactivity [18]. Nevertheless, there 
is a paucity of studies on the long-term consequences of ELS on spinal 
nociceptive processing in later life. This is surprising since the spinal dorsal 
horn constitutes the CNS input station that transmits nociceptive information to 
supra-spinal brain structures and thus is a crucial site for pain modulation [19]. 
Previous findings from our group suggested that repeated MS carried out during 
the first two postnatal weeks may lead to the decrease of neuropathy-related 
pain hypersensitivity [20]. Considering the crucial role of immunocompetent 
cells in the induction of chronic pain disorders [21], we also hypothesized that 
this result could depend on MS effects on the immune system. 
The goal of the present study was to determine whether early life stress-related 
decrease of pain sensitivity is specific for neuropathy or can also be observed 
in the framework of inflammatory pain. For this purpose we assessed 
mechanical and thermal pain sensitivity prior to and after induction of 
inflammation via intraplantar injection of Complete Freunds Adjuvant (CFA). 
We also aimed to evaluate the impact of our MS protocol on HPA axis activity 
and on anxiety-related behavior.  
6.3. Material and methods: 
6.3.1. Animals 
Male and nulliparous female Sprague-Dawley rats were purchased from Harlan 
laboratories (Netherland) and reared in our facility. Their breeding provided the 
subjects for the following experiments. The animals were kept under 
standardized housing conditions: room temperature 22 ± 1°C, relative humidity 
of 60 ± 10 %, 12h dark/light cycle (07:00-19:00) and with food and water 
provided ad libitum. Male rats used throughout the experiments were kept 
pairwise in 42x26x20 cm Plexiglas cages from weaning to the end of the 
experimental protocol.  
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Animals were divided into four groups (n=10 per group) according to the stress 
and pain conditions: control group CON (underwent no manipulations), 
CON+CFA (no MS, CFA injection), MS (MS, no CFA injection), MS+CFA 
(MS and CFA injection).  
All animal manipulations were carried out in accordance with the Directive 
2010/63/EU of the European Parliament and of the Council of 22 September 
2010 on the protection of animals used for scientific purposes and met the 
ARRIVE guidelines. Experimental procedures involving animals were 
approved by the Animal Experimentation Ethics Committee (AEEC) of the 
University of Luxembourg (Project ID 15-SPM-01-UH) and the "Ministère de 
l'Agriculture, de la Viticulture et de la Protection des consommateurs". 
6.3.2. Maternal separation 
Gestating females were isolated from cage mates few days prior labor and 
checked twice per day (morning and the evening) for birth. The day the pups 
were first observed was determined as post-natal day 0 (P0). At P1 pups were 
briefly removed, counted and if necessary the litter was reduced to 12 pups per 
dam. Litters were randomly attributed to either the MS or the CON groups. CON 
pups were left undisturbed except for cleaning. The MS procedure was carried 
out from P2 to P12. Pups were removed from the dam’s home cage, placed on 
heated pad at 33°C (+/- 2°C) and left undisturbed for 3 hours/day. After the 10 
days of maternal separation (from P13 on), MS pups and dams were treated 
identically as CON animals. Both MS and CON litters were weaned at P21 and 
did not undergo other manipulation until habituation.  
6.3.3. Experimental design 
Before the initiation of the behavioral experiments, animals were habituated to 
the testing room, the testing devices and the experimenter for one week. 
Procedures depicted below started at 8 weeks of age. Following habituation all 
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groups underwent blood sampling at 8:00h for determining their plasmatic 
corticosterone concentration. To limit further stress, animals were returned to 
their home cage and left undisturbed that day. The next morning, animals were 
transferred to the open field room and left there for 24h to habituate to the testing 
room. After terminating the open field test, animals were returned to their home 
cage and left undisturbed until the next morning. Then all groups were tested for 
baseline mechanical thresholds and baseline noxious heat sensitivity three days 
in a row and the paw volume of both hind-paws was assessed. At experimental 
day 0, inflammatory pain was induced by injection of CFA. Subsequently, 
mechanical thresholds, thermal sensitivity and paw edema were recorded at 
post-injection days 4, 7, 10, 14 and 21. Following the last testing, rats were 
sacrificed.  
6.3.4. Blood Corticosterone measurements: 
Blood sampling was carried out at 8:00h at the beginning of post-natal week 8. 
Rats were loosely held in a towel and a small incision was made at the distal 
part of their tail, about 15-20 mm from the tip. Blood was collected using a 300 
µL capillary EDTA-coated tube (Microvette CB300, Sarstedt, Essen, Belgium). 
Samples were immediately placed on ice before and then centrifuged at 4C° for 
10 minutes to separate the plasma. It was collected and stored at -20C°until 
further analysis. Plasmatic CORT concentration were measured using an 
Enzyme-Linked Immunosorbent Assay (ELISA) kit (Assay Designs, USA). 
Analysis was performed according to the “small-sample” protocol provided by 
the manufacturer. The CORT concentrations were determined with a plate 
reader (Sunrise Magellan, Austria) linked to an appropriate software (Magellan 
Software, V6.4 standard, Austria).     
6.3.5. Open Field test: 
This test was performed 24 hours after the start of the habituation period 
between 9:00h and 12:00h.  The test room had similar conditions as the housing 
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room but the light was dimed to 40 lux in the center of the maze. The open field 
is a rectangular arena (1m x 1m) with walls (35 cm high) to prevent escape. It 
was divided in sixteen equal squares and the central area corresponded to the 4 
central squares. A video camera (the Imaging Source) attached to the sealing 
was used to record the behavioral responses during the entire 10 minutes of test. 
Parameters were recorded and analyzed using a video tracking system (ANY-
Maze Video Tracking System). The total distance travelled was used as a 
measure of locomotor activity. The number of entries and the time spent 
exploring within the central area were considered as indexes of anxious 
behavior.  
6.3.6. Complete-Freund adjuvant injection: 
Following baseline testing, we induced persistent inflammatory pain in the 
respective groups by a subdermal injection of CFA (100 µl, 1mg/ml 
Mycobacterium) into the middle plantar region of the left hind paw. For this 
procedure, rats were anaesthetized with isoflurane (4.5% for induction, 2.2% for 
maintenance) using a Univentor 400 apparatus (Zejtun, Malta). The contralateral 
(right) hind paw served as a control for effects of the injection itself and was 
thus injected with an equal volume (100 µl) of 0.9% saline solution.  
6.3.7. Evaluation of paw edema: 
We used a plethysmographic device (TSE volume meter 602060, TSE Systems 
GmbH, Hombury, Germany) to measure alterations of paw volume (edema) 
before and at different time points after CFA-induced inflammation in the four 
different groups of rats. The animals were held in one hand and the hind paw 
was immersed (up to the ankle) into a cuvette filled with distilled water. The 
volume of dispersed water was measured by a sensor that was connected to a 
computer. The measurements were performed on each test day after the 
assessment of pain thresholds. Each hind-paw was measured three times and the 
values were averaged to obtain a mean score per day. 
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6.3.8. Assessment mechanical threshold 
In order to measure mechanical allodynia, a dynamic plantar aesthesiometer 
(Ugo Basile) was used. For acclimation, animals were brought in the testing 
room at least one hour before the start of the experiment and placed 10-15 
minutes before testing in Plexiglas chamber (19.5 x 19.5 x 14 cm) with a wire 
mesh floor. To test for the mechanical pain threshold, a blunt filament was 
applied to the mid plantar surface of the hind paw and pressure was increased 
until a withdrawal reaction occurred. The applied force was preset prior the 
experiment to a slow linear increase of 50 grams over 35 seconds (1.43 g/s) and 
a cut-off point of 50 g. The force applied at the moment of withdrawal was 
defined as mechanical pain threshold. For each rat, both hind-paws were tested 
alternately three times and the values obtained were averaged to give the 
mechanical pain threshold per day. The baseline was calculated as the mean of 
the three consecutive testing days.  
6.3.9. Assessment of noxious heat sensitivity 
The noxious heat sensitivity was assessed at least 30 minutes after the 
measurement of mechanical thresholds. The animals were placed in a plastic 
cylinder (30 cm of height) on a heated plate (19 cm of diameter, 50 ± 0.1 C°; 
Ugo Basile, Italy) and the time until they displayed nocifensive behavior was 
measured. Only jumping and/or lifting or licking of the hind-paw was regarded 
as nocifensive behavior. To avoid damage to the tissue and pain, a cut-off time 
limit of 20 s was chosen. The animals were immediately removed from the hot 
plate when they displayed pain or when the 20 s time limit was reached. The test 
was carried out twice per animal with an interval of at least 10 min and both 
scores were averaged to give the latency per animal per time point. 
6.3.10. Statistical analysis 
All results are presented as mean ± SEM. Normality was assessed with the 
Levene’s test or Schapiro-Wilk test. A two way (Stress condition x time) 
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analysis of variances (ANOVA) with repeated measures was performed to 
determine statistical significance for the paw edema, mechanical thresholds and 
hot plate measures. Bonferroni multiple comparison post hoc tests then assessed 
group differences. The different open field parameters and the measures of 
plasmatic CORT concentration were analyzed using a two-tailed t-test. 
6.4. Results 
6.4.1. Locomotor activity and anxiety-like behavior 
The open field paradigm is commonly used to measure general locomotor 
activity and willingness to explore by assessing the time spent moving or the 
distance covered. It is also used to assess anxiety by including additional 
measures of time spent in the center of the field and the number of entries in this 
central zone. Therefore, prior to any manipulation, except the maternal 
separation in the respective groups, rats were subjected to this test to examine 
possible distinctions in locomotor activity and anxiety-like behavior between 
non-stressed and early life stressed individuals. The test revealed no differences 
in the total distance moved between CON (66.26 ± 3.48 m) and MS (65.91 ± 
2.95 m) rats suggesting no locomotor deficit in maternally stressed animals 
(Fig. 1, left). Additionally, no significant differences were observed regarding 
the time spent (CON: 22.09 ± 5.06 s; MS: 29. 87 ± 6.43s) (Fig. 1, middle) or the 
number of visits (CON: 9.25 ± 1.96; MS: 12.69 ± 2.19) (Fig. 1, right) in the 
central zone.   
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Figure 18: Locomotor activity and anxiety-like behavior of 8-week-old non-stressed (CON, black bars) and 
maternally separated (MS, white bars) rats were assessed with the open field paradigm after the habituation 
period. Left: Total distance (m) covered by CON and MS during the 10 min of the test; no difference was found 
between groups. Middle: Time (s), CON and MS spent in the central zone of the field. Both groups did not 
significantly differ in their behavior. Right: Number of entries of CON and MS animals into the central zone of 
the field. The groups showed no significant different explorative behavior. Data are expressed as mean ± SEM. 
6.4.2. HPA-axis activity in early life stressed and non-stressed 
animals 
At an age of 8 weeks, after the habituation period and before the start of the 
behavioral tests and the induction of inflammation, blood was taken and the 
serum corticosterone levels were determined. No significant differences in 
corticosterone concentration were seen between the non-stressed CON (27.38 ± 
9.13 ng/l) and the early life stressed MS rats (25.01 ± 6.37 ng/l) (Fig. 2). 
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Figure 19: Effect of maternal separation stress on blood serum 
corticosterone levels in early adulthood. Blood was taken to measure 
corticosterone concentration after the habituation period and before 
any manipulations like behavioral tests and induction of inflammation. 
The corticosterone levels of the maternal separated (MS, white bar) 
animals did not differ from those of the control (CON, black bar) rats. 
Data are presented as mean ± SEM. 
6.4.3. Inflammation-induced development of paw edema 
Volumes of the left (ipsilateral) and the right (contralateral) hind-paw of each 
animal were measured and the relative paw volume expressed as ratio left/right 
was calculated.  
At baseline, before induction of inflammation, the relative hind paw volumes 
did not show significant differences between any of the four groups (CON: 1.00 
± 0.01, MS: 1.01 ± 0.01, CON+CFA: 1.02 ± 0.02, MS+CFA: 1.02 ± 0.02) 
(Fig. 3). The relative paw volumes of animals (CON and MS) that were not 
injected with CFA remained at the same level throughout the 21 days of 
experiment without exhibiting significant inter-group differences (CON: d4: 
1.02 ± 0.02, d7: 0.99 ± 0.01, d10: 0.98 ± 0.00, d14: 0.98 ±0.01, d21: 0.97 ± 0.00; 
MS: d4: 0.99 ± 0.00, d7: 0.99 ± 0.01, d10: 1.01 ± 0.02, d14: 0.99 ± 0.00, d21: 
0.99 ± 0.00). In the groups receiving CFA injection (CON+CFA and MS+CFA) 
a pronounced edema developed in the ipsilateral (left) hind-paw. The relative 
paw volume peaked at day 4 (CON+CFA: 1.82 ± 0.05, p<0.001 vs. CON; 
MS+CFA: 1.84 ± 0.08, p<0.001 vs. MS) and decreased from there on until the 
end of the experiment at day 21. At all-time points measured, CON and 
CON+CFA as well as MS and MS+CFA significantly differed in their relative 
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paw volume (p<0.001 for all time points and both comparisons). However, no 
significant differences between CON+CFA (d7: 1.76 ± 0.05, d10: 1.63 ± 0.03, 
d14: 1.56 ± 0.03, d21: 1.50 ± 0.03) and MS+CFA (d7: 1.72 ± 0.04, d10: 1.69 ± 
0.05, d14: 1.56 ± 0.05, d21: 1.39 ± 0.03) were found, although a trend to less 
edema in the MS+CFA group could be observed at day 21. 
Figure 20: Development of inflammation-induced paw edema. The relative paw volume of the left hindpaw 
(expressed as ratio left paw/right paw) was assessed before the induction of inflammation (baseline, BL). No 
difference was obtained in the four groups (CON: black circles, CON+CFA: white circles, MS: black triangles, 
MS+CFA: white triangles). Injection of CFA in the respective groups (CON+CFA, MS+CFA) produced a 
pronounced swelling which peaked at day 4 in CON+CFA as well as in MS+CFA, leading to significant 
differences between CON and CON+CFA (***p<0.001) and between MS and MS+CFA (***p<0.001) at each 
time point throughout the experiment. The relative paw volume did however not significantly differ between 
CON+CFA and MS+CFA, although a tendency to less edema in MS+CFA is visible at day 21. Data are expressed 
as mean ± SEM. 
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6.4.4. Mechanical pain thresholds differ in inflamed animals 
that were subjected to early life stress 
A two-way (condition x time) repeated measures ANOVA revealed significant 
differences in mechanical pain thresholds following CFA injection (F (15.180) 
= 8.40, p<0.0001 time x group interaction). The Bonferroni multiple comparison 
post hoc test was applied to check for group differences. At baseline, mechanical 
sensitivity was comparable between all four groups (CON: 26.34 ± 1.09, MS: 
27.16 ± 0.59, CON+CFA: 25.42 ± 0.84, MS+CFA: 27.57 ± 0.79) (Fig. 4). In 
CON and MS animals that were not inflamed, the mechanical pain thresholds 
stayed at around baseline level throughout the 21 days of experimentation. No 
significant difference between these groups were seen (CON: d4: 25.20 ± 0.99, 
d7: 24.96 ± 1.11, d10: 24.43 ± 1.76, d14: 27.00 ± 0.90, d21: 25.79 ± 0.80; MS: 
d4: 26.51 ± 0.91, d7: 26.08 ± 0.55, d10: 27.73 ± 1.04, d14: 27.38 ± 0.66, d21: 
27.43 ± 0.77). The injection of CFA into the left hind-paw in CON+CFA and 
MS+CFA animals significantly decreased the mechanical pain threshold of the 
ipsilateral paw already at day 4 (CON+CFA: 14.73 ± 0.78, MS+CFA: 17.05 ± 
2.15), peaked at day 7 (CON+CFA: 9.95 ± 0.90, MS+CFA: 12.86 ± 0.91) and 
started to recover from day 10 to the end of the experiment (CON+CFA: d10: 
12.07 ± 1.16, d14: 13.86 ± 1.42, d21: 16.33 ± 1.11; MS+CFA: d10: 15.42 ± 
0.74, d14: 17.89 ± 0.90, d21: 21.13 ± 1.00). However, their mechanical pain 
thresholds remained significantly lower than their non-inflamed counterparts 
CON resp. MS throughout the entire inflammation period (p<0.001 for both 
groups and for all time points). Comparing the two inflamed groups, CON+CFA 
and MS+CFA, the maternally separated animals seemed to be less affected by 
the inflammation. From day 4 to 10, there was a clear trend to higher pain 
thresholds in the MS+CFA group that became significant at days 14 (p<0.05) 
and 21 (p<0.01). 
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Figure 21: Effect of early life stress on inflammation-induced mechanical allodynia/hyperalgesia. Mechanical 
pain thresholds were assessed before (baseline, BL) and at different time points after the induction of 
inflammation (Infl.). At baseline no differences between groups (CON: black circles, CON+CFA: white circles, 
MS: black triangles, MS+CFA: white triangles) were obtained. Induction of inflammation by injection of CFA 
into the left hindpaw of CON+CFA and MS+CFA animals resulted in a decrease of pain thresholds in these 
groups, peaking at day 7 and partially recovering until the end of the experiment at day 21. Significant 
differences between CON and CON+CFA (***p<0.001) and between MS and MS+CFA (***p<0.001) where 
obtained at each time point throughout the experiment. When comparing the two inflammation groups, 
MS+CFA seemed to be less affected by the inflammation than CON+CFA. In the early phase of inflammation 
(day 4 to 10) there was a tendency in MS+CFA to develop less mechanical allodynia/hyperalgesia. In the later 
phase there was a significant difference between these groups (day 14: #p<0.05, day 21: ##p <0.01). Data are 
shown as mean ± SEM. 
6.4.5. Thermal pain sensitivity differs MS animals 
The two-way repeated measures ANOVA revealed a significant effect of time 
(F (5, 180) = 43.86, p<0.0001), group (F (3, 36) = 19.09, p<0.0001) and 
interaction (F (15, 180) = 4.197). Differences between groups were then 
evaluated by running Bonferroni multiple comparison post hoc test. Contrary to 
what was obtained for mechanical pain thresholds, CON (16.61 ± 0.48) and MS 
(11.49 ± 0.55) rats displayed significantly different latencies to exhibit signs of 
nocifensive behavior at baseline with MS being more sensitive (p<0.001) (Fig. 
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5A). Repeated testing in the course of the experiment “sensitized” the CON rats 
to the manipulations and resulted in a drop of latency until day 21 (d4: 13.46 ± 
1.49, p<0.05 to MS; d7: 11.21 ± 1.12, d10: 10.88 ± 0.89, d14: 10.69 ± 0.88, d21: 
9.39 ± 1.24). The MS rats that started with significantly lower latencies, did not 
change the nocifensive reaction to heat during the experiment (d4: 9.39 ± 0.77, 
d7: 9.61 ± 0.91, d10: 9.37 ± 0.93, d14: 9.15 ± 0.99, d21: 8.81 ± 1.01). At the end 
of the testing period, CON and MS exhibited nearly identical latencies. 
Figure 22: Effect of early life stress on thermal pain sensitivity, (A). Thermal pain sensitivity was assessed by 
recording the time (= latency) animals spent on a hot plate (50 ± 0.1 °C) until they displayed nocifensive 
behavior like jumping or lifting/licking of the hindpaw. At baseline (BL), the latency of non-stressed control 
animals (CON, black circles) differed significantly from that of maternal separated rats (MS, white circles). 
Repeated testing sensitized CON to noxious heat, whereas MS rats stayed unaffected by the continuous 
measurements. Data are expressed as mean ± SEM. *p < 0.05, ***p<0.001.  
In order to exclude the habituation phenomenon described above and to be able 
to judge the impact of inflammation on controls resp. maternally separated 
animals, we calculated the ratio of CON+CFA to CON and of MS+CFA to MS 
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and expressed it as percentage. This allowed us to compare the thermal 
sensitivity of CON+CFA and MS+CFA rats. 
The statistical analysis revealed that the ongoing inflammation (F (5, 90) = 
14.79, P < 0.0001) and the group (F (1, 18) = 16.03, P = 0.0008) had significant 
effects, but no significant interaction was found. The induction of inflammation 
induced a decrease of the latencies in CON+CFA (d4: 64.17 ± 5.92, d7: 44.27 ± 
4.16, d10: 43.41 ± 3.65, d14: 52.09 ± 4.48, d21: 72.50 ± 6.03) as well as in 
MS+CFA (d4: 94.92 ± 10.31, d7: 65.27 ± 10.06, d10: 63.07 ± 8.49, d14: 62.72 
± 5.36, d21: 72.50 ± 6.03) animals (Fig. 5B). A tendency for MS+CFA was seen 
to be less sensitive to thermal stimuli than CON+CFA. The difference was 
however only significant at day 4 (p<0.01). 
Figure 23: Effect of early life stress on thermal pain sensitivity, (B). The impact of CFA-induced inflammation 
(Infl.) was different in controls (CON+CFA, black circles) and maternally separated rats (MS+CFA, white circles). 
The MS+CFA animals were significantly less affected by CFA-injection in the early phase of inflammation, which 
was moving on to a tendency (days 7 and 10) and finally vanishing in the sub-chronic phase (days 14 and 21). 
To exclude the sensitization phenomenon seen in (A) when comparing non-stressed and maternally stressed 
animals, the ratio of CON+CFA to CON resp. MS+CFA to MS was calculated and expressed in percentage (%). 
Data are shown as mean ± SEM. **p < 0.01 
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6.5. Discussion 
There has been an ongoing debate regarding the potential influence of enduring 
stressors, especially when occurring in early life, on the vulnerability to chronic 
pain development [14]. In this framework, we investigated the behavioral and 
endocrine consequences of MS for ongoing pain. In our hands, MS did not lead 
to phenotype changes indicative of a comorbidity between anxiety/stress and 
inflammatory pain. On the contrary, our results suggest that MS can lead to 
alterations of baseline and CFA-induced inflammatory pain independently of 
changes in anxiety-like behaviors and basal plasmatic corticosterone levels.  
6.5.1. Stress-related phenotype 
The open field test is classically used to evaluate anxiety in rodents. It relies 
upon the inner conflict between exploration of unknown environment and fear 
of exposed and well-lit areas [22]. Classically, rodents displaying anxious 
features show less exploratory behavior [23,24]. Here we observed that CON 
and MS animals were not presenting any differences regarding explorative 
behavior and time spent in the potentially anxiety-inducing well-lit central area. 
Adverse early-life experiences have often been associated with a dysregulation 
of the HPA axis and anxio-depressive states in later life [6,25,26]. The HPA axis 
activity has been extensively studied in the context of early life stress and in the 
etiology of stress-related disorders such as anxiety and depression [27]. As it is 
the final effector, corticosterone is classically measured to evaluate possible 
alterations of the HPA axis. In our hands, plasmatic corticosterone levels were 
comparable in CON and MS animals confirming previous results from our 
laboratory (unpublished results). However, despite multiple studies showing 
heightened corticosterone levels in later life in animals exposed to MS [28], it is 
increasingly recognized that corticosterone levels and stress do not linearly 
relate [29]. 
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Taken together, the lack of anxiety-related behaviors during the open-field test 
coupled with the comparable blood corticosterone levels between CON and MS 
animals suggest that early life stress, as performed with repeated short episodes 
of MS may not have a long term influence on the stress-related neuro-circuitry 
function. Therefore, it would be interesting to complement this result with 
measurements of the glucocorticoid receptor expression in structures involved 
in the regulation of the HPA axis activity (e.g. hippocampus, pituitary gland). 
6.5.2. MS reduces CFA-induced mechanical hyperalgesia 
CFA has been shown to induce mechanical allodynia rapidly after its injection 
and generally to lead to the development of rheumatoid arthritis, an 
inflammatory chronic pain condition affecting all levels of the pain system, from 
peripheral to central nervous system [30–32]. The effects of CFA administration 
have been commonly divided in early (roughly the first 10-14 days) and late 
phases (from 14 days and on) [33]. Our current results seem to confirm previous 
findings. Indeed, CON and MS rats did not present any differences in baseline 
mechanical thresholds [20]. However, MS animals tended to be less sensitive to 
the CFA-induced decrease of mechanical thresholds during the early phase and 
displayed considerably higher thresholds in the later phase of inflammation. 
Hence, it seems that the impact of MS on pain processing remains minor until a 
new insult such as inflammation unravels its long-term consequences. In the 
present study we did not observe “classical” stress-induced alterations of 
neuroendocrine circuits nor of anxiety-related behaviors suggesting that our MS 
protocol might not have led to long-standing consequences. However, stress-
related alterations do not only apply to eventual changes in neural structures 
[2,34,35]. The immune system also is of great interest in this context. Indeed, 
MS has been shown to act on the immune system which does e.g. result in 
enhanced circulating interleukin levels in the early phase after MS [8] but also 
later in life [36]. This will have aggravating consequences for pain syndromes 
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such as irritable bowel syndrome or neuropathy [20,37].We did not evaluate 
circulating interleukins. However, we can speculate that the long-term effects of 
our MS procedure would have been “too mild” to lead to direct immune system-
mediated adverse repercussions. In physiological conditions MS would then not 
result in an activation of HPA axis associated with anxio-depressive states. 
However, after an insult, the “minor” differences of neuro-immune functioning 
between MS and CON animals could lead to different inflammatory pain 
thresholds and hypothetically to dissimilar stress-related neuro-endocrine 
circuits and/or behaviors. This remains to be tested in future studies, however 
the measure of stress related parameters often rely on movement and the 
impairment of locomotor activity induced by pain models such as neuropathy or 
hind paw inflammation,  might limit the evaluation of anxio-depressive 
symptoms.  
6.5.3. MS modulates noxious thermal sensitivity during 
normal and inflamed conditions 
Contrary to the von Frey measures, the hot plate test revealed shorter latencies 
of nocifensive behavior, hence hypersensitivity to 50°C heat, in the MS group. 
These results may seem confounding since von Frey results suggested that CON 
and MS had similar baseline thresholds for mechanical noxious stimulation 
while thermal noxious stimuli elicited a quicker nocifensive behavior in MS 
animals. However, noxious mechanical and heat stimuli involve different 
peripheral processing mechanisms [37]. Furthermore, contrary to the paw lifting 
behavior used to determine mechanical thresholds, licking and jumping used in 
the hot plate test as experimental endpoints are considered to be supra-spinally 
integrated responses [38]. 
We can also observe the reduction in hot plate latencies in CON animals that did 
not undergo CFA-inflammation. This phenomenon has already observed been 
in early studies using repeated testing protocols [39,40]. The behavioral 
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tolerance [41] expressed in this way was suggested to be related to the test 
endpoint and to daily and/or weekly test repetitions. Since jumping and licking 
are supra-spinally mediated responses to noxious stimulation, it was suggested 
that this habituation phenomenon [42] leads to a reduction of the tonic 
descending serotoninergic inhibition [39]. Other investigators have more 
recently proposed that first exposures to the hot plate lead to a potent stress 
induced analgesia. Stress and concomitant stress-induced analgesia would then 
decrease with the successive tests leading to a shortening of the nocifensive 
behaviors latencies [41]. Interestingly, MS animals did not display a reduction 
of hot plate latencies comparable to the CON group. This could reflect an 
inability of rats exposed to early life stress to habituate to the repeated hot plate 
tests. Considering the overlapping structures involved in pain and stress 
processing and phenomenon like stress induced analgesia [43], we speculate that 
MS could have altered rats’ capacity to display stress induced analgesia.  
In order to bypass the problem of having the behavioral tolerance added to the 
CFA-induced decrease in noxious heat sensitivity, we used respectively the 
CON and MS groups as “references” for the CON-CFA and MS-CFA groups. 
As a result, MS animals display a slower development of CFA-induced 
hyperalgesia than CON. This is in line with the CFA-induced changes of 
mechanical thresholds despite differences in the time course. Indeed, MS 
animals displayed a reduced sensitivity to CFA–induced mechanical 
allodynia/hyperalgesia during the late phase inflammation whereas this was the 
case in the early phase for noxious heat. To our knowledge, the long-term impact 
of MS on CFA-induced allodynia/hyperalgesia has not been investigated yet. 
However, it has been observed that analgesics may differentially affect 
mechanically and thermally induced pain. Administration of amitriptyline 9 
days after CFA injection induced a full recovery of thermal hyperalgesia but had 
not effect on mechanical allodynia [44]. Amitriptyline is a tricyclic 
antidepressant and mainly acts via inhibition of serotonin and noradrenalin 
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reuptake. The differential effect of MS on mechanical and thermal 
allodynia/hyperalgesia could point alterations of different levels of nociceptive 
processing, conceivably serotoninergic descending inhibition and spinal cord 
nociceptive transmission. Furthermore, early life stress has been shown to 
modulate the neuro-immune system [7,9,45].  
The immune system crucially participates in the establishment of peripheral and 
central sensitization, particularly in the framework of inflammatory pain. 
Reduced immune function and/or the availability of peripheral pro-
inflammatory cytokines could e.g. decrease the CFA-induced hypersensitivity. 
However, since we did not observe any difference in paw edemas, peripheral 
effects accounting for the effects of MS on pain sensitivity are quite unlikely. 
6.5. Conclusion 
Altogether, the present study tends to confirm our previous results on 
neuropathic pain. Early life stress did thus lead to a reduction of pain 
hypersensitivity in young adulthood, under conditions of neuropathy as well as 
of inflammation. The observed differences in the respective time courses 
suggest differential mechanisms underlying the regulation of neuropathy- and 
inflammation-related pain sensitivity. The present data add an additional another 
level of complexity since MS animals displayed an enhanced sensitivity to 
noxious heat during baseline conditions but a reduced one during the early phase 
of inflammation. According to our results, changes of pain sensitivity did not 
seem to depend on HPA axis alteration or anxiety-related behavior. The 
programming of pain sensitivity by early life stress might thus depend on 
substrates other than the well-established stress-related neuro-circuitry.  
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7.1. Abstract: 
The cumulative and match/mismatch hypotheses of stress are still under 
discussion regarding the effects of early life stress on vulnerability or resilience 
to psychopathology such as depression and frequent comorbid pain states under 
conditions of additional stress in later life. Previous results from our laboratory 
suggested that rats exposed to maternal separation (MS), a common model of 
early life stress, leads to a reduced vulnerability for neuropathy- and 
inflammation related- pain). In the present study we investigated the respective 
effects of an additional stressor (second hit applied in young adult rats) on the 
vulnerability to inflammatory pain.  
Sprague Dawley pups were divided into 4 groups: controls (no stress), MS, 
social stress (SS) and finally the accumulation of MS+SS. At young adult age, 
psychobiological (blood corticosterone level, sucrose preference and forced 
swim test) as well as pain- and inflammatory-related (von Frey hair test and hot 
plate test) parameters were evaluated prior and following the induction of paw 
inflammation with complete Freund’s adjuvant (CFA). Following 21 days of 
inflammation, spinal glutamatergic transmission, immunocompetent cells, pro-
inflammatory cytokines and growth factors levels were evaluated using qPCR.  
None of the stress conditions had an obvious impact on corticosterone levels and 
sucrose preference. However, while MS and SS displayed increased immobility 
in the forced swim test, the combination of both stressors brought immobility 
back to CON levels. Regarding pain sensitivity, no stress application seemed to 
have an influence on basal (prior to inflammation) mechanical thresholds and 
heat sensitivity. All stress groups displayed lower mechanical thresholds than 
CON at day 4 after the induction of paw inflammation but the respective values 
were comparable at 7, 10, and 14 days. On day 21, MS rats seemed to be more 
sensitive to mechanical stimulation than all the other groups. Regarding noxious 
heat sensitivity, MS+SS animals were generally less sensitive, this difference 
was however only significant at 10 and 21 days after CFA-injection. qPCR 
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results are mitigated. Despite the finding that stress conditions differentially 
affected different players of glutamatergic transmission, astrocyte activity and 
NGF expression, our biochemical results cannot readily be related to the 
behavioral observations, precluding a congruent conclusion.  
Despite some alterations specific to stress conditions we are not thus not able to 
corroborate or dismiss either the cumulative or match/mismatch hypothesis.   
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7.2. Introduction 
While stress normally engenders autonomic, neuroendocrine and neuro-immune 
mechanisms aimed at preserving health under conditions of enhanced strain, it 
may lead to deleterious reactions if threatening life conditions are sustained for 
prolonged periods of time. In this context, a major research emphasis was 
recently put on the long-term consequences of early life stress (ELS) on the 
processing of novel stress exposure throughout adulthood. Several concepts 
aimed at predicting these programming effects have been advanced, ranging 
from the cumulative stress hypothesis to the match/mismatch hypothesis and 
finally the three-hit concept of vulnerability and resilience [1] According to the 
two-hit-related match/mismatch theory ELS can have beneficial consequences 
if the respective individual is exposed to similar (matching) adversities in 
adulthood while a mismatching environment may lead to enhanced vulnerability 
for psychopathological diseases [2]. 
Until recently, most of the studies investigated the brain mechanisms underlying 
the impact of ELS on vulnerability/resilience to stress-related cognitive or 
emotional impairment later in life [2–4]. Only few studies focused on altered 
vulnerability for potential comorbid pathologies such as chronic pain [5–7] that 
is commonly associated with negative emotions and that may at least partly be 
processed via overlapping brain structures and pathways [8]. Although there is 
some data on the effects of ELS on neuropathic pain and inflammatory pain 
sensitivity and potentially involved brain circuits [5,9] even less is known about 
alterations of biochemical pathways that might also be involved in the regulation 
of nociceptive processing at the level of the spinal cord. This region is however 
of major importance since it constitutes the point of entry and distribution of 
noxious information throughout the central nervous system [10]. We have 
previously observed that maternal separation (MS), a rodent model of ELS could 
per se have a protective effect regarding the establishment of neuropathic and 
inflammatory pain conditions in later life [11]. 
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Considering the above mentioned concepts on ELS and consequences for stress 
reactivity and affective disorders in later life, we sought to determine whether 
ELS-treated rats displayed altered vulnerability for inflammatory pain and 
concomitantly altered processing of negative emotions when exposed to 
ongoing social stress (SS) in young adulthood. The second goal of our study was 
to investigate the ELS- and SS-dependent regulation of spinal biochemical 
markers involved in the processing of stress and/or nociception. For this purpose 
we assessed stress-related alterations in the mRNA expression of spinal 
glucocorticoid receptors (GR) and of mediators involved in glutamatergic 
transmission. GR may play a critical role in the framework of chronic pain since 
it has been shown to be involved in injury-induced NMDA receptor upregulation 
[12,13]. The NMDA receptor is an ionotropic glutamate receptor crucial for 
central sensitization [14], its sub-units NR1 and NR2 have been shown to 
undergo genomic and non-genomic regulation following acute or persistent 
inflammatory stimuli [15,16]. Furthermore, metabotropic group 1 glutamate 
receptors (mGluR), particularly mGluR1 and 5, have been shown to be 
implicated in increased excitability and central sensitization [17]. In addition it 
has been shown that in terms of the two-hit hypothesis ELS primes brain 
microglia, leading to an enhanced response to subsequent stress [18]. Since 
microglia activation also plays a critical role in inflammation [19,20], we 
included the measurement of ionized calcium binding adaptor molecule 1 (Iba1) 
mRNA as a marker for microglial activity. In the same line of reasoning, 
astrocytes are also activated and are known to upregulate the expression of glial 
fibrillary acidic protein (GFAP) [20].  It is has been shown that chronic stress 
may activate spinal glia cells [21] and it is well established that activated glial 
cells have the ability to release several mediators, including pro-inflammatory 
cytokines that may in turn enhance the sensitivity of nociceptive neurons [22–
25]. Among these mediators, spinal tumor necrosis factor alpha (TNF-α), 
interleukin-1β (IL-1β) and interleukin-6 (IL-6) are of major importance as their 
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release in the spinal cord leads to exaggerated pain experience and persistent 
pain [26,27]. 
Finally, in addition to the described markers, we investigated the mRNA 
expression of the neurotrophic factors nerve growth factor (NGF) and glial cell 
line-derived neurotrophic factor (GDNF) that have both been discussed to be 
implicated in chronic stress/depression as well as in nociception [28]. 
7.3. Material and Methods 
7.3.1. Animal housing 
Male Sprague Dawley rats taken for the experimental procedures described 
below were obtained from our in-house breeding facility. All animals were kept 
under standardized housing conditions in a temperature (22 ± 1°C), humidity 
(60 ± 10%) and light/dark cycle (12h, 7 am to 7 pm) controlled room. Food and 
water were provided ad libitum. Unless indicated differently, animals were 
handled twice per week during the cleaning of the cages.  
7.3.2. Breeding 
Sprague Dawley males and females used in the breeding were purchased from 
Harlan Laboratories (Netherland). After a week of habituation to the housing 
conditions, two females were mated with a male for 4 days. Gestating females 
were housed individually 15 days after the end of mating. From day 18 after the 
first day of breeding on, we checked for litters daily at 8:30 am and 7:00 pm. 
When the litter was observed, the day of birth was defined as post-natal day 0 
(P0). 
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7.3.3. Experimental procedure 
The experimental design of this study is graphically summarized in Figure 1. 
Four groups of rats were used: CON (underwent neither MS nor SS, n=23), MS 
(underwent MS but not SS, n=16), SS (underwent SS but not MS, n=12) and 
MS+SS (underwent the combination of MS and SS, n=12). 
Apart from MS, rats were not subjected to any manipulation until the age of 6 
weeks. At that stage they were habituated to the experimenter and experimental 
devices. At 7 weeks of age, the experimental procedures started with blood 
sampling to measure basal corticosterone levels and behavioral tests to obtain 
baseline values. Mechanical (von Frey test) and thermal (hot plate test) noxious 
sensitivity as well as depressive (sucrose preference test) behavior were 
assessed. Once the pre-stress baseline was established, the animals in the 
relevant groups were subjected to the social stress paradigm. Blood sampling 
and the two bottle choice sucrose preference test were performed during the SS 
period in order to evaluate the effect of stress across time. After the 6 weeks of 
SS, all animals underwent a second and similar baseline testing (=post-stress 
baseline). One supplementary test was added in order to complete the 
assessment of depressive like behaviors by using the forced swim test (FST). 
Subsequently, all animals were injected with Complete Freund's Adjuvant 
(CFA) to induce chronic inflammatory pain and noxious sensitivity was tested 
at post-injections days 4, 7, 10, 14 and 21. Finally, animals were euthanized and 
L4-L6 levels of the spinal cord were sampled to assess mRNA expression of 
spinal biomarkers involved in the modulation and the transmission of noxious 
signals. 
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Figure 24: Experimental design. The course of the experiment is depicted in a) and the experimental 
procedures carried out are outlined in detail in b) by giving the exact timeline. After birth (P0), rats were 
separated into two experimental groups: the control group that was left undisturbed until the age of 7 weeks 
and the MS group that underwent the maternal separation from postnatal day 2 (P2) to 12 (P12). At an age 
of 7 weeks, each of the two groups were further divided into a non-stressed group (CON resp. MS) and a stress 
group (CON+SS resp. MS+SS) that underwent the social stress paradigm. Baseline values were collected for 
blood corticosterone levels (blood sampling, BS), basal mechanical (von Frey test, VF) and thermal (hot plate 
test, HP) sensitivity and for depressive behavior (sucrose preference test, SP). The animals in the CON+SS and 
the MS+SS groups were then subjected to the social stress for 6 weeks. Blood was taken and sucrose 
preference was measured during the social stress period after week 2 and 4. After the stress, BS, VF, HP and 
SP were performed to reveal a post-stress baseline. Additionally, the animals were subjected to a forced swim 
test. Following that, inflammation was induced by Complete Freunds Adjuvant (CFA) in all four groups. 
Mechanical and thermal noxious sensitivities were further measured on days 4, 7, 10, 14 and 21. After the 
last testing, animals were sacrificed. 
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7.3.4. Maternal Separation 
Early life stress consisting of a maternal separation (MS) procedure was 
performed on at least 4 different litters. Every day, from P2 to P12, pups and 
dams were brought in an adjacent room with similar housing conditions and 
separated from each other. Pups were transferred to another cage equipped with 
a heated pad having a temperature of 33 ± 2°C and left undisturbed for 3 hours. 
After each separation, they were returned to their home cage with the dam. Rats 
from the experimental groups CON and SS that were not selected for the MS 
procedure were left undisturbed during this period.  
7.3.5. Social stress 
The social stress (SS) paradigm used was based on studies performed in mice 
by Schmidt and colleagues [29,30] and on a model initially developed in rats by 
Mormede and colleagues [31]. Young siblings from 4 different litters were 
housed 3 per cage until they reached the age of 8 weeks. The group composition 
in the cages was then changed twice per week during cage cleaning, for a period 
of 6 weeks. The redistribution of the rats was performed in a manner to ensure 
a minimum of interactions between already familiarized rats and siblings. At the 
end of the SS period, rats were brought together with their original siblings. 
Animals that did not undergo the SS procedure were left undisturbed. 
7.3.6. Pain sensitivity assessment 
Mechanical thresholds and thermal sensitivity testing were performed 
successively on the same day with a minimum of 30 min interval to minimize 
phenomenon of nociceptor sensitization.  
Mechanical noxious sensitivity 
Mechanical thresholds were assessed by using an electronic version of the Von 
Frey test (dynamic plantar aesthesiometer; Ugo Basile, Milan, Italy). Animals 
were transferred to the testing room between 7:15 and 7:30 am and left 
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undisturbed for at least one hour before each rat was individually placed in a 
Plexiglas chamber with wire mesh floor. Both hind paws were tested 3 times 
alternatively with at least a 5 minute interval. A device-controlled pressure was 
progressively applied on the plantar hind paw surface by a blunted metallic 
filament (ramp of 50 g in 35 s). The pressure that evoked a withdrawal of the 
tested hind paw was recorded automatically and was considered as the 
mechanical nociceptive threshold. Each paw was tested three times and the 
results were averaged for each day of test. For the pre-stress baseline animals 
were tested on 3 consecutive days and the thresholds obtained per day were 
averaged and the mean was defined as the mechanical sensitivity threshold of 
the animal. 
Thermal noxious sensitivity 
Thermal noxious sensitivity was evaluated as the latency to show nocifensive 
behavior when placed on a temperature controlled (50 ± 1°C) hot plate. The hot 
plate apparatus (Ugo Basile, Milan, Italy) is composed of a flat metal plate (19 
cm in diameter) surrounded by a Plexiglas cylinder (30 cm of height). For the 
test, animals were placed on the hot metal plate within the cylinder and left 
undisturbed until they presented signs of noxious behavior. At the first clear 
signs of painful behavior, the test was stopped and the animals removed from 
the hot plate. Tests were recorded using a camera (Sony HDR-CX220E) and the 
latency to display a nocifensive behavior was measured by using a stopwatch.  
7.3.7. Depressive-like behavior assessments 
Sucrose preference test: two bottle choice 
Anhedonia is one of the traits observed in patients suffering from depression. In 
animal models of depression, the two bottle choice paradigm is commonly 
chosen to evaluate this behavior. This test was performed before, during (week 
2 and 4) and after the SS period. Each rat was housed individually for a 24 hour 
period. During this period, they were given the possibility to drink from two 
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bottles, one containing tap water and the other a 0.8 % sucrose solution. In order 
to avoid a side preference effect, the bottles were randomly distributed between 
left and right sides. After the 24 hours of test, animals were returned to their 
home cage. Food, water and sucrose solution were weighed before and after the 
24 hours in order to obtain the raw consumption of food and liquids. The 
preference was then calculated as the volume of sucrose solution ingested over 
the total volume consumed during the 24 hours of test. 
% Preference = [(Sucrose Intake/Total Intake) x 100] 
For anhedonia to be confirmed, the sucrose consumption had to be below 60%. 
Values were removed if a bottle presented a damage provoking a leakage of 
sucrose solution or water. 
Forced swim test 
We used a modified version of the forced swim test [32]. The forced swim test 
was performed only once at the end of the SS period since it puts a strain on the 
animals. It consisted in placing the rats in glass cylindrical tanks (diameter: 
24cm, height: 45cm) containing water (23.5 ± 0.5°C, 35 ± 2 cm of water depth) 
on 2 consecutive days. The water was changed after each swim test. As for other 
behavioral tests, animals were brought to the experimental room at least one 
hour before the beginning of the testing session. On the first test day, animals 
were submitted to a 15 minutes swim (pre-test) session that was recorded with 
a camera (Sony HDR-CX220E). The session on the second day consisted in a 
shorter forced swim (5 min). As previously, this test was video recorded and the 
time rats spent immobile, climbing or swimming was acquired. An animal was 
considered to be immobile only when floating or performing very slight 
movements allowing it to keep its head above water level. After the test sessions, 
rats were dried in a towel and returned to their home cage. 
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7.3.8. Induction of peripheral inflammation and evaluation of 
CFA-induced edema 
Rats were briefly anesthetized with isoflurane (4.3% for induction and 2.5% for 
maintenance) using an anesthesia unit (Univentor 400, Zejtun, Malta). 
Inflammation was induced by injecting 0.1 ml of CFA (suspended in oil/saline 
emulsion 1:1) into the plantar surface of the left hind paw. The contralateral hind 
paw was injected with an equal volume of saline.  
The CFA-induced hind paw edema was evaluated by measuring the paw 
circumference after the behavioral tests at day 4, 7, 10, 14 and 21 after the 
injection. Rats were loosely immobilized in a towel, the hind paw was held and 
a second experimenter measured the circumference by the use of a string. Three 
measures per paw and measurement day were performed and averaged. In order 
to normalize the paw size among rats and avoid weight and body size effects, 
the ratios of the circumferences of ipsi- to contralateral side were computed for 
each animal and expressed in percent. 
        7.3.9. Blood sampling and measurement of plasma corti-
costerone levels 
In order to evaluate the impact of maternal separation stress and of social stress, 
as well as their combination, we determined the blood corticosterone 
concentration before, during and after the SS period. Blood was taken from 
awake rats in the morning, between 8 and 9 am. To reduce stress reactions, 
animals were loosely held in a towel and a small incision in the distal part of 
the tail was performed by the use of a scalpel. About 300 µl of venous blood 
was collected with an EDTA-coated capillary tube (Microvette CB300, 
Sarstedt, Essen, Belgium). The blood samples were immediately placed on 
ice and then centrifuged at 12000 rpm for 10 min at 4°C. The segregated 
plasma was collected in 0.5 ml tubes and stored at -20°C until further 
analysis. 
Plasma corticosterone levels were measured using an ELISA (Enzyme-Linked 
Immunosorbent Assay) kit (Assay Design, USA). The “small samples volume” 
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protocol was used according to the manufacturer's provided information. Data 
were acquired using the Sunrise Magellan (Austria) plate reader and analyzed 
with the corresponding software package (Magellan Software, v6, 4 standard, 
Austria). 
7.3.10. Tissue sampling and RNA extraction 
After 21 days of CFA-induced peripheral inflammation animals were deeply 
anesthetized with isoflurane and decapitated. Spinal cord levels L5-L6 were 
removed and divided into ipsilateral and contralateral side. Total RNA was 
extracted by the acid guanidium–thiocyanate–phenol–chloroform method using 
TRIzol® reagent (Life Technologies, Halle, Belgium). After centrifugation, the 
aqueous phase was collected and the RNA was precipitated with isopropanol. 
The pellet was rinsed with 70% ethanol, air dried, dissolved in RNase free water 
and finally stored at -80 °C until further analysis. RNA quality was assessed 
with either the Experion system or the Experion Automated Electrophoresis 
Station (Bio-Rad Laboratories, Nazareth, Belgium) using StdSens chips (Bio-
Rad). RNA concentration was measured by using the Nanodrop 2000 
spectrophotometer quantification system (Isogen Life Sciences, Netherlands). 
7.3.11. Reverse transcription and Real-Time qPCR 
Using the Improm-II reverse transcription kit (Promega, Leiden, Netherlands), 
500 ng of total RNA was reverse transcribed into cDNA with 0.5 µg/ml of oligo 
dT15 primer in a C1000 Touch thermocycler (Bio-Rad, Nazareth, Belgium). 
Real-Time qPCR experiments were performed on a CFX 96 real time system 
(Bio-Rad, Nazareth, Belgium) with 12.5 ng of cDNA in a final volume of 20 µl 
by the use of PerfeCTa® SYBR® Green SuperMix (VWR, Leuven, Belgium) 
containing 2X reaction buffer with optimized concentrations of MgCl2, dNTPs, 
AccuStart Taq Polymerase, SYBR Green I dye, stabilizers and forward and 
reverse primers at 2 µM (for the list of primers see Table 1). 
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Primers were designed with the Beacon Designer™ software. Their sequence 
specificity was tested using the Basic Local Alignment Search Tool at NCBI 
and they were validated on spinal cord samples. The following steps were 
performed: polymerase activation at 95 °C for 3 min, 40 cycles of amplification 
at 95 °C for 10 sec, annealing at 61 °C for 30 sec, recording of melting curves 
between 65 °C and 95 °C in 0.5 °C intervals. All samples were run in triplicate 
and no-template controls were added as negative controls. Relative expression 
levels were estimated using the ∆∆Ct-method with β-actin as the reference. 
Threshold cycle values (Cq) were used to calculate the amount of target gene 
mRNA in relation to the reference gene mRNA (β-actin). Therefore, ∆Cq 
represents the difference between the number of cycles that were necessary to 
detect the PCR products of the target and the reference genes. ∆∆Cq indicates 
the difference between the ∆Cq of the experimental groups (CON+SS, MS and 
MS+SS) and the ∆Cq of the control animals (CON). The data were expressed as 
2-∆∆Cq and the mean of the left (ipsilateral) inflamed side was computed for
each group.
7.3.12. Statistical analysis 
Data are presented as mean ± SEM. Homogeneity of variance was tested using 
Levene’s or Shapiro-Wilk test. The sucrose preference, corticosterone level and 
hot plate data were analyzed by a Kruskal-Wallis test followed by a Dunn’s 
multiple comparison test. For the forced swim test we used a one-way analysis 
of variance (ANOVA) and a Tukey’s multiple comparison post hoc test to check 
for differences between groups. The statistical analysis for the paw 
circumference measurements and the von Frey experiments were carried out 
using a two-way (time x condition) repeated measures ANOVA followed by 
Tukey’s multiple comparison post hoc test. 
For all gene expression experiments, the ipsilateral spinal cord of CON served 
as control and the relative expression level was set to 1. The expression levels 
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of the treatment groups MS, SS and MS+SS were expressed as fold of CON. 
For statistical analysis, these relative expression levels (fold) were compared 
using the one-way ANOVA followed by Tukey’s multiple comparison post hoc 
test. 
7.4. Results 
7.4.1. Behavioral assessments 
Sucrose preference was not affected by stress 
At the beginning of the experiment, under baseline conditions, the group that 
was assigned to MS+SS conditions unexpectedly showed a significantly lower 
sucrose preference as compared to CON (p<0.001) and to MS (p<0.01) (Fig. 
2a). Since sucrose preference is commonly considered as anhedonia when being 
below 60%, this result cannot be interpreted as anhedonic behavior. Over the 
course of the experiment, no differences between groups were observed in this 
respect. 
MS and SS animals showed depression-like behavior in the forced swim test 
The time (s) rats spent immobile during the testing session was significantly 
impacted by the different manipulations (F3, 59 = 10.168, p<0.001) (Fig. 2b). 
The post hoc analysis revealed a significant increase of immobility in the MS 
(178.21 ± 6.42; p<0.01) and SS (198.30 ± 10.37; p<0.001) groups when 
compared to CON (141 ± 6.3). Combining the two stressors, MS+SS, did not 
result in a further increase of immobility but, in contrast, reduced the time spent 
immobile to control levels (152.63 ± 10.79). 
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Figure 25: Depression-like behavior. a) Sucrose preference was measured before (baseline), during (d23-24 
and d37-38) and after (d53-54) the social stress period. The four groups, control (CON, black circles), 
maternally separated (MS, white circles), social stress exposed (SS, black triangles) and the combined maternal 
separation and social stress subjected group (MS+SS, white triangles) exhibited similar preference levels 
throughout the stress period. At baseline the MS+SS group unexpectedly showed significantly lower sucrose 
preference, although it cannot be interpreted as anhedonic behavior. Data are expressed as mean ± SEM. * 
represents a significant difference between CON and MS+SS (***p < 0.001). # indicates a significant difference 
between MS and MS+SS (##p <0.01). b) Forced swim test: the time (s) rats spent immobile was measured after 
the social stress period at d54-d55. MS (white bar) and SS (dark gray bar) animals exhibit a significant higher 
immobility than CON (dark bar) whereas the combination of the two stressors (MS+SS, light grey bar) reduced 
the immobility time to control levels. Data are expressed as mean ± SEM. (**p<0.01, ***p<0.001) 
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Early life stress (MS) and social stress (SS) only slightly alter inflammation-
induced development of mechanical allodynia/hyperalgesia 
Mechanical pain thresholds, assessed by a dynamic plantar aesthesiometer, did 
not differ between groups at the beginning of the experiment prior to stress 
application in the respective groups (Fig. 3a). Post-stress, CON, MS and MS+SS 
exhibited slightly increased mechanical thresholds, which could be interpreted 
as habituation to the testing conditions. In SS animals such an increase could not 
be observed, however the statistical analysis did not reveal a significant 
difference to the other groups. After CFA injection all animals progressively 
developed a strong tactile allodynia/hyperalgesia on the ipsilateral side peaking 
at day 7 and then slowly recovering without coming back to baseline levels at 
day 21. At day 4 inter-group comparisons revealed a significantly lower 
mechanical threshold of CON when compared to MS (p<0.05), SS (p< 0.001) 
and MS+SS (p<0.05). From day 7 to 14, no differences between groups were 
observed and at day 21 MS had a significantly lower mechanical threshold than 
CON (p<0.01), pointing to a slower recovery of the maternally separated 
animals.  
There is no pronounced difference in inflammation-induced development 
of thermal hyperalgesia under MS and SS conditions 
In the hot plate test no significant difference in noxious heat sensitivity was 
found between any of the groups at baseline (Fig. 3b). After the social stress 
period, a slight decrease in thermal sensitivity was observed in MS and SS 
animals, possibly due to habituation. However, it turned out not to be of 
statistical significance. The induction of inflammation rapidly and lastingly 
decreased the latency for the animals to present nocifensive behaviors. At day 
10 post-injection, significant differences in thermal sensitivity were only seen 
between CON and MS+SS (p<0.05) and at day 21 between CON and MS+SS 
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(p<0.01) and between MS and MS+SS (p<0.05). In both cases, the MS+SS 
animals showed slightly less thermal hyperalgesia than the other groups. 
Figure 26: Effect of early life stress (MS) and social stress (SS) on inflammation-induced mechanical and 
thermal allodynia/hyperalgesia. a) Mechanical pain thresholds were assessed before (baseline) and after the 
social stress period (post-stress). In both cases no significant difference was found between groups (CON: black 
circles, MS: white circles, SS: black triangles, MS+SS: white triangles), although there was a tendency in the SS 
group to be more sensitive after the stress. Induction of inflammation by injection of CFA into the left hindpaw 
resulted in a decrease of pain thresholds in all groups, peaking at day 7 and partially recovering until the end 
of the experiment at day 21. The onset of mechanical allodynia/hyperalgesia was significantly delayed in all 
three stress groups (MS, SS, MS+SS) at day 4 when compared to CON. The recovery (day 21) was only 
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significantly delayed in MS animals. Data are expressed as mean ± SEM. * represents a significant difference 
between CON and MS+SS (*p < 0.05), ♦ between CON and MS (♦p <0.05, ♦♦p <0.01) and † between CON 
and SS (†††p <0.001). b) Thermal pain thresholds did not differ between groups (CON: black circles, MS: white 
circles, SS: black triangles, MS+SS: white triangles) before (baseline) and after the social stress period (post-
stress). Injection of CFA into the left hindpaw induced thermal hyperlagesia in all groups persisting until the 
end of the experiment at day 21. There was a tendency for the MS+SS animals to show less hyperalgesia in the 
course of the experiment reaching significance at day 10 and 21. Data are expressed as mean ±  SEM. * 
represents a significant difference between CON and MS+SS (*p < 0.05, **p<0.01) and # between MS and 
MS+SS (#p <0.05). 
       7.4.2. The  development  of  CFA-induced  paw  edema is 
different  in  MS  and  SS  animals  only  in  the early  phase  of 
inflammation 
No significant difference in paw circumference (data computed as percentage of 
the contralateral, non-injected hind paw) was found between any of the 4 groups 
before induction of inflammation (Fig. 4). CFA injection produced a significant 
swelling of the paw in every group (p<0.001 for all time points) as revealed by 
a two-way repeated measures ANOVA (F5, 348 = 194.1, p <0.0001). A 
significant group effect was also seen (F3, 348 = 5.045, p = 0.002). In CON 
(130.8 ± 0.83) and SS (136.8 ± 2.17; p<0.05 vs. CON) the paw circumference 
peaked on day 4 and in MS (133.3 ± 2.01) and MS+SS (132.9 ± 1.70) on day 7 
post-inflammation, pointing to a small delay in the development of edema in 
maternally separated animals. Consequently, significant differences between 
groups were seen at day 7, when the maximum swelling was reached in the MS 
and MS+SS animals, whereas in CON and SS a recovery was already observed 
(MS vs. CON: p<0.01, MS+SS vs. CON: p<0.05; MS vs. SS: p<0.001, MS+SS 
vs. SS: p<0.001). At day 10, the edema decreased also in the MS and MS+SS 
groups. Significant differences where however still be seen between MS and 
CON (p<0.05) and between MS and SS (p<0.01). On later days the paw 
circumferences leveled off to about 120% in all four groups. 
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Figure 27: Development of inflammation-induced edema. The circumference of the left hindpaw (expressed 
as % of the circumference of the right hindpaw) was assessed before the induction of inflammation (pre-
infl.). No difference was obtained in the four groups (CON: black circles, MS: white circles, SS: black 
triangles, MS+SS: white triangles). Injection of CFA produced a pronounced swelling which peaked at day 4 
in the CON and SS groups and at day 7 in MS and MS+SS leading to significant differences in the 
early phase of edema development between CON and SS (†p<0.05) at day 4, between CON and MS 
(♦♦p<0.01), CON and MS+SS (**p<0.05), SS and MS+SS ($$$p<0.001), MS and SS (p<0.001) at day 
7 and between CON and MS (♦p<0.05) and MS and SS (p<0.01) at day 10. Data are expressed as 
mean ± SEM. 
      7.4.3. There is no clear correlation between stress conditions 
and corticosterone levels 
Baseline measurements revealed a small tendency to lower corticosterone levels 
in maternally separated animals (MS and MS+SS groups) (Fig. 5). However, 
this difference turned out to be not significant when compared to CON whereas 
it was significant as compared to SS (p<0.05 for MS and MS+SS) although the 
two groups, CON and SS, where not subjected to different manipulations at this 
time point. Two weeks after the start of the social stress paradigm, the 
corticosterone levels increased in all experimental groups, but no inter-group 
differences could be seen. In CON and MS+SS the ongoing stress resulted in a 
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further increase of the blood corticosterone concentration 4 weeks after the 
beginning of the social stress period, leading to a significant difference between 
the SS and MS+SS groups (p<0.05). After the 6th week of social stress, no 
further changes were observed. The following inflammation period of 21 days 
either had no influence on the corticosterone levels in CON animals or the 
concentration turned back to the pre-inflammation level after this period. In the 
groups with a history of stress manipulation, the blood corticosterone 
concentration was likewise increased at that time point and a higher intra-group 
variation was noticeable. Significant differences were revealed for SS vs. CON 
(p<0.05) and for MS+SS vs. CON (p<0.01). No significant difference was 
obtained for MS vs. CON, probably due to the mentioned intra-group variation. 
Figure 28: Effect of early life (MS) and social stress (SS) and their combination (MS+SS) on blood serum 
corticosterone levels. Blood was taken and corticosterone levels were measured before (baseline), during (end 
of week 2 and 4) and after (week 6) the social stress period as well as 21 days after the onset of inflammation. 
At baseline, the maternal separated animals (MS, white bars and MS+SS, light grey bars) tended to have lower 
blood corticosterone concentration when compared to controls (CON, black bars) and to SS (dark grey bars). 
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Two weeks after the start of social stress in the respective groups, the corticosterone levels increased in all 
animals, independent of the stress condition. After week 4, the corticosterone concentration further increased 
in CON, SS and MS+SS but not in MS and roughly stayed at that level after week 6. The CFA-induced 
inflammation increased the concentration of serum corticosterone as well as the intra-group variability in the 
stress groups MS, SS and MS+SS but not in CON. Data are expressed as mean ± SEM. (*p<0.05, **p<0.01). 
      7.4.4. Are  spinal  pain-  and  stress-related  biomarkers  dif-
ferentially  affected  by  early  life  or/and  social  stress 
under inflammatory conditions? 
Stress-mediated alterations of the mRNA expression of spinal 
glucocorticoid receptor (GR) and receptors of the glutamatergic system 
Glucocorticoid receptor: The regulation of the GR mRNA expression did not 
seem to be affected by any of the stress conditions. No significant difference 
between groups was found (Fig. 6). 
Glutamatergic system: In order to evaluate the implication of the glutamatergic 
system in the alteration of noxious sensitivity following different stress 
conditions and concomitant inflammation we focused on the regulation of 
mRNA expression of the NMDA receptor subunits NR1 and NR2a. We also 
Figure 29: Regulation of the spinal glucocorticoid 
receptor (GR). Gene expression of GR was 
examined in the ipsilateral (left) spinal cord 
segment L5/L6 of controls (CON, black bars), 
maternally separated rats (MS, white bars), 
animals subjected to social stress (SS, dark grey 
bars) and rats that were exposed to both 
stressors (MS+SS, light grey bars), 21 days after 
induction of inflammation. GR mRNA expression 
was not influenced by any of the three stress 
conditions. Data are expressed as relative 
expression level (fold) of CON (control group = 1) 
and are shown as mean ± SEM. 
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investigated the effects on the group I metabotropic receptors mGluR1 (GRM1) 
and mGluR5 (GRM5). After 21 days of inflammation, the NR1 mRNA levels 
were upregulated in all the experimental groups as compared to the controls 
(1.01 ± 0.05) and reached statistical significance in MS (1.30 ± 0.08, p<0.05) 
and MS+SS (1.25 ± 0.05, p<0.05), but not in SS (1.22 ± 0.05) despite a strong 
tendency (Fig. 7a). NR2a expression was affected in a different manner as it was 
upregulated in MS (1.32 ± 0.07, p<0.01), downregulated in SS (0.79 ± 0.04, 
p<0.05) and not significantly altered in MS+SS (1.17 ± 0.06) when compared to 
CON (Fig. 7b). 
Concerning the metabotropic glutamate receptors, there was a clear tendency for 
mGluR1 mRNA to be upregulated in the MS group (1.22 ± 0.03) when 
compared to CON (Fig. 7b). This increase reached significance in comparison 
with SS (0.92 ± 0.06, p<0.05) and MS+SS (0.97 ± 0.03, p<0.05). In the case of 
mGluR5 mRNA there was no significant alteration in the stress groups relative 
to CON. Only a significant inter-group difference could be found for SS vs. 
MS+SS (p<0.05) (Fig. 7b). 
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Figure 30: Regulation of spinal ionotrophic and metabotrophic glutamate receptors. The gene expression of 
two subunits of the ionotrophic NMDA receptor, NR1 and NR2a (a), and of the group I metabotropic receptors 
mGluR1 and mGluR5 (b) was examined in the ipsilateral spinal cord segment L5/L6 of controls (CON, black 
bars), maternally separated rats (MS, white bars), animals subjected to social stress (SS, dark grey bars) and 
rats that were exposed to both stressors (MS+SS, light grey bars), 21 days after induction of inflammation. 
Data are expressed as relative expression level (fold) of CON (control group = 1) and are shown as mean ± 
SEM. a left: NR1 mRNA was slightly upregulated in all three stress groups reaching significance in MS and 
MS+SS animals. a right: NR2a mRNA was upregulated in MS, downregulated in SS and not significantly altered 
in MS+SS. b left: mGluR1 mRNA showed an upregulation trend in the MS group. SS and MS+SS conditions had 
no influence on the mGluR1 mRNA expression. b right: No significant alteration of the mGluR5 mRNA level was 
found in the three stress conditions when compared to CON. (*p<0.05, **p<0.01, ***p<0.001) 
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Stress-mediated alterations in the mRNA expression of activation markers 
of immunocompetent cells and of pro-inflammatory cytokines  
Activation of astrocytes and microglia: To assess differences in the activation 
level of glial cells between the experimental groups, the mRNA expression of 
the astrocyte marker GFAP and the microglia marker Iba1 was examined. 21 
days after CFA-induced hind paw inflammation a significant reduction of GFAP 
mRNA expression level was observed in animals subjected to social stress, SS 
(0.81 ± 0.08, p<0.05) and MS+SS (0.83 ± 0.02, p<0.05) but not in MS (0.99 ± 
0.11) when compared to CON (1.01 ± 0.04) group (Fig. 8a). No significant 
differences between groups were observed for the regulation of Iba1 mRNA 
expression (Fig. 8a).  
Pro-inflammatory cytokines: After 21 days of inflammation, no statistically 
significant inter-group differences could be found in the mRNA expression 
levels of IL-1β and IL-6. In the case of TNF-α, an upregulation trend was 
observed in the MS group (1.39 ± 0.17). Due to a pronounced intra-group 
variance, no statistical significances were obtained (Fig. 8b).  
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Figure 31: Regulation of glial activation markers and pro-inflammatory cytokines. The gene expression 
of the astrocyte marker GFAP and the microglia marker Iba1 (a), and of the pro-inflammatory 
cytokines IL-1β, IL-6 and TNFα (b, c) was examined in the ipsilateral spinal cord segment L5/L6 of 
controls (CON, black bars), maternally separated rats (MS, white bars), animals subjected to social 
stress (SS, dark grey bars) and rats that were exposed to both stressors (MS+SS, light grey bars), 
21 days after induction of inflammation. Data are expressed as relative expression level (fold) of CON 
(control group = 1) and are shown as mean ± SEM. a left: GFAP mRNA was downregulated in SS 
and MS+SS animals, but not in the MS group (*p<0.05). a right: the three stress conditions (MS, SS, 
MS+SS) had no influence on Iba1 mRNA expression. b: the mRNA expression of IL-1β (left) and IL-
6 (right) was not altered by stress. c: TNFα mRNA expression was slightly, but not significantly 
upregulated in MS. Social stress (SS) and the combination of early life and social stress (MS+SS) 
had no effect on the regulation of the TNFα gene. 
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Stress-mediated alterations in the mRNA expression of the growth factors 
GDNF and NGF 
The three examined stress conditions did not differentially regulate spinal 
GDNF mRNA levels. No significant inter-group differences were obtained (Fig. 
9). Concerning the expression of NGF mRNA, the stress groups did not exhibit 
any significant difference to the CON group (1.02 ± 0.07) although an 
upregulation tendency was observed in MS (1.17 ± 0.05) and SS (1.17 ± 0.05) 
groups (Fig. 9). An opposite trend was seen in MS+SS animals (0.93 ± 0.04) 
which led to the expression of significant differences of this group to MS 
(p<0.05) and SS (p<0.01).    
Figure 32: Regulation of spinal growth factors. The gene expression of the growth factors GDNF (left) and NGF 
(right) was examined in the ipsilateral spinal cord segment L5/L6 of controls (CON, black bars), maternally 
separated rats (MS, white bars), animals subjected to social stress (SS, dark grey bars) and rats that were 
exposed to both stressors (MS+SS, light grey bars), 21 days after induction of inflammation. Data are expressed 
as relative expression level (fold) of CON (control group = 1) and are shown as mean ± SEM. Left: the different 
stressors had no effect on the mRNA expression of GDNF. Right: None of the three stress conditions resulted 
in significant alterations of NGF mRNA expression when compared to the controls (CON). Slight upregulation 
in MS and SS animals and slight downregulation in the MS+SS group led to significant differences between MS 
and MS+SS and between SS and MS+SS. (*p<0.05, **p<0.01) 
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7.5. Discussion: 
Considering the high comorbidity between stress-related disorders and chronic 
pain we sought to determine if individuals exposed to ELS and then undergoing 
a prolonged period of social stress during adulthood could be more susceptible 
to chronic inflammatory pain.  
In order to induce early life stress in rats we chose a maternal separation (MS) 
model that we previously used in combination with neuropathic pain in young 
adulthood [11]. MS has been shown to enhance vulnerability for psychiatric 
diseases (O'Mahony et al, 2009) and chronic pain conditions ([33–35]), but it 
may also lead to resilience against the same pathologies [11,36] 
Impact of MS and/or SS on anxio-depressive-like disorders 
In adult animals, commonly used chronic stress paradigms using repeated 
exposure to adverse physical stimuli such as restraint do not readily mimic the 
etiology of stress-related disorders found in humans since the increased 
prevalence of psychiatric disorders is mainly related to adverse psycho-social 
conditions [29,37]. Other experimental approaches like the resident intruder and 
visible burrow system paradigms may hence be more relevant for the 
comprehension of coping strategies and vulnerability/resilience mechanisms 
and were used in the present study [38].  
We did not observe significant differences in sucrose preference between any of 
the groups after 2, 4 and 6 weeks of the accordingly applied social stress. 
Surprisingly however, MS+SS animals presented a significantly reduced 
sucrose preference compared to all the other groups at baseline, prior the start 
of the SS period. Therefore this result can probably be ascribed to the variability 
inherent in our experimental design. In spite of the significantly reduced sucrose 
preference of the MS SS animals, they did not reach the reduction to 65 % 
commonly used as the threshold value for anhedonia [39,40] which was hence 
not displayed by our animals. 
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The forced swim test has long been considered as an animal paradigm inducing 
depression and it has traditionally been used for screening potential 
antidepressant molecules [41]. However, recent views claim that the FST 
provides a model for responses to an acute uncontrollable stress rather than for 
depression [42]. Our results show that animals undergoing MS or SS presented 
enhanced immobility compared to CON animals. Immobility is considered to 
reflect behavioral despair or the development of passive coping when facing an 
uncontrollable stress [43]. Previous experiments demonstrated that micro-
injections of GABA, lidocaine or antidepressant in structures involved in the 
processing of stress and pain such as the amygdala [44] or the periaqueductal 
gray [45] lead to reduction of immobility time in the FST. Furthermore, 
chromatin reorganization and changes in histone regulation have been observed 
after chronic stress in CORT-sensitive meso-limbic structures. Also, these 
genomic and non-genomic modifications are suggested to underlie behavioral 
despair after additional acute FST [41,46]. Since these structures are involved 
in the affective dimension of pain [47], the enhanced immobility observed in 
MS and SS groups could also reflect an altered pain sensation or unpleasantness. 
Interestingly however, animals undergoing the combination of MS and SS 
displayed a comparable total time of immobilization behavior as the CON rats 
pointing to the possibility that the combination of MS and SS may have led to 
more resilience to stressful situations as also expressed by the enhancement of 
active coping in the FST.  
Taken together our anhedonia and FST-related results may seem confusing since 
other authors observed anhedonia associated with an increased swimming in the 
FST [48]. However other investigators showed anhedonia and FST-immobility 
could be dissociated [49]. Moreover, it has been emphasized that anhedonia and 
immobility in the FST following a chronic stress were linked to submissive 
behavior [50]. We did not test submission in our experiment. However we 
believe that the social instability model we used here, mingling cage mates and 
hence dominance/submission relationships is hardly reconcilable with tests of 
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susceptibility to submission because individuals are not put in a situation where 
they are forcefully dominated or dominating. Indeed, in our social stress 
paradigm, a rat displaying submissive behavior on one week might be dominant 
rather than submissive on the next week when the composition of the cage 
partners is changed. Furthermore it should be noted that despite the overall non-
anhedonia displayed in the FST, we observed some rare case of anhedonia at 
specific time-points that always recovered in the following tests. Using a defeat 
paradigm, Willner and colleagues [51] found that loss of social rank induces a 
decrease of sucrose preference. This could suggest that an “ectopic” decrease of 
sucrose preference may be indicative of a formerly dominant rat now in turn 
being dominated by other companions while the recovery of sucrose preference 
could be indicative of a re-establishment of the social status. Pure social defeat 
stress may hence induce a more homogenous stress than the model proposed by 
Strekalova and colleagues [50] that induces impairment that is less dependent 
of rats’ submissive traits. Another possibility explaining the discrepancies 
between studies is the impairment of locomotor activity since the FST also 
relays on motricity [52]. We did however never observe such an impairment in 
MS or SS in the open field test nor the zero-elevated maze (non-published 
observations).  
Stress-induced modification of CORT blood concentration 
Corticosterone was measured to assess possible ELS-induced changes in 
hypothalamic-pituitary-adrenal (HPA) axis activation during social stress and at 
the end of the chronic inflammatory period. Early life stress has been shown to 
lead to higher CORT levels in later life but this is not a uniform finding as factors 
like genetic background, type of stress and  later experiences can differentially 
influence the HPA axis [1,2]. In our hands, MS tended to reduce CORT levels 
as shown in the baseline measurement. It is important to note that the baseline 
measurements were done at the end of the late rodent adolescence period (P46 
to P59) [53]. At this stage of life the HPA axis is still sensitive [54,55] to 
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maturation-related phenomena such as puberty that could influence CORT 
levels in MS animals [56]. The lack of difference between the CON and SS 
groups before and throughout the social stress period is surprising but could be 
related to the timing of the social stress. Indeed, social stress performed during 
adolescence have been shown to cause lasting alterations of behavioral [57] and 
neuro-endocrine [29] features. However, in our experiments rats underwent 
social stress during the late adolescence/beginning of adulthood, thus possibly 
after the high adolescence-related vulnerability window and consequently may 
have displayed lower alterations of their HPA axis. Early experiments have 
focused on social stress in adult rats, however only a confrontation with 
unfamiliar and aggressive males in combination with the presence of females 
provoked social instability and was linked to increased adrenal weight and 
CORT levels [31]. As we did neither assess our animals for dominant behaviors 
nor introduce a competition for females, social stress could have been too mild 
to induce elevated CORT levels. After 21 days of inflammation we observed a 
significant increase of CORT in SS and MS+SS groups and a strong tendency 
in MS, when compared to CON group. This could suggest that the CFA-induced 
increase of CORT levels may be potentiated by a history of SS but not MS. 
CORT levels have been shown to increase with the onset of rheumatoid arthritis 
triggered by CFA injection [58] but results are not always congruent [59]. It 
should be kept in mind here that CFA-induced arthritis aggravating factors may 
depend upon factors like rat gender and animal supplier [60,61] that may explain 
a lack of CORT increase in some animals. Since the loss of CORT diurnal 
rhythm has also been reported following CFA injection [58] measures done prior 
to and after 21 days of inflammation may be difficult to compare. Nevertheless, 
our result seems to indicate that social stress leads to an enhanced HPA axis 
activity during a chronic inflammatory state. Indeed, despite a trend toward an 
increase observed in MS, only SS and the combination of MS+SS lead to 
significant differences. However, the high level of variability of our ELISA data 
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preclude a confirmation of a heightened HPA axis activity during chronic 
inflammation in the MS group.   
The possible sustained activation of the HPA axis observed (through elevated 
CORT levels) may inhibit or enhance immune responses as it leads to alterations 
in the release of pro- and anti-inflammatory cytokines [21]. On days 4 and 7 
after CFA-induced inflammation, we observed that MS animals presented the 
most pronounced edema. Due to the anti-inflammatory effect of CORT [62,63], 
this result could be due to the (insignificant) reduction of CORT levels observed 
in MS group after the 6 weeks of SS period. However, despite comparable levels 
of CORT in CON, SS and MS+SS groups at the end of the SS period, CFA-
induced paw edemas differed. Recently, plasma corticosteroid binding globulin 
(CBG), has proposed to play a key role in the susceptibility to inflammation as 
this protein can deliver CORT to inflammation sites [64,65]. Therefore, in spite 
of equivalent CORT levels, distinct CBG levels could have led to different 
CORT reservoirs readily available to reduce paw swelling. The development of 
inflammation depends on the clinical and preclinical state [60] of the immune 
system which can be influenced by environmental factor such as stress. As our 
study only evaluates biochemical markers during inflammation, it is premature 
to speculate on the direct link between circulating CORT and CFA-induced paw 
edema.  
Modulation of mechanical and thermal CFA-induced hyperalgesia by 
chronic stress 
The present study confirms prior results [11,57] as we do not see differences in 
thermal and mechanical sensitivity between CON groups and all three stress 
groups before inflammation. However the measurement of noxious sensitivity 
during periods of ongoing inflammation may lead to misleading results. CFA-
induced inflammation has been divided in different early and late phases [20,66] 
and animals with different stress experiences may display differential reactivity 
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at these different stages. In our study, all stress groups displayed lower 
mechanical but comparable thermal sensitivity as compared to CON during the 
early or subacute phase. While acute stress is commonly accepted as producing 
a so called “stress-induced analgesia” (SIA) [67], the situation is less clear for 
chronic stress. It has e.g. been shown that MS or SS may either induce analgesia 
or hyperalgesia [68].  
Despite possible FST-engendered stress-induced analgesia (SIA) [67,69] the 
von Frey results obtained in the present study seem to support previous reports 
from our laboratory. Indeed, previous data [11] suggest an MS-related protective 
effect against CCI-induced mechanical hyperalgesia in the developmental 
phase. Considering the common neuro-inflammatory mechanisms involved in 
neuropathy [70,71] and inflammation [20] it is conceivable that the analgesic 
effects observed in our studies share common mechanisms. Moreover, chronic 
stress as performed via MS [2] but also SS [72] has been shown to alter HPA 
axis function and CORT secretion which could lead to a “long term SIA” [73] 
during the early phase of chronic pain.  
Interestingly, the MS group displayed decreased mechanical thresholds at day 
21 after CFA injection. A similar shift, from analgesia in the early phase to 
hyperalgesia in the late phase was previously observed around day 21 [57]. In 
that particular study, SS rats displayed an enhanced cold allodynia 28 days after 
CCI while being less sensitive shortly after CCI. A similar phenomenon was 
observed in MS animals undergoing CCI as their mechanical sensitivity kept 
decreasing until post-CCI day 21 whereas CON rats started to recover [11]. 
Longer observation periods may be required to confirm that these results 
indicate a shift from analgesia to hyperalgesia, possibly due to a general 
allostatic load [68,74].  
Noxious thermal sensitivity did not present the same pattern of modulation by 
stress as seen for the mechanical sensitivity. Indeed, despite CFA eliciting the 
expected decrease of paw withdrawal latency (PWL), no significant differences 
were seen during the early phase of the inflammation between any of the groups. 
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However, MS+SS group displayed a tendency to be less sensitive to noxious 
heat that became more evident during the later phase of inflammation. In order 
to understand how and why the stress seems to impact the noxious modalities in 
a differential way, further experiments are needed. Also, it is important to 
consider other levels of regulation. For instance, Banik and colleagues [75] 
investigated paw edema latency and paw swelling following CFA injection in 
different rat strains. Interestingly, Sprague Dawley rats turned out to be the less 
sensitive to CFA. This was represented by a lesser incidence and longer latency 
to develop arthritis, accompanied by a greater paw volume variation and less 
pronounced edema. Here we did not observe a clear impact on paw swelling, 
however this could be related to the lack of precision of our paw measurement 
procedure. It is nevertheless conceivable that interindividual differences in 
susceptibility and/or the longer latency of arthritis establishment together with 
the enhanced variability inherent to the multiple manipulations could have led 
to mitigated results. Furthermore, other investigators have observed a link 
between blood and paw tissue content of pro-inflammatory cytokines [75,76] 
and susceptibility to inflammation and inflammatory pain. Indeed, interleukins 
can activate TRPVs [77] and differences in interleukin levels displayed by more 
or less susceptible animals could lead to different heat sensitivities  
Some issues that could have enhanced the variability of our data and hence 
mitigated the results should be addressed. Early life stress and social stress have 
been shown to possibly lead to vulnerability [30,78] however interindividual 
variability exists [79,80]. Much research has been done on susceptibility and 
resilience and has been mainly linked to genetic predispositions [81] and 
epigenetic mechanisms [36,82]. As we did not investigate epigenetic 
mechanisms in this study, we cannot rule out this possibility. Also the severity 
of CFA-induced arthritis has been shown to fluctuate across and among rat 
strains. Indeed, in Sprague Dawley rats and despite a high dose of CFA (1.2 mg) 
paw edema was reduced, appeared later and was less consistent (in only 38% of 
the cohort) than in Lewis or Fisher that had received lesser doses [75]. We did 
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not observe such fluctuations of paw edema in our Sprague Dawley population. 
However, slight differences in paw edema and hence sensitivity at measurement 
days could have existed, enhancing variability within groups. Furthermore the 
small number of animals does not allow us to define clear clusters of animals 
susceptible or resilient to develop a mild, moderate or severe inflammation.  
Spinal GR expression is not affected by stress under CFA-induced 
inflammation 
Spinal GR expression was previously studied in the context of neuropathic pain. 
Furthermore GR upregulation seemed to be required for CORT-mediated spinal 
sensitization [12,13,83]. In our hands GR mRNA expression did not change 
throughout 21 days of inflammation. This result is in agreement with our 
previous data, since we did not observe any change of spinal GR expression in 
animals undergoing CCI, MS nor the combination of both [11].  
Modulation of glutamatergic receptors by stress in an inflammatory 
context  
Accumulating evidence show that chronic stress and glucocorticoid levels have 
a significant effect on glutamatergic synapses [84]. NMDA receptors are a 
crucial component for the establishment and maintenance of central 
sensitization involved in chronic pain phenomenon [85]. However, alterations 
in the expression of NMDA subunits depend on brain structures and on stress 
parameters [86].  Our data indicate that the spinal cord mRNA content of the 
NR1 subunit of the NMDA receptor was equivalent after 21 days of 
inflammation in all three groups of stressed animals, suggesting comparable 
NR1-dependent glutamatergic [87]. This result might hint at an enhanced spinal 
sensitization in stressed animals as compared to controls, resulting in higher 
noxious sensitivity. However, the properties of NMDA receptors are largely 
defined by their subunit composition [88]. Indeed, NR2a containing receptors 
are characterized by a fast deactivation and hence mediate short depolarization 
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[89]. Our results showed that while MS increased and SS decreased NR2a 
mRNA expression, the combination of both stressors resulted in expression 
levels that were comparable to the ones observed in CON. Even though, the 
enhanced NR2a expression seen in MS could concord with the reduced 
mechanical sensitivity. Nevertheless, other sub-units such as NR2B, shown to 
play a crucial role in CFA-induced hyperalgesia should be included [15,90].  
Pharmacological activation of Group I metabotropic glutamate receptors such 
as mGluR 1 and 5 can elicit spontaneous nocifensive behaviors [91] and 
potentiates the responses of AMPA and NMDA receptors [92]. Furthermore, 
their activation following peripheral inflammation plays an important role for 
central sensitization as they do in turn activate phospholipase C [93] and trigger 
the intracellular ERK/MAPK cascade [94] thus directly or indirectly modulating 
spinal plasticity [95].  
On one hand, mGluR1 has been implicated in models of chronic pain due to its 
Importance in central sensitization. Indeed, mGluR1 and 5 agonists but not 
selective mGluR5 agonists have been shown to enhance spino-thalamic tract 
(STT) cell responses to innocuous mechanical stimuli in monkeys undergoing 
capsaicin-induced inflammation [17]. On the other hand, selective agonists of 
mGluR5 have been shown to produce mechanical hyperalgesia while 
antagonists elicit a dose dependent reversal of CFA-induced inflammatory 
hyperalgesia [96]. Furthermore selective mGLuR5 antagonists induce a reversal 
of mechanical hyperalgesia in CFA model of inflammation [97]. We did not 
observe any significant differences in mGluR5 gene (GRM5) expression in any 
of the stress groups during ongoing inflammation. Also, mGluR1 expression 
was only different between MS and the groups that underwent SS (SS and 
MS+SS). However, behavioral results collected after 21 days of inflammation 
indicate that MS animals only displayed significant differences to CON 
(mechanical thresholds) and MS+SS (thermal sensitivity). Hence, mGluRs 
levels are difficult to relate to the noxious behavior with the noxious behavior 
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even though we cannot completely rule out their implication in the regulation of 
mechanical and thermal sensitivity between groups.   
Astrocytes but not microglial activation are modulated by stress in the late 
phase of inflammation 
Following CFA-induced paw inflammation microglial cells display a rapid and 
intense activation at the L5 level of the spinal cord as shown by Raghavendra 
and colleagues [20] even if this result is not always consistent following 
intraplantar CFA injection [59,98]. Chronic stress has been shown to have an 
impact on microglia. Indeed, rats undergoing a similar protocol of MS (3h/days 
during the SHRP) as used in the present study displayed enhanced microglial 
activity [99]. Furthermore, neonatal rats experiencing paw incision at 3 days of 
age presented enhanced hyperalgesia following incision at adult age. This was 
accompanied by a more intense Iba1 staining in the spinal cord at 7, 14 but not 
28 days after incision, suggesting that the neonatal incision is amplifying 
microglial response to later injuries [100]. At adult age, chronic restraint stress 
led to an increased number of iIba1-positive cells in various stress-sensitive 
brain regions [101] while chronic unpredictable stress induced an initial phase 
of activation and proliferation followed by apoptosis of hippocampal microglia 
cells [102]. Here, we did not observe any differences in Iba1 mRNA expression 
between any of the groups 21 days after CFA-injection. This result could be due 
to two reasons 1) as the spinal cord is not a “stress-sensitive” CNS region, the 
various stresses might not have impacted this tissue 2) it is also conceivable that 
microglial activation could have already subsided due to the late measurement 
after the onset of inflammation. 
Contrary to microglial cells, astrocytes are not rapidly activated after CFA 
injection. However their activation was sustained from day 4 to at least day 14 
after CFA paw injection as seen by the GFAP and S100β astrocytic marker 
mRNA levels [20]. Like microglial cells, astrocytes have been shown to be 
sensitive to both early life and adult chronic stress. Indeed, early life stress seems 
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to induce a rapid (after 24h) downregulation of astrocytic markers GFAP and 
S100β in the anterior cingulate cortex (ACC), a crucial region for pain 
processing [103]. Also, chronic unpredictable stress or repeated administration 
of CORT led to GFAP downregulation in the prefrontal cortex and hippocampus 
[104,105]. Here we showed that SS and the combination of MS and SS but not 
MS per se reduced GFAP mRNA expression in the spinal cord 21 days after 
CFA-injection. GFAP expression is an indicator of astrocyte reactivity and is 
involved in the maintenance of their structure. The reduced GFAP mRNA levels 
seen in SS and MS+SS could be indicative of an enhanced astrocyte 
reorientation, a reorganization of the astrocytic cytoskeleton or astrocytic death 
following nociceptor activation [106]. In order to determine if our results 
represent a difference in astrocytic morphology or a reduction of the astrocyte 
population it would be necessary to complete our protocol with other markers 
such as S100β or other techniques such as immunostaining. Furthermore, 
astrocytes directly participate in the homeostasis of the glutamatergic synapse 
[84,107] and are able to modulate spinal nociceptive processing via the release 
of cytokines [20]. Concerning the MS and MS+SS animals this could be of 
particular interest as they respectively display different mechanical and thermal 
sensitivities 21 days after CFA injection.  
Stress does not change the expression of spinal pro-inflammatory cytokines 
after 21 days of CFA-inflammation 
Clinical and preclinical settings often associated chronic stress exposure with 
major depressive disorders and enhanced pro-inflammatory cytokine levels, 
most consistently IL-1β and L-6 [108,109]. Preclinical studies have shown that 
pro-inflammatory cytokines are mediating the long-term effects of chronic stress 
exposure [102,110–112]. We did not observe any significant differences 
between the 4 groups in any of the three cytokines measured after 21 days of 
inflammation. These results are surprising since TNF-α, IL-β and IL-6 
expression has been shown to be changed by social [113–116] and by post-natal 
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stress [9,117]. One possibility is that inflammation may have raised to the same 
level possible pre-existing differences in cytokine mRNA. These previous were 
investigating cytokine expression in the spleen or plasma [9,113–117].  Despite 
evidence supporting the ability of peripheral cytokines to signal through the 
blood brain barrier [118] it seems that spinal TNF-α, IL-β and IL-6 levels do not 
directly correlate with enhanced circulating cytokines [21], a priming of CNS 
glia could nevertheless exist. As microglia-induced immune activation and 
cytokine production are believed to be critical for the onset of arthritis [119,120]. 
Hence, differences to be expected during the initial phase of inflammation could 
have waned 21 days after CFA-injection.  
NGF but not GDNF is influenced by stress under CFA-induced chronic 
inflammation  
Neurotrophic factors have been shown to be crucial for C-fiber nociceptor 
development and survival upon insults [121,122]. In this context, two C-fiber 
sub-classes have been classified according to the neurotrophic factor affecting 
them. The tyrosine kinase A receptor (Trk A) expressing neurons depend on 
NGF while the Trk rearranged during transfection (Ret) neurons depend on 
GDNF [123]. Stress has been found to affect NGF levels however results are not 
always congruent. Adult animals undergoing chronic stress have been shown to 
display decreased protein levels in the prefrontal cortex, the hypothalamus and 
the hippocampus [124–127]. On the contrary, early maternal separation in rats 
induced NGF increases in those same structures a few days after the stress 
protocol  [128,129] or following a stressful event at adult age [130] suggesting 
that individuals undergoing MS might have a better coping ability. However, 
spinal NGF has been shown to mediate neuronal plasticity involved in visceral 
hypersensitivity [35]. Also, socially stressed rats undergoing chronic 
constriction injury (CCI) displayed higher NGF levels and enhanced pain 
sensitivity than rats only undergoing CCI [57]. In our hands, MS and had a 
tendency to increase NGF mRNA levels after 21 days of inflammation. This 
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effect was not found in animals that experienced both stressors. However, 21 
days after CFA-injection, MS+SS rats displayed longer nocifensive behavior 
latencies on the hot plate than MS and CON group. Hence, it is difficult to draw 
any explicit conclusions about a possible cause-effect relationship between NGF 
gene expression and stress-related behaviors.  
GDNF delivered intrathecally has been shown to be a potent analgesic agent 
[131,132]. However, endogenous GDNF is believed to play a role in 
sensitization and the decrease of mechanical thresholds [133,134]. Nevertheless, 
we did not observe any significant differences between any of the groups which 
could suggest that GDNF was not involved in the CFA-induced central 
sensitization.  
7.6. Conclusion 
This study aimed to test the commonly expressed assumption that the 
combination of early life adversity and adult exposure to social stress 
predisposes rats to affective disorders and comorbid pain states. While we did 
indeed observe more pronounced maintenance of inflammatory reactions in rats 
exposed to the two stressors, this group of animals did not display any alterations 
in mood and pain related behavior. In addition, the measurement of biochemical 
markers of stress- and/or pain processing did not reveal any congruent 
differences between the experimental groups. In spite of potential limitations 
related to sample size and measurement time points we believe that these 
negative results may allude to a more complicated interdependence of stress, 
affect and pain processing than initially assumed. Future studies should be 
aimed at a systematic evaluation of potentially relevant parameters. 
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Clinical and experimental studies have demonstrated a strong relationship and 
comorbidity between stress-related disorders and pain conditions. Stress and 
pain are both relying on common brain structures such as the limbic system and 
the hypothalamus. In addition to the brain sustained stress can affect endocrine 
and immune systems. Early life stress is believed to be associated with long 
lasting alterations of neuro-endocrine and neuro-immune systems and a higher 
risk to develop anxio-depressive disorders. In this context, only few studies 
focused on the effect of early life stress on adult vulnerability to pain and on 
underlying spinal cord mechanisms. Hence, during my Ph.D. I investigated the 
long term effect of early life stress on pain sensitivity later in life and on 
potentially involved spinal mediators.  
In the first study, I submitted rats to a maternal separation procedure and 
evaluated, once they reached adult age, their mechanical and cold noxious 
sensitivity during baseline and neuropathic conditions. Rats undergoing 
maternal separation had a comparable noxious sensitivity during normal 
conditions. However, following the induction of neuropathic pain, rats 
experiencing early life stress were less sensitive than controls and the 
appearance of mechanical allodynia/hyperalgesia seemed to be delayed. 
Behavioral results were accompanied by various alterations of spinal 
biomarkers, notably of immunocompetent cells and pro-inflammatory 
cytokines.  
These results led me to determine if the protective effect of maternal separation 
was specific to the neuropathic pain condition or if it could be reproduced under 
conditions of inflammatory pain. Furthermore, I wanted to characterize MS-
related alterations of the HPA axis through measurement of blood corticosterone 
and of stress-related behaviors.  In order to induce inflammatory pain, we chose 
the complete Freund’s adjuvant model due to its temporal characteristics 
allowing us to compare this study with the previous one. Our results did not 
reveal any differences in corticosterone levels nor in anxiety-related behaviors 
as observed in the open field test. Similarly to the first study, maternal separation 
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did not impact mechanical thresholds under normal conditions. Since cold 
allodynia is a typical and quite specific symptom of neuropathic pain, I changed 
the tested thermal modality from cold to heat. In this case, baseline sensitivity 
was changed. Indeed, MS animals presented shorter latencies to exhibit 
nocifensive behaviors in reaction to noxious heat. Furthermore, this test revealed 
the incapacity of MS animas to habituate to the test which could possibly be 
ascribed to alterations of higher brain centers normally inducing stress-induced 
analgesia.  
Finally, considering theories relating to early life stress, we aimed to investigate 
the cumulative and match/mismatch hypothesis of vulnerability and resilience 
to stress. The goal of the third project was thus to determine if a stress 
experienced at adult age in addition to early life stress would lead to enhanced 
or reduced pain sensitivity. For this purpose rats were submitted to maternal 
separation and later on, at adult age to social instability stress. In order assess 
relevant stress-related psychological disorders, rats also underwent the zero 
elevated plus maze (data not published), the sucrose preference test and the 
forced-swim test. Then, nociceptive mechanical and thermal sensitivities were 
evaluated as previously done. The results of these experiments were mitigated 
and I was not able to reproduce previously obtained findings regarding pain 
sensitivity during physiological (no differences in noxious heat sensitivity) and 
inflammatory conditions. The multiple animal groups and repeated testing, 
sometimes generating intense stress (e.g. isolation during sucrose preference, 
forced swimming) may have led to high levels of variability and to erratic 
effects.  
The results obtained during my Ph.D. thesis still require to be deepened in order 
to be able to have an insight of the mechanisms involved in the effects of MS on 
pain sensitivity. First, an analysis of spinal protein content in complement to the 
mRNA evaluation seems necessary. It could also be interesting to determine the 
immediate alterations caused by early life stress. Indeed, to my knowledge no 
study ever determined the effect of repeated MS on the still immature spinal 
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microglia, astrocytes, nociceptive neurons and the crosstalk between 
immunocompetent and neural cells. Another point could be the better 
characterization of MS-related HPA axis alteration. Even though we did not 
obtain any significant differences regarding the CORT levels, MS can lead to 
various alterations of HPA axis reactivity during times of stress. A short restraint 
stress associated with blood sampling could be helpful in this respect.  
Nevertheless our overall results seem to point out two major leads: 1) MS seems 
to alter immunocompetent cells which could have repercussions for the 
establishment of sustained and/or enhanced noxious sensitivity later on, 2) 
differences in heat sensitivity and lack of habituation in the hot plate test suggest 
that descending pain control pathways might be altered.  
8.1. Does early life stress-related resilience of neuropathic 
pain critically depend on altered microglial reactivity? 
8.1.1. Scientific background 
The goal of this project is to characterize the long-term consequences of 
maternal separation for pain-related behavior and to investigate to what extent 
neuro-immune system alterations can relate to these behaviors. It was shown 
recently that early life stress has to the capacity to impact immune system 
responsiveness (Roque et al. 2014, Roque et al. 2015) and is associated with 
many disorders ranging from depression to irritable bowel syndrome 
(O’Mahony et al 2009) in later life. Mechanisms by which immunocompetent 
cells such as microglia are capable of enhancing nociceptive processing remain 
incompletely understood. However it seems that microglial activation is 
accompanied by a loss of inhibitory tone in the spinal cord, therefore enhancing 
spinal nociception (Coull et al. 2005, Sorge et al. 2015). Hence, microglial cells 
are an essential component of the onset of several chronic pain conditions 
(Raghavendra et al. 2003, Ledeboer et al. 2005). The first study of my thesis 
suggested a pain hyposensitivity of MS animals (compared to CON animals) 
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during neuropathy. Beside the change in growth factor expression other 
molecular markers of nociceptive processing were affected. Indeed, the 
behavioral results were associated with reduced spinal Iba-1 (marker of 
microglial cells) and IL-1β mRNA levels. This could be particularly interesting 
since pro-inflammatory cytokines released by activated microglia are capable of 
enhancing spinal nociceptive processing (Ren and Torres 2009, Yan et al. 2014). 
We hypothesize that the reduced noxious sensitivity we observed could be 
related to a dampened immune system reactivity. In this framework, upon injury 
or inflammation, MS-induced inhibition of microglial cells would prevent or 
delay the full extent of injury-induced hyperalgesia. The first objective was to 
determine if the behavioral differences observed previously may originate from 
an altered microglia reactivity. In order to evaluate the potential impairment of 
microglial cell in the neuropathy-induced phenotype observed in MS animals 
we undertook to activate microglia pharmacologically using Amphotericin b 
(AmpB) (Motoyoshi et al., 2008; Döring et al., 2015). Secondly, we aimed to 
investigate the molecular basis of MS-induced modulation of neuropathic 
painful behaviors using immunohistochemistry and RT-qPCR. 
8.1.2. Methods 
As described in previous studies, baseline mechanical and thermal noxious 
sensitivity were evaluated using the von Frey hair and cold plate tests in MS and 
CON animals. Then, both MS and CON rats received intraperitoneal injections 
of amphotericin B (activator of microglial cells) or sodium deoxycholate 
(vehicle) prior and during the neuropathic pain period. The neuropathy was 
induced using the chronic constriction injury model described in chapter 3. 
Animals were then retested 4 and 7 days after CCI-surgery in order to see if the 
pharmacological activation of microglial cell can reinstall a “normal” 
neuropathy-induced hypersensitivity in MS animals. Finally, part of the animals 
were sacrificed by overdose of pentobarbital (60mg/ml) and perfused 
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transcardially. The spinal cord was then be dissected and immunochemistry 
using anti Iba-1 and anti F4-80 was performed in order to put in evidence the 
total number of cells and the number of cells activated by the neuropathy. The 
second part of MS and CON animals were used to examine spinal mRNA and 
protein expression that was associated with microglial cells and the onset of 
neuropathic hypersensitivity. This could lead to the identification of key 
molecular targets for future therapies alleviating the neuronal long-term 
consequences of maternal separation. 
Figure 33: Experimental timeline 
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8.1.3. Preliminary results: 
Figure 34: Mechanical thresolds of MS and CON rats undergoing (or not) AmpB injections and/or CCI surgery. 
Black circle: CON-sham-deox, white circle: CON-sham-AmpB, black square: MS-sham-dox, white square: MS-
sham-ampB, Black triangle: CON-CCI-deox, white triangle: CON-CCI-ampB, Black diamond: MS-CCI-deox, white 
diamond: MS-CCI-ampB. Data are shown as mean ± SEM.  
Mechanical pain thresholds were measured by the Von Frey test before and 
during the injection of amphotericin b or its vehicle (sodium deoxycholate) as 
well as during the 7 days of neuropathy. Regardless of the stress condition or 
the injection regime, sham operated animals did not see their mechanical 
threshold change throughout the testing period. Animals undergoing CCI 
surgery displayed reduced mechanical thresholds as a consequence of the CCI, 
however the amphotericin treatment seemed not to have a great impact.  
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Figure 35: Thermal (cold) sensitivity of MS and CON rats undergoing (or not) AmpB injections and/or CCI 
surgery. Black circle: CON-sham-deox, white circle: CON-sham-AmpB, black square: MS-sham-dox, white 
square: MS-sham-ampB, Black triangle: CON-CCI-deox, white triangle: CON-CCI-ampB, Black diamond: MS-
CCI-deox, white diamond: MS-CCI-ampB. Data are shown as mean ± SEM.  
Sensitivity to an above threshold cold stimuli was not affected by solely stress 
and/or drug treatment throughout the experiments. At days 4 and 7 following 
CCI surgery, CON animals injected with the vehicle (sodium deoxycholate) 
displayed an increase of the number of paw lifts reflecting a higher sensitivity 
to 5°C stimulus. MS-CCI-deox animals displayed a lesser increase of paw lifts 
following the CCI surgery suggesting a reduced CCI-induced cold 
hypersensitivity. Finally the amphoterin B treatment significantly increased the 
sensitivity to cold of MS-CCI-ampB but not CON-CCI-ampB animals.   
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Figure 36: Regulation of microglial cell activation and BDNF expression. Gene expression in the spinal cord was 
examined for the microglial marker Iba1 (A) and the growth factor BDNF (B). mRNA levels where assessed in 
CON and MS animals under 4 conditions (sham-deox, sham-ampB, CCI-deox, CCI-ampB). Data are shown as 
mean ± SEM.  
Analysis of Iba-1 and BDNF expression revealed that MS and or ampB have no impact on 
their own or combined. Only the induction of neuropathy was able to increase 
significantly Iba-1 and BDNF mRNA levels.  
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Figure 37: Regulation of microglial cell activation and BDNF expression. Gene expression in the spinal cord 
was examined for the TNF-α (A), the interleukin 1β (B) and the interleukin 6 (C). 
8.2. Impact of early life stress on electrophysiological response 
behavior of spinal nociceptive neurons and on descending pain 
control pathways in young adult rats.  
8.2.1. Scientific background 
In rodents, the maturation of nociceptive system components such as spinal 
glutamatergic transmission occurs during the first weeks of life (Bardoni et al 
1998; Li et al 1998). Also the descending modulatory pain pathways that will 
comprise inhibitory as well as facilitatory components maturate functionally 
during the first three weeks (Fitzgerald and Koltzenburg, 1986; Kwok et al., 
2014). They are inefficient at birth, then excitatory before they gain their 
“normal” modulatory activity in the course of the early postnatal development. 
Cortical and subcortical structures such as the anterior cingulate cortex (ACC), 
the prefrontal cortex (PFC), the ventral tegmental area (VTA) and the nucleus 
accumbens (NaC), controlling emotional and cognitive processes, are tightly 
connected to descending modulatory pathways (Ossipov et al 2014). In this 
framework it may be expected that neonatal maternal separation, an emotional 
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and physical stressor, permanently affects descending modulation, possibly 
leading to alterations of normal/nociceptive (Schwaller and Fitzgerald, 2014) 
and neuropathic pain sensitivity (De Felice et al. 2011). Some of our 
experimental results (e.g. hot plate test) may suggest that higher brain center 
processing could be involved in the differences observed between CON and MS. 
Furthermore, the transition from acute to chronic pain, as seen e.g. in 
neuropathic pain states or chronic inflammation, involves plastic remodeling of 
nociceptive processing at the level of the spinal dorsal horn and at supra-spinal 
levels, a phenomenon called central sensitization (Kuner and Flor, 2017). 
Furthermore, it is now clear the balance between inhibition and facilitation 
existing during healthy conditions is disturbed in chronic pain and can mediate 
spinal central sensitization with descending facilitatory effects dominating 
under pathological conditions (Kim et al, 2015). However the exact process by 
which nerve injury or chronic inflammation lead to the enhancement of 
nociceptive information transmission is not yet fully understood, especially 
when pathologies linked to stress and pain are co-occurring. Our objective thus 
is to establish whether maternal separation has an impact on spinal nociceptive 
transmission using in vivo electrophysiology under normal and chronic pain 
conditions and to determine if alterations in descending modulation are 
involved. Then, we plan to use repetitive electrical stimulation of peripheral 
nociceptors to induce the wind-up phenomenon which is considered to 
constitute a simple form of sensitization of dorsal horn neurons. This approach 
will allow us to elucidate differences in spinal plasticity between rats undergoing 
early life stress and controls. Finally, a reversible cold block of descending 
pathways will cancel the potential differences in descending pain control 
between these two groups of animals.  
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8.2.2. Method: 
This study uses the in vivo extracellular recording technique allowing us to 
characterize the electrophysiological response behavior of dorsal horn neurons 
in a dynamic manner during physiological and pathological pain conditions. In 
order to perform these experiments, deeply anesthetized animals undergo a 
surgical procedure aiming to expose their spinal cord. In order to isolate a single 
neuron, a stainless steel electrode is inserted and penetrates into the dorsal horn 
in steps ranging from 10 to 50 μm. In the same time, the ipsilateral hind paw is 
stimulated by light taps to find responding neurons and to assess their receptive 
fields. Once a neuron is detected, it can be characterized according to its 
response to natural stimulations (brush, pressure, and heat), its depth 
(determined from the surface of the dorsal horn, nociceptive specific neurons in 
the superficial laminae and WDR in the deeper ones), latency of firing (Aβ, Aδ 
and C fibers responses) and action potential wave form.  
Altogether, this setup allows us to investigate spinal conduction but also dorsal 
horn plasticity (via the described induction of wind up-by repeated electrical 
stimulations) and the respective functional state of descending pathways.  
8.2.3. Objectives 
The experimental protocol we use will allow us to investigate several hypotheses 
in the same animal. First, we will record from dorsal horn neurons in CON and 
MS rats while stimulating the rat hind paw mechanically. Using a standardized 
forceps developed for that particular purpose, 5 different pressures will be 
applied (stimulus response function). This will give us first indications 
concerning the underlying neuronal excitability possibly accounting for prior 
behavioral results obtained.  
Secondly, wind-up (temporal summation of discharge behavior of dorsal horn 
neurons, an experimental model of central sensitization), will be induced 
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through a train of electrical impulses (1Hz) applied to hind paw primary 
afferents. 
Subsequently, the responses to mechanical stimuli (mechanical stimulus-
response functions) are reassessed, allowing us to evaluate to what extent MS 
modifies spinal cord processing and plasticity during pathological conditions.  
Wind-up is a short lasting state (Eide, 2000) allowing us to perform additional 
recordings after a “recovery period” of about 15-20 min without contamination 
by eventual wind-up related functional plasticity. Hence, following an 
appropriate resting time, we will proceed to a reversible block of nerve fiber 
conduction (application of cold Tyrode) at the lower cervical/upper thoracic 
levels of the dorsal and dorsolateral spinal cord. This will allow us to transiently 
eliminate descending modulatory inputs without altering nociceptive 
transmission at the recording site. A third mechanical stimulus-response 
function will be performed informing us about purely spinal nociceptive 
processing.  
Finally, animals will again receive electrical stimulation trains in order to re-
induce the wind-up phenomenon under conditions of cold block. A mechanical 
stimulus-response function will be performed as explained previously. The 
blockade of descending modulatory influences will allow us to determine their 
involvement in the establishment of spinal sensitization in control animals and 
furthermore, it will give us a clue to what extent they are modified or are 
modifying the spinal sensitization in MS animals.   
This first set of experiment will give us a great deal of information regarding the 
possible alterations of spinal nociceptive transmission in MS animals. However, 
most of the behavioral differences regarding pain sensitivity obtained in the first 
studies of my Ph.D. thesis were during chronic pain conditions. Hence, after 
assessing the impact of MS on spinal nociceptive transmission, plasticity and 
descending modulatory pathways (questions 1 to 4) in normal conditions, we 
will use the same setting and protocols to investigate pathophysiological 
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(neuropathic) pain processing in animals that underwent a chronic constriction 
injury (CCI, a rodent model of neuropathic pain). 
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“As for me, all I know is that I know nothing” 
Socrates 
470-399 BC
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Clinical data have shown that chronic exposure to stress may be accompanied by an
enhancement of inflammation-related pain sensitivity. In this context, little is however
known on the impact of stress on neuropathic pain. In the present study we addressed
this issue by combining the chronic constriction injury (CCI) model with an ongoing social
stress (OSS) paradigm. Cold plate and von Frey tests were performed in 48 rats divided
into four groups: OSS exposed to OSS, CCI subjected to chronic nerve constriction,
OSS+CCI with a combination of neuropathy and stress and CON, a control group
lacking any manipulation. While we did not observe any stress-related differences in
mechanical sensitivity throughout the observation period, CCI rats were more sensitive
to cold stimulation than OSS+CCI in the initial phase of neuropathy. A switch was
observed at a later stage, leading to a hypersensitivity of the OSS+CCI compared
to the CCI rats. At this time point we investigated the spinal mRNA expression of
neuron and glia related molecules potentially involved in neuropathic pain and stress. The
combination of psychosocial stress and neuropathic pain seemed to enhance glial cell
activation, pro-inflammatory cytokine and neurotrophic factor mRNA levels, rather than
glutamatergic transmission. Our data show that long lasting social stress may lead to
time-dependent alteration of neuropathy-related cold pain sensitivity while mechanically-
induced pain remains unchanged.
Keywords: neuropathy, social stress, cold sensitivity, mechanical sensitivity, biochemical pathways
INTRODUCTION
While exposure to stress may lead to the classically described phenomenon of stress-induced
analgesia (SIA, for review see Butler and Finn, 2009), increasing amounts of data suggest
that it may under certain conditions also lead to an enhancement of pain, denominated as
stress-induced hyperalgesia (SIH, see Jennings et al., 2014). In this context, research has laid
a more pronounced emphasis on inflammatory as compared to neuropathic pain, a clinical
entity that remains difficult to treat (Finnerup et al., 2010). In this context comorbidities
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between chronic stress and pain may also have to be considered
(Sharp and Harvey, 2001; Shipherd et al., 2007). Recent
preclinical studies have also shown that exposure to chronic
stress may lead to an exacerbation of pain sensitivity (Shi et al.,
2010; Bravo et al., 2013; Burke et al., 2013).
Several biochemical pathways and mediators known to be
involved in the processing of stress may also play a major role
in regulating neuropathic pain. Stressors such as early life stress
(Burke et al., 2013) and stress-related catecholamine release
(O’Connor et al., 2003; Johnson et al., 2005) have e.g., been
described to lead to neuroinflammatory reactions encompassing
the peripheral and central release of pro-inflammatory cytokines
like IL-1β and IL-6. These substances have been shown to play
a crucial role in the enhancement of nociceptive processing
(for review, see Watkins et al., 2001). Another major player
in the context of the present article is glutamate, the principal
excitatory neurotransmitter in the central nervous system
(CNS). Glutamatergic transmission is significantly modulated
by stress-related release of corticosteroids. On one hand stress
may exacerbate neuropathic pain via glucocorticoid-dependent
enhancement of NMDA receptor activation and glutamate
release (Imbe et al., 2006; Alexander et al., 2009; Popoli
et al., 2012). On the other hand it has recently been shown
that corticosterone may also mediate analgesia via the spinal
production of neuroactive metabolites that enhance GABAergic
inhibitory transmission (Zell et al., 2015). With regard to
neurotrophic factors, stress-induced release of nerve growth
factor (NGF) and brain-derived neurotrophic factor (BDNF) is
involved in the neurobiological alterations underlying increased
vulnerability to disease in humans (Cirulli and Alleva, 2009);
but NGF is also a critical mediator for the enhancement and
maintenance of inflammatory (Woolf et al., 1994; Watson et al.,
2008) and neuropathic pain (Santos et al., 2012). Recently,
dynamic epigenetic regulations of the glial cell line-derived
neurotrophic factor (GDNF) promoter in the nucleus accumbens
(NAc) also have been shown to play important roles in
determining both the susceptibility and the adaptation responses
to chronic stressful events (Uchida et al., 2011). In the context
of the present article, GDNF has been demonstrated to have
a beneficial effect in neuropathic pain states (Boucher et al.,
2000).
Stress-related activation of the HPA axis leads to the release
of glucocorticoids (GC). Alterations of adrenocortical reactivity
have been shown to impinge on the further coping with stress
(Heim et al., 2000) as well as on nociceptive processing (Straub
et al., 2002; Geiss et al., 2005; Le Coz et al., 2014a,b). In a model
of persistent stress in rodents, Schmidt et al. (2007) highlighted
lasting adaptations of the HPA axis that could modify the
biochemical cascades described above (i.e., glial cell activation,
pro-inflammatory cytokines release, neurotrophic factors and
glutamatergic transmission).
The effects of stress on the processing of nociception and
pain may depend on a host of factors including the kind of
stress (physical or psychological), the intensity as well as the
temporal characteristics (Jennings et al., 2014). In order to take
into account that humans are mainly exposed to persistent or
intermittent psychosocial stress in modern societies we used
a psychosocial stress paradigm initially introduced in mice by
Schmidt et al. (2007) but inspired by previous models in rats
(Mormède et al., 1990).
Taking into account the findings and considerations
described above, we hypothesized that long lasting social stress
may enhance pain sensitivity related to chronic constriction
injury (CCI), a well-established model of neuropathic pain
(Bennett and Xie, 1988). Matching alterations of biochemical
pathways concomitantly involved in the processing of stress and
pain should provide clues to potentially involved mechanisms.
For the biochemical analyzes we focused on the spinal cord,
which constitutes the first relay station and site of complex
processing and gating of nociceptive information and contains all
the mentioned stress- and pain-related mediators (Golovatscka
et al., 2012).
MATERIALS AND METHODS
Animals
Experiments were performed in 48 male Sprague Dawley rats
being 3 weeks old and weighing 48–86 g at arrival. We only
used male rats to avoid estrogen-related effects on glucocorticoid
release. The animals (Harlan Laboratories, Netherlands) were
housed three per cage in a temperature-controlled room
(20–22◦C) under a 12 h day-night cycle. Food and water were
provided ad libitum. Starting 1 week before initiation of the
behavioral experiments, the animals were handled daily and
habituated to the testing room and devices.
All animal experiments were carried out in accordance with
the European Communities Council Directive of September
22, 2010 on the protection of animals used for scientific
purposes (2010/63/EU). The animal procedures were approved
by the Animal Care and Use Committee of the University of
Luxembourg.
CCI Surgery
For CCI surgery at an age of 8 weeks, the animals were
anesthetized with isoflurane (4.3% for induction and 2.5% for
maintenance) using an anesthesia unit (Univentor 400, Zejtun,
Malta). The right sciatic nerve was exposed at the level of the
thigh, as described in the classical model by Bennett and Xie
(1988) and three loose ligatures using natural chromic gut 4–0
(Stoelting Europe, Dublin, Ireland) were placed around the nerve
with an interspace of 1 mm. The muscle layers were stitched
together with 4–0 silk sutures and the skin layer was closed with
surgical skin staples.
Experimental Protocol
The rats were divided into four groups: the control group CON
undergoing no manipulation (n = 12), the ongoing social stress
group (OSS) being exposed to the stress procedure (n = 12), CCI
subjected to chronic constriction injury (n = 12), and OSS+CCI
combining the CCI surgery with chronic social stress (n = 12).
The course of the experiment was as follows (see Figure 1):
4 weeks before the CCI surgery in the respective groups (day 0),
the chronic stress protocol was started in the OSS and OSS+CCI
rats and continued until the end of the experiment at day 49.
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FIGURE 1 | Timeline of the experimental protocol. Testing paradigms and stress induction were initiated at the age of 4 weeks.
The social stress therefore was performed during adolescence and
early adulthood in the age ranging from 4 to 11 weeks and had
a total duration of 7 weeks. The cold plate and Von Frey tests
were performed once a week (days 0, 7, 14, 21 and 27) in all
groups in the morning hours. At day 28, the CCI and OSS+CCI
rats underwent the CCI surgery. Testing for cold and mechanical
sensitivity went on at days 32, 35, 38, 42 and 49 in all groups.
Animals were sacrificed after the experiments at day 49 in the
early afternoon and the spinal cord was removed and processed
for qPCR.
Chronic Social Stress Protocol
Rats were placed three per cage at their arrival and were enabled
to habituate to this situation for 1 week before starting the
stress protocol. The chronic social stress paradigm consisted
in changing the composition of the adolescent cage-mates
twice a week starting 4 weeks before the eventual CCI
surgery until 21 days post CCI. A group size of 12 rats was
chosen to avoid a recurrent composition of the cage-mates
(Schmidt et al., 2007).
Cold Plate Test
The cold plate (Hot/cold plate, Ugo Basile, Varese, Italia) was
used to assess the sensitivity to thermal stimuli. A temperature
of 5◦C has been shown by Jasmin et al. (1998) to be optimal for
testing cold hyperalgesia. Rats were placed three times on the cold
plate for 3 min. The three repetitions were separated by a time
out of 10 min in their respective home cages. The paw lifts were
counted during the 3 min and the mean of the three sessions was
calculated for each rat. Finally the mean for each group and day
was calculated.
Von Frey Monofilament Test
We used the Von Frey test to measure mechanical
allodynia/hyperalgesia. Rats acclimated 10 min in Plexiglasr
cages with wire mesh bottoms before the tests. Each
monofilament (OptiHair, MarstockNervTest, Germany) was
placed perpendicularly onto the midplantar region of the hind
paw and pressure was increased until the point of deflection of
the filament was reached. The ascending and descending method
of limits was applied with forces ranging from 8 mN to 256 mN
in 11 logarithmic steps to determine pain thresholds (Chaplan
et al., 1994). Ascending and descending series were repeated
three times and the thresholds obtained in the respective series
were averaged for each paw. We then referred the ipsilateral
paw values to the results of the contralateral side (control)
set at 100%.
Tissue Sample and RNA Collection
At day 49 (= 21 days post surgery), rats were deeply
anesthetized with isoflurane and decapitated. Levels L4/L5 of
the spinal cord were removed, the right (ipsilateral) side
separated from the left (contralateral) side and the total
RNA was extracted with the Invitrap Spin Tissue RNA
Microkit (Invitek, Germany). The RNA concentration was
determined by measuring the absorbance at 260 nm, using
a Nanodrop ND-2000 spectrophotometer (Thermo Fisher
Scientific, Wilmington, DE, USA).
Reverse Transcription and Real-Time
qPCR
Total RNA (500 ng) was reverse transcribed into cDNA
using the ImProm-II Reverse Transcription System (Promega
Corporation, Madison, WI, USA). Real-time PCR reactions were
performed from 10 ng of cDNA with a CFX-96 thermocycler
(Bio-Rad Laboratories, Nazareth, Belgium) using SYBR
green Supermix PerfeCTa (95053-02K, Quanta Biosciences,
Gaithersburg, MD, USA). The primers used for the reference
gene, β-actin, and the genes of interest are presented in Table 1.
The steps consisted of one cycle of 3 min at 95◦C and 40 cycles
of amplification (10 s at 95◦C, 30 s at 61◦C). All samples were
run in triplicate. Relative expression was estimated using the
∆∆Ct-method with β-actin as the reference. Threshold cycle
values (Ct) were used to compute the amount of target gene
mRNA in relation to the reference gene mRNA (β-actin). ∆Ct
represents the difference between the number of cycles that
were necessary to detect the PCR products of the target and the
reference genes. The ∆∆Ct indicates the difference between the
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TABLE 1 | Sequences of primers used in this study.
Name Accession Sequence
b-actin NM_031144 5′ GCT GAG AGG GAA ATC GTG CGT GAC 3′
5′ GGA GGA AGA GGA TGC GGC AGT GG 3′
Iba1 NM_017196 5′ TCC CAT CCA ACC TCT CTT CC 3′
5′ GCA GCC TCA TCG TCA TCT C 3′
GFAP NM_017009 5′ TGA GTC GCT GGA GGA GGA G 3′
5′ GCT GTG AGG TCT GGC TTG G 3′
IL-1β NM_031512 5′ GTT GAA TCT ATA CCT GTC CTG TG 3′
5′ TGG TCT TGA CTT CTA TCT TGT TG 3′
IL-6 NM_012589.1 5′ CCA GAG TCA TTC AGA GCA ATA C 3′
5′ CTT CTC CAT TAG GAG AGC AT 3′
GDNF NM_019139.1 5′ GTG TTG CTC CAC ACC GCG TCT 3′
5′ GGT CTT CGG CGG GCG CTT C 3′
NGF NM_001277055.1 5′ CAC GGA CAT CAA GGG CAA GGA 3′
5′ GCT CGG CAC TTG GTC TCA AA 3′
EAAT3 NM_013032.3 5′ TCA TAG TCG GGA AGA AC 3′
5′ AGC GGA ATG TAA CTG GAA GG 3′
NR1 NM_001270607 5′ GGT TGC GTG GGC AAC ACC AA 3′
5′ CCG TCC GCA TAC TTA GAA GA 3′
NR2a NM_012573.3 5′ CAG ATA ACA ATA AGA ACC ACA AG 3′
5′ AAC ATC GCT ACA GTC CTT 3′
∆Ct of the individual groups (CCI, OSS, OSS+CCI) and the∆Ct
of the control (CON) animals. The data were then expressed as
2−∆∆CT. The presented data are the mean values of the ipsilateral
side for each group.
Data Analysis
Statistical analyzes for the behavioral tests (cold plate and Von
Frey) were carried out using a two-way (time × condition)
analysis of variance (ANOVA) followed by a Tukey’s multiple
comparison post hoc test to check for differences between
groups. Data are presented as mean ± SEM. The qPCR data
were analyzed by using one-way ANOVA followed by Scheffé’s
multiple comparison post hoc test. They are presented as
mean ± SD. A summary of the statistical analysis is given in
Table 2.
The level of significance was defined as p < 0.05. Statistical
tests were performed with IBM SPSS Statistics version 21 (IBM
corporation, Somers, NY, USA).
TABLE 2 | Analysis of variance (ANOVA)—summary of F-values of the
behavioral (two-way) and biochemical (one-way) studies.
Two-way ANOVA
Interaction Time Condition
Cold plate test F(27,425) = 38.79 F(9,425) = 113.80 F(3,425) = 278.20
Von Frey test F(27,437) = 40.63 F(9,437) = 118.06 F(3,437) = 360.46
p < 0.0001 for all values
One-way ANOVA
GFAP F(3,20) = 6.00 p = 0.004
Iba1 F(3,20) = 19.65 p < 0.0001
IL-1β F(3,20) = 32.27 p < 0.0001
IL-6 F(3,19) = 16.38 p < 0.0001
GDNF F(3,18) = 35.11 p < 0.0001
NGF F(3,18) = 11.39 p < 0.0001
NR1 F(3,18) = 9.27 p = 0.001
NR2a F(3,18) = 3.25 p = 0.046
EAAT3 F(3,18) = 6.36 p = 0.004
RESULTS
Development of Cold Hypersensitivity
Following CCI Surgery and Chronic Social
Stress
Four weeks (day 0) before the CCI surgery in the CCI and
OSS+CCI animals (performed at day 28), at the beginning of the
stress paradigm, we started to assess the cold sensitivity in all
groups (Figure 2A). The measurements were carried out once
a week (days 0, 7, 14, 21, 27). Paw lifts could be observed in none
of the four groups indicating that there was no effect of the social
stress itself on thermal pain sensitivity in the OSS and OSS+CCI
groups.
The CON and the OSS groups did not display any cold
hyperalgesia throughout the observation period. The groups
undergoing CCI at day 28 (CCI and OSS+CCI) developed
increasing cold sensitivity throughout the next 21 days of
observation. However, the extent of paw lifts differed between
the two groups at the different time points. Whereas shortly
after surgery (day 32) the CCI animals exhibited a statistically
significant higher cold sensitivity compared to the OSS+CCI
group (5.5± 0.6 vs. 3.5± 0.6; p = 0.0052) they were significantly
less sensitive at the end of the experiment at day 49 compared
to OSS+CCI (11.2 ± 0.8 vs. 14.3 ± 1.3; p < 0.0001). However,
as can be seen in Figure 2A, a ‘‘switch’’ in sensitivity seemed to
take place 7–14 days after the surgery (day 35: CCI 7.6 ± 0.7,
OSS+CCI 6.1 ± 0.7; day 38: CCI 8.4 ± 1.1, OSS+CCI 8.2 ± 0.8;
day 42: CCI: 8.9± 1.5; OSS+CCI: 9.8± 0.9).
Obviously, the cold sensitivity of the CCI and OSS+CCI rats
was significantly higher compared to CON and also to OSS
animals after the CCI surgery (p< 0.0001 for all time points).
Onset and Maintenance of Mechanical
Hypersensitivity Following the CCI Surgery
and Stress Protocol
Throughout the observation period and as displayed in
Figure 2B, the CON and OSS groups did not display any
differences in mechanical sensitivity as compared to basal levels
(values are given in Table 3).
The CCI and OSS+CCI groups showed a strong increase in
pain sensitivity from 4 days post-surgery (day 32) until the end
of the experiment on day 49. We did however not find any
significant differences between these two groups.
Statistical differences were only observed from day 32 to day
49 (p < 0.001) between the CON and OSS groups on one hand
compared to the CCI and OSS+CCI rats on the other hand.
Impact of Ongoing Social Stress and CCI
Surgery on Spinal Glial Cell Activation
We examined the spinal mRNA expression of two glial cell
markers, GFAP for astrocytes and Iba1 for microglia at the
end of the experiment at day 49, when the cold sensitivity was
highest in CCI and OSS+CCI (Figure 3). We aimed to see if
chronic social stress was modifying the neuropathy-mediated
activation. In this respect, we focused on changes in the mRNA
expression in the right spinal cord levels L4/L5 corresponding to
Frontiers in Behavioral Neuroscience | www.frontiersin.org 4 May 2017 | Volume 11 | Article 70
Le Coz et al. Chronic Stress and Neuropathic Pain
FIGURE 2 | Effect of ongoing social stress (OSS) and chronic constriction injury (CCI) on thermal pain sensitivity measured with the cold plate test
and on mechanical allodynia/hyperalgesia. (A) The number of right paw lifts (ipsilateral to constriction injury) per 3 min is expressed as mean ± SEM per group
per day. In the 28 days preceding the CCI surgery, no paw lifts were observed in the four groups (n = 12 per group): CON (no manipulation, white triangles), OSS
(exposed to ongoing social stress, light gray triangles), CCI (subjected to constriction injury, dark gray squares) and OSS+CCI (constriction injury under social stress
conditions, black circles). After CCI surgery at day 28, cold hypersensitivity developed in the CCI and OSS+CCI groups with CCI being more sensitive in the first days
and less sensitive after 49 days post-surgery than OSS+CCI. (B) Paw withdrawal response was measured by the Von Frey test. The CON and OSS groups did not
display any differences in pain sensitivity compared to baseline during the entire experiment. The CCI and OSS+CCI rats demonstrated an important increase of pain
sensitivity following the CCI surgery but no differences were observed between these two groups at any time point. Data are shown as mean ± SEM per group per
day. # represents a significant difference between the CCI and the OSS+CCI group for the individual time point (##p < 0.01, ###p < 0.001). Asterisks indicate a
significant difference between the CCI or OSS+CCI group and the OSS as well as the CON group (∗∗∗p < 0.001).
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TABLE 3 | Von Frey thresholds—data presented as % of baseline for each group.
Group/Days 0 7 14 21 27 32 35 38 42 49
CON 98.6 ± 1.8 101.7 ± 2.9 95.6 ± 2.5 101.4 ± 2.4 95.8 ± 3.8 99.2 ± 3.7 96.2 ± 3.4 102.8 ± 6.8 100.9 ± 5.0 102.9 ± 5.0
OSS 101.8 ± 2.0 100.6 ± 2.2 103.1 ± 4.9 100.5 ± 2.7 106.1 ± 4.4 100.2 ± 3.1 103.4 ± 3.5 98.3 ± 3.1 97.5 ± 3.3 107.6 ± 4.8
CCI 96.3 ± 2.7 101.3 ± 1.4 98.9 ± 3.0 104.3 ± 2.5 103.3 ± 2.5 19.4 ± 3.0 16.5 ± 1.5 15.4 ± 1.2 21.1 ± 4.1 19.3 ± 2.1
OSS+CCI 100.5 ± 3.0 100.2 ± 5.2 95.4 ± 3.8 99.9 ± 3.4 104.2 ± 3.7 28.8 ± 9.8 17.4 ± 1.6 17.2 ± 2.1 19.3 ± 1.6 17.7 ± 2.1
FIGURE 3 | Influence of social stress and CCI on the mRNA expression
of markers for the activation of astrocytes (GFAP) and microglia (Iba1)
in the ipsilateral spinal cord levels L4/L5 at day 49. Data are expressed
as relative expression level (fold) of CON (control group = 1, white column) and
are shown as mean ± SD (n = 6 per group). Left: GFAP mRNA expression
was increased only in the groups subjected to chronic social stress: OSS (light
gray column) and OSS+CCI (constriction injury under social stress conditions,
black column), but not in the group that solely underwent CCI (dark gray
column). Right: Iba1 mRNA expression was increased in the group subjected
to constriction injury (CCI) and in the OSS+CCI group where stress enhanced
the effect of the constriction injury. No effect was noticeable in the stress
group OSS. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
the side of CCI surgery. For all mRNA expression experiments,
the ipsilateral spinal cord of the CON group served as control
(relative expression level = 1) and the expression levels of the
three treatment groups were expressed as fold of CON. For
statistical analysis, we compared the expression levels of the
experimental groups OSS, CCI and OSS+CCI to CON and the
obtained p-values are given together with the respective means.
Regarding the activation of astrocytes, there was a significant
upregulation in the OSS group (1.49 ± 0.39; p = 0.050), a
small but not significant increase in the CCI rats (1.35 ± 0.28;
p = 0.237) and an even more distinct increase in the
OSS+CCI animals (1.66 ± 0.12; p = 0.006). These data exhibit
an amplification of CCI-mediated astrocyte activation under
conditions of OSS.
In the case of microglial activation we observed a different
pattern. The stress protocol alone did not impact the spinal
Iba1 mRNA expression (1.3 ± 0.21; p = 0.434) while CCI led
to a significant activation of microglia (1.66 ± 0.41; p = 0.008).
CCI injury under conditions of stress in the OSS+CCI group,
however, amplified the mRNA expression of the microglial
marker (2.20 ± 0.25; p < 0.001). Statistical analysis revealed also
significant differences between OSS and OSS+CCI (p< 0.001) as
well as between CCI and OSS+CCI (p = 0.03).
Spinal mRNA Expression of the
Pro-Inflammatory Cytokines IL-1β and IL-6
Following CCI and Chronic Social Stress
In this experiment, we observed a slight, but not significant
increase in the spinal mRNA expression of IL-1β in the stress
(1.81 ± 0.42; p = 0.068) and CCI (1.47 ± 0.58; p = 0.503)
groups (Figure 4). The combination of CCI and OSS however
ended up with a pronounced and highly significant upregulation
of this pro-inflammatory cytokine (3.47 ± 0.45; p < 0.001).
Furthermore there was a statistically significant increase of IL-1β
mRNA in the OSS+CCI group as compared to OSS (p < 0.001)
and CCI (p< 0.001).
Regarding IL-6, we did not find any impact of the
chronic social stress paradigm on the spinal mRNA expression
(0.97 ± 0.25; p = 1.00; Figure 4). In contrast, the expression
was highly upregulated following CCI surgery (8.63 ± 3.42;
p < 0.001). Combination of constriction injury with social
stress did not further enhance the expression level (7.26 ± 3.45;
p = 0.003). Additionally, we found statistically significant
differences between OSS and CCI (p < 0.001) as well as between
OSS and OSS+CCI (p = 0.002) but not for CCI vs. OSS+CCI
(p = 0.82).
FIGURE 4 | mRNA expression of the pro-inflammatory cytokines IL-1β
and IL-6 in the ipsilateral spinal cord segment L4/L5 following the
chronic social stress protocol (OSS, light gray column), CCI (dark gray
column) or the combination of both models (OSS+CCI, black column)
at day 49. Data are expressed as relative expression level (fold) of CON
(control group = 1, white column) and are shown as mean ± SD (n = 6 per
group). Left: IL-1β mRNA expression was significantly enhanced only in the
OSS+CCI animals. Right: IL-6 mRNA expression was greatly increased in
animals that underwent nerve injury (CCI and OSS+CCI). Social stress alone
(OSS) and in combination with CCI (OSS+CCI) had no (additional) effect on
the relative expression level of IL-6. ∗∗p < 0.01, ∗∗∗p < 0.001.
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Effect of CCI and Chronic Social Stress on
the mRNA Expression of the Neurotrophic
Factors GDNF and NGF
Chronic social stress during adolescence/early adulthood slightly
but not significantly increased the spinal expression level of
GDNF mRNA (1.42 ± 0.29; p = 0.139; Figure 5), whereas CCI
surgery significantly decreased the mRNA level (0.58 ± 0.21;
p < 0.001). The stress component in the OSS+CCI group greatly
outweighed the decreasing effect of the constriction injury and
finally led to a two-fold increase (2.06 ± 0.32; p < 0.001)
in the mRNA expression level of GDNF. Statistical analysis
also unravelled significant differences between OSS and CCI
(p < 0.001), OSS and OSS+CCI (p = 0.004), as well as between
CCI and OSS+CCI (p< 0.001).
The expression of spinal NGF mRNA was unaffected by the
chronic social stress procedure (1.30 ± 0.32; p = 0.515) and by
the CCI surgery (0.91 ± 0.11; p = 0.967; Figure 5). However,
the combination of both manipulations resulted in a significant
upregulation of the NGF mRNA (1.85 ± 0.45; p = 0.004).
The expression level was also significantly different from OSS
(p = 0.044) and CCI (p< 0.001).
Implication of the Glutamatergic System in
CCI and Chronic Social Stress
Mechanisms
To investigate the involvement of the glutamatergic system in
the development and maintenance of neuropathic pain and
FIGURE 5 | Effect of chronic social stress and nerve injury on the
mRNA expression of the neurotrophic factors glial cell line-derived
neurotrophic factor (GDNF) and nerve growth factor (NGF) in the
ipsilateral spinal cord level L4/L5 at day 49. Data are expressed as relative
expression level (fold) of CON (control group = 1, white column) and are
shown as mean ± SD (n = 6 per group). Left: GDNF mRNA expression was
slightly but not significantly increased in the group subjected to OSS (light gray
column) and significantly downregulated after nerve injury (CCI, dark gray
column). However, after CCI under conditions of social stress (OSS+CCI,
black column) the relative expression levels of GDNF mRNA were significantly
upregulated. Right: NGF mRNA expression did neither change after exposure
to chronic social stress (OSS) nor following CCI surgery (CCI). Nerve injury
under chronic social stress (OSS+CCI) did however lead to a significant
upregulation of NGF mRNA expression. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
in the processing of chronic social stress, we measured the
mRNA expression of NR1 and NR2a, two common subunits
of the NMDA receptor and of EAAT3, a glial transporter of
glutamate.
The spinal NR1 mRNA expression was slightly, but not
significantly decreased in the OSS group (0.73 ± 0.14;
p = 0.243; Figure 6A). The CCI surgery alone had no effect on
NR1 expression levels (1.11 ± 0.31; p = 0.908) but induction
of neuropathy under stress conditions caused a significant
downregulation of NR1 mRNA transcription (0.54 ± 0.10;
p = 0.020) exceeding the decrease related to stress alone.
This reduction in the OSS+CCI group turned out to be also
statistically significant compared to CCI (p = 0.002). Although
the expression level in the OSS group was not significantly
different from the CON, it differed from the CCI group
(p = 0.039).
Regarding the NR2a subunit of the NMDA receptor, we did
not find any significant alteration in the mRNA expression,
although a small decrease was apparent for the OSS+CCI group.
OSS significantly downregulated the spinal mRNA expression
of EAAT3 (0.64± 0.21; p = 0.046; Figure 6B). On the other hand,
neuropathy had no impact on the regulation of this transporter
(0.93 ± 0.13; p = 0.954). In the OSS+CCI group the impact of
the social stress predominated and led likewise to a significant
downregulation of EAAT3 mRNA in the ipsilateral spinal cord
level L4/L5 (0.62 ± 0.21; p = 0.033). Glutamate might hence
have accumulated in the synaptic cleft, reinforcing synaptic
transmission.
DISCUSSION
In the present study the major finding resulting from the
combination of preclinical models of neuropathic pain and
psychosocial stress was a switch in cold pain sensitivity from
initially dampened to exacerbated allodynia. For mechanical
sensitivity no differences were observed between stressed and
non-stressed neuropathic rats. Biochemical results revealed an
activation of astrocytes in a stress condition but also of microglia
under conditions of combined stress and neuropathic pain,
a differential regulation of pro-inflammatory cytokine mRNA,
IL-1β being more prone to the combination of stress and
neuropathy while the expression of IL-6 was mainly enhanced
in neuropathic conditions, a synergistic effect of stress and
neuropathy regarding the expression of neurotrophic factor
mRNA, and finally a decrease of the transporter EAAT3 and
NMDA receptor subunit NR1 in the stress group and in
the group exposed to both stress and chronic constriction
injury.
Selection of the Chronic Social Stress
Model
As mentioned in the introduction, our goal was to focus on the
impact of psychosocial stress on neuropathic pain sensitivity.
While some studies using psychological stressors observed an
enhancement of pain sensitivity (Rivat et al., 2007; Burke et al.,
2013), others failed to identify similar effects (Bravo et al.,
2012, 2013). These divergent findings may partly be related
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FIGURE 6 | Modifications of the glutamatergic system following a
chronic social stress protocol and/or CCI surgery. The mRNA expression
of the two NMDA receptor subunits NR1 and NR2a and the glial glutamate
transporter EAAT3 were measured in the ipsilateral spinal cord segment
L4/L5 following either chronic social stress (OSS, light gray column), or CCI
(dark gray column), or the combination of both conditions (OSS+CCI, black
column), at day 49. Data are expressed as relative expression level (fold) of
CON (control group = 1, white column) and are shown as mean ± SD
(n = 6 per group). (A) The NR1 mRNA expression was slightly decreased by
social stress (OSS), not affected by the CCI surgery (CCI), but significantly
downregulated after nerve injury under stress conditions (OSS+CCI). The
relative expression level of NR2a did not significantly change in the three
experimental groups, although a small decrease could be observed for the
OSS+CCI group. (B) The EAAT3 mRNA expression was significantly
downregulated in the two groups subjected to chronic social stress: OSS and
OSS+CCI. CCI alone had no effect on the relative expression level of the glial
glutamate transporter. ∗p < 0.05, ∗∗p < 0.01.
to methodological differences with respect to the approaches
chosen for stress induction.
In the present study, we did therefore aim at using a
rodent model that would as closely as possible match ongoing
psychosocial stress situations that humans are commonly
exposed to. The model we chose was introduced in mice
by Schmidt et al. (2007) and derived from a model initially
developed in rats by Mormède et al. (1990). Briefly, the group
composition of male rat cage mates was changed in regular
intervals starting at the age of 4 weeks until the end of the
experimental protocol at 11 weeks. The stress hence started
during the adolescence period, meaning in puberty, a period
of life that is highly adaptive and during which substantial
remodeling occurs in areas involved in emotional and learning
processes (Tsoory et al., 2007). Furthermore, this period is
also of much importance regarding social interaction and
acquisition of social skills that will induce stability in adulthood
(Sachser et al., 1998). Hence stressing the animals in this
precise period when the behavior and neuroendocrine system
are fine-tuned can have important repercussions in adulthood.
Finally, contrary to many stress models used in the literature,
this ongoing social stress is continuous (most of the stressors are
only applied during some time of the day), inescapable for the
animal, applicable to a large number of animals in order to have
an adequate rotation schedule and less offensive than most other
models such as social defeat or chronic unpredictable stress.
In order to have objective markers of the impact of stress we
measured plasmatic corticosterone levels once a week during all
the experiment. However we were not able to demonstrate any
statistical differences between the groups (data not shown). This
is in accordance with several studies (Norman et al., 2010b; Shi
et al., 2010) and can be explained by an adaptation of the HPA
axis over time. Regarding the body weight of the animals also, it is
known that chronic stress can induce a reduction (Shi et al., 2010;
Bravo et al., 2012). We did however not observe any differences
between the four groups. In this respect Schmidt et al. (2007)
have claimed that the animals have a different weight regulation
during the adolescent period where the stress paradigm has been
started and that during this period the regulation of growth is
less influenced by environmental factors. In addition adolescent
animals might compensate more easily for weight loss than adult
animals.
Finally, we only used male rats. It is however established that
sex can have an influence on pain sensitivity (for review, see
Mogil, 2012) but also on stress impact (Burke et al., 2013).We did
not observe any stress model-related differences in mechanical
sensitivity for the male rats we used, in accordance with Burke
et al. (2013) who did however observe a reduction in mechanical
pain threshold and a sensitization of the contralateral paw in
female Wistar rats. These findings point to the importance of
considering sex-related effects.
Development and Maintenance of Cold
and Mechanical Hypersensitivity
Regarding the assessment of pain sensitivity, the cold plate
test has been shown to reliably reveal cold hypersensitivity,
a characteristic of CCI-induced neuropathic pain (Berrocoso
et al., 2011). We chose this paradigm because exacerbated cold
sensitivity is more often observed than heat hypersensitivity in
clinical neuropathic conditions (Attal et al., 2008). The test was
performed regularly from the beginning of the stress protocol
(day 0) to 21 days after the eventual CCI surgery (day 49). Before
CCI, no paw lifting was observed for any group, confirming that
we observed neuropathy-related allodynia. CCI and OSS+CCI
rats started to display cold plate related pain behavior a few days
post-surgery, with the stress seeming to have a protective effect
in the OSS+CCI group as compared to the CCI group.
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Acute and chronic stressors may differentially affect pain.
Under acute conditions, ‘‘stress-induced analgesia’’ (SIA) is
commonly observed (for review, see Amit and Galina, 1998)
while chronic stress may more regularly be accompanied by
hyperalgesic states (Suarez-Roca et al., 2006; Jennings et al.,
2014). Our results from days 32 and 35 could reflect SIA.
At day 38, the two groups had equivalent sensitivities when
finally, at day 49, we observed a switch, the OSS+CCI rats
displaying a hypersensitivity to cold as compared to the CCI
group. This phase could correspond to the SIH phenomenon that
to our knowledge has not yet been described for neuropathic
pain conditions. While these results may seem contradictory
to observations by Aghajani et al. (2012) who did not detect
any impact of a social instability model on chronic pain
in mice, other studies using cold stress (Imbe et al., 2006)
or social defeat (Marcinkiewcz et al., 2009) demonstrated
increased nociceptive responses. Other stress paradigms such
as repeated swim stress (Suarez-Roca et al., 2006; Quintero
et al., 2011) or chronic restraint stress (da Silva Torres et al.,
2003; Bardin et al., 2009) also ended up with a long lasting
hyperalgesia. It should however be kept in mind that these
physical stressors may not match our conditions of ongoing
social stress. Ultimately, the described reversion in behavioral
sensitivity came quite as a surprise to us at this time point and
experiments using a longer observation period than the initially
scheduled 49 days are required to confirm the significance of this
effect.
Concerning our failure to identify differences in mechanical
sensitivity between CCI and OSS+CCI groups, it is interesting
to note that Bardin et al. (2009) as well as Bravo et al.
(2012, 2013) reported similar findings in a model of chronic
mild stress and in a model of social isolation. Whereas the
temperature of the cold plate test (5◦C) used in the present
study quite selectively stimulates cold nociceptors of the C-fiber
type (Simone and Kajander, 1996), the von Frey filaments
may activate a larger range of nociceptors belonging both
to the C- and A-delta fiber categories (Martin et al., 1997).
In the framework of the present study, it could hence be
speculated that the ongoing psychosocial stress primarily affected
the processing of C-fiber rather than A-delta fiber mediated
nociceptive processing. In line with this reasoning, there is
evidence for an interaction of stress hormones with nociceptive
C fibers (Chen and Levine, 2005). Selective pharmacological
inhibition of C- but not A-delta fiber-mediated nociception
has recently been described by You et al. (2009). Alternatively,
stress-mediated effects may have depended on factors like
stimulus modality, sensory transduction, stimulation surface and
duration. It should also be noted that for both stimulation
modalities we did not observe any neuropathic pain-related
effects at the contralateral paw, findings that are congruent with
earlier studies (Pitcher and Henry, 2004; Benbouzid et al., 2008;
Zeng et al., 2008).
Glial Cell Activation and Pro-Inflammatory
Cytokine Expression
Regarding astrocytes and microglia, we observed different
patterns of activation pointing to distinct roles in the
mediation of pain and stress signals. In agreement with
previous investigators (Lambert et al., 2000), we noticed a
stress-related enhancement of GFAP mRNA expression. This
expression was similar in the OSS+CCI group, indicating
that astrocyte activation might primarily have depended
on stress- rather than on neuropathy-related mechanisms.
While the CCI group displayed an activation of microglia,
the greatest increase in mRNA expression was observed for
OSS+CCI. The finding that microglial activation is usually
accompanied by a behavioral hypersensitivity (Watkins
et al., 2001; Zhuo et al., 2011) is in accordance with the
OSS+CCI group expressing more pronounced cold hyperalgesia
at day 49.
Microglial and astrocytic activation induces the release of
pro-inflammatory cytokines (for review, see Watkins et al.,
2001). This is in agreement with the enhanced expression of
IL-1β mRNA noticed in the OSS+CCI group. In addition,
psychosocial stress-related microglia activation has previously
been observed in different brain areas such as the hippocampus,
amygdala and prefrontal cortex, leading to the production of
IL-1β (Wohleb et al., 2011; Hinwood et al., 2012). Also, in a
model of isolation stress combined with a model of cardiac
arrest surgery (Norman et al., 2010b), and under conditions of
maternal deprivation combined with spinal nerve ligation (SNL)
neuropathy model (Burke et al., 2013), mRNA for Il-1β was
shown to be upregulated in the hippocampus. The expression
of IL-6 mRNA was significantly increased to a similar extent
in the CCI and OSS+CCI groups and thus seemed to be
selectively implicated in inflammatory processes inherent to
CCI-related neuropathic pain. Our finding is in accordance
with hippocampus-related data from Burke et al. (2013) but
contradictory to previous results describing a stress-mediated
release of this cytokine in mice (Norman et al., 2010a; Aghajani
et al., 2012). This could be due to the use of different stress
paradigms or to species differences. The fact that in our
hands IL-1β mRNA expression was most pronounced in the
OSS+CCI rats may point to a combined induction by stress- and
pain-related mechanisms.
Implication of Neurotrophic Factors
Our major observation concerning the spinal mRNA expression
pattern of NGF and GDNF was that stress led to enhanced
levels, while a diminished expression was exhibited by the CCI
group. In the OSS+CCI rats, the respective expression changed
into the same direction as for the stress group, albeit to a more
pronounced extent.
GDNF is involved in cell survival, differentiation and
migration. Its serum level is reduced in patients with major
depression (Miller, 2011) and decreased in the dorsal root ganglia
(DRG) after nerve injury (Nagano et al., 2003). It has also been
demonstrated that GDNF has a beneficial effect on neuropathic
pain. A continuous administration ameliorated pain responses
and suppressed pain behavior following SNL or CCI (Boucher
et al., 2000; Nagano et al., 2003; Chou et al., 2014). These data
are in accordance with our observations in the CCI group. The
most important increase noticed in the OSS+CCI group at day
49, when the respective animals were hypersensitive to the cold
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plate, seems to indicate that GDNF could have an additional
stress-related function that could be more pronounced than the
neuropathy-related effects per se. In addition, an increase in
GDNF could result from the activation of astrocytes (Bian et al.,
2012). This observation could corroborate our data, the GFAP
marker mRNA displaying the same pattern of expression as
GDNF.
Regarding NGF, controversial findings have been described.
While some studies demonstrated a stress-related decrease of
NGF mRNA expression in DRG or hippocampus (Nagano et al.,
2003; Alfonso et al., 2004), others revealed an increase under
such conditions (for review, see Miller, 2011). On the other
hand, NGF has been shown to be a major contributor to
the production of inflammatory hyperalgesia and maintenance
of neuropathic pain (Matsuura et al., 2013). An increased
expression has been observed in a CCI model of neuropathic
pain (Nagano et al., 2003; Santos et al., 2012) and a single
injection of NGF has been shown to induce hyperalgesia (Lewin
et al., 1993). In the present study we observed almost no
change in the mRNA expression of NGF in the CCI group.
We did however find an increase in the OSS group that
was even more pronounced in the OSS+CCI group. In our
setting, NGF could hence have been more implicated in stress
mechanisms than in pain processing itself. The fact that we
observed comparable bilateral patterns of mRNA expression
for GDNF and NGF (data not shown) seems to support this
hypothesis.
Since it has also been shown that the pro-nociceptive effect
of NGF is blocked by MK-801, an NMDA receptor antagonist
(Herzberg et al., 1997), we investigated the implication of
glutamatergic transmission via the mRNA expression of a
glutamate transporter and two subunits of the NMDA receptor.
Involvement of the Glutamatergic System
Regarding the glutamate transporter EAAT3 and the
NR1 subunit of the NMDA receptor, comparable patterns
of mRNA expression, namely a downregulation, were noticed in
the OSS and OSS+CCI groups.
It has been shown that the glutamatergic system has a
predominant implication in the relationship between the HPA
axis, activated by stress mechanisms, and neuropathic pain (Le
Coz et al., 2014a). The NMDA receptor may be implicated
both in neuropathic pain and in stress mechanisms (Gould
and Tanapat, 1999). Repeated cold stress leads to an enhanced
sensitivity of the NMDA receptor and to a facilitation of
glutamate release in the spinal cord and hippocampus (Imbe
et al., 2006; Quintero et al., 2011). This is also true in conditions
of neuropathic pain (Wang et al., 2005). We did however observe
the opposite effect for OSS and no change for CCI. Since
the mRNA expression of NR1 was even more decreased in
the OSS+CCI rats, the stress-related mechanisms might have
overruled the nociception-related ones.
To our knowledge, there are no published data on transporter
expression in a context of psychosocial chronic stress. Our
observations seem to indicate a more important impact of the
chronic social stress than of the CCI procedure on the spinal
expression of EAAT3 mRNA. One study showed that a repeated
restraint stress enhanced glutamate release and uptake (Imbe
et al., 2006). This increase can be interpreted as an augmentation
in the expression of transporters, but in the present study
we observed the opposite effect regarding EAAT3. Gosselin
et al. (2010) also observed a decrease in glutamate transporter
(EAAT1) in the spinal astrocytes of rats undergoing maternal
separation. These discrepancies may be related to the use of
different stress paradigms.
As previously described, a link is possible between the
neurotrophic factor NGF and the NMDA receptor. An activation
of NMDA receptors will induce an increase of NGF expression
(Herzberg et al., 1997). In the OSS+CCI group we did however
observe an increase of the NGFmRNA expression and a decrease
of the NR1 subunit of the NMDA receptor. Also, we did not
detect any differences regarding the mRNA expression of the
NR2a subunit of the NMDA receptor. These discrepancies may
be due to the stress and pain models used in the present study.
Other subunits that could be involved should be considered in
further investigations.
Concluding Remarks
Our exploratory study confirms that exposure to long lasting
social stress starting during adolescence may enhance
neuropathic pain-related cold sensitivity in adulthood. At
the level of the spinal cord, the combination of psychosocial
stress and neuropathic pain may have an important incidence
on glial cell activation, on the release of pro-inflammatory
cytokines and of neurotrophic factors and to a lesser extent
on glutamatergic transmission. Further studies will have
to include protein level measurements. For correlative
purposes, the observation period should be extended and
the measurements of biochemical markers should include
earlier time points preceding and including the observed
switch of pain sensitivity. The potential role of ongoing stress
on descending pain control pathways will also have to be
considered.
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